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CHAPTER I 
 
INTRODUCTION 
 
 The neural crest (NC) is a multipotent, migratory progenitor population that 
is unique to vertebrates. During development of the embryo, NC cells generate a 
diverse array of cell types including neurons and glia of the peripheral nervous 
system (PNS), bones and cartilage of the face and neck, melanocytes of the skin 
and inner ear, and smooth muscle of the great vessels and outflow tract (OFT) of 
the heart (Le Douarin and Kalcheim, 1999). Because of their inherent 
multipotency and tremendous contribution to the embryo, the NC is sometimes 
referred to as the fourth germ layer (Gilbert, 1991; Hall, 2000). NC progenitors 
employ many of the cellular mechanisms critical for embryogenesis including 
tissue induction, migration, multipotency, self-renewal, cell fate specification and 
differentiation, and thus represent an important model system to investigate the 
molecular mechanisms that control these developmental events. Further, NC 
defects underlie a variety of human congenital disorders, termed 
neurocristopathies (Bolande, 1997), highlighting the direct clinical relevance of 
the study of NC development.  
 
Formation of Neural Crest Progenitors 
 First identified by the Swiss embryologist Wilhelm His in 1868, the NC was 
originally termed “zwischenstrang” meaning the intermediate cord, due to its 
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position between the developing neural tube and epidermis (His, 1868). It was 
renamed “neural crest” by Arthur Milnes Marshall soon thereafter to more 
accurately reflect the position of cells at the “crest” of the neural folds (Marshall, 
1879). During neurulation, as the borders of the neural folds converge at the 
dorsal midline to form the neural tube, cells that generate the NC are located at 
the junction of the neural plate and the non-neural ectoderm (see drawing in 
Figure 1A).   
 In response to morphogen-derived signals from the non-neural ectoderm 
and underlying mesoderm, including members of the Wingless-Int (Wnt), bone 
morphogenetic protein (BMP) and fibroblast growth factor (FGF) signaling 
pathways, the neural plate border begins to express a distinct set of transcription 
factors (termed neural plate border specifiers) that uniquely define this region 
(reviewed in Sauka-Spengler and Bronner-Fraser, 2008; Nelms and Labosky, 
2010). These genes include Msx1, Pax3, Pax7 and Zic1, among others, and 
together their expression confers competency of these cells to form either NC 
progenitors or ectodermally-derived placodal cells (Selleck and Bronner-Fraser, 
1995). NC induction was previously thought to occur as a consequence of the 
juxtaposition of the neural plate and the non-neural ectoderm (Selleck and 
Bronner-Fraser, 1995; Mancilla and Mayor, 1996) and intermediate levels of 
BMP signals (Marchant et al., 1998). However, recent studies in both frog and 
chick suggest that NC induction is initiated at earlier stages, during gastrulation 
(Monsoro-Burq et al., 2005; Basch et al., 2006). A two-step induction process 
has been suggested in which NC induction is first dependent upon Wnt activation 
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and BMP inhibition, and subsequently, at neurulation, activation of both pathways 
(Steventon et al., 2009).  
 The combined activity of these signals at the neural plate border results in 
expression of another set of transcription factors, termed NC specifier genes 
(Figure 1B), including Foxd3, Snail, Snail2/Slug, AP2α, and the SoxE family 
members Sox8, Sox9, and Sox10 (Sauka-Spengler and Bronner-Fraser, 2008; 
Nelms and Labosky, 2010). These NC specifier genes orchestrate a complex 
gene regulatory network that functions to alter the adherence, motility, and cell 
fate potentials that definitively specify NC identity. Subsequently, NC cells 
undergo an epithelial to mesenchymal transition (EMT), emigrate from the dorsal 
aspect of the neural tube and then migrate throughout the embryo (Figure 1C). 
Both gain and loss of function experiments demonstrated that the NC specifier 
gene regulatory network contains complex feedback mechanisms in which these 
transcription factors reinforce each other’s expression. For example, Sox10 
expression is maintained, in part, by the combined actions of Pax3, AP2α, Sox9, 
and Sox10 itself at a conserved Sox10 regulatory region (Werner et al., 2007). 
Though there is some evidence from experiments in Xenopus that AP2α 
regulates initial expression of Snail2/Slug and Sox9, and may be the first NC 
specifier gene expressed (Luo et al., 2003), the direct regulatory mechanisms 
that establish and maintain this important gene network remain elusive. Further 
analysis is required to identify transcriptional regulation at genomic promoter and 
enhancer elements for NC specifier genes.  
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Figure 1.  Formation of NC progenitors.  (A) NC induction initiates at the 
neural plate border (green), at the junction of the neural plate (light blue) and 
non-neural ectoderm (dark blue). Morphogen signals from the surrounding 
mesoderm (pink) and non-neural ectoderm, including Wnt, FGF, and 
intermediate levels of BMP induce expression of the neural plate border specifier 
genes Pax3, Pax7, Zic1 and Msx1. (B) Neural plate border genes act 
synergistically with Wnt and BMP signals to induce expression of NC specifiers 
transcription factors including Snail, Slug, AP2a, SoxE proteins, and Foxd3. (C) 
After specification, NC progenitors undergo EMT, delaminate from the dorsal 
aspect of the neural tube and migrate throughout the embryo. Figure redrawn 
after (Selleck et al., 1993; Gammill and Bronner-Fraser, 2003). 
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 While NC specifier genes undoubtedly function early within the NC 
lineage, they also may have continuing and diverse roles in NC development, 
including regulation of cell migration, self-renewal and NC potency. The 
expression of some NC specifier genes, including Foxd3 and Sox10, is 
maintained in at least a subpopulation of NC cells as they migrate and 
differentiate (Kuhlbrodt et al., 1998; Labosky and Kaestner, 1998; Britsch et al., 
2001; Dottori et al., 2001), whereas others, such as Snail2/Slug, are only 
transiently expressed during EMT (Nieto et al., 1994). Additionally, both Sox9 
and Sox2 show biphasic expression in which they are expressed in the neural 
tube, downregulated during EMT, and expression is re-initiated later in distinct 
NC lineages as they differentiate (Lefebvre et al., 1997; Spokony et al., 2002; 
Wakamatsu et al., 2004). 
 
Migration and Fate of Neural Crest Progenitors 
 In order to emigrate from the surrounding neuroepithelium, newly specified 
NC cells must activate genes involved in EMT and cell migration. Similar to 
neurulation and NC specification, EMT and emigration of NC is first initiated in 
the anterior of the embryo and proceeds posteriorly through the trunk during 
progressive stages of development. During this process, NC cells undergo 
cytoskeletal rearrangement and changes in their adhesion properties, including 
increased expression of β1 Integrin and a switch from expression of type I 
cadherins, such as E-cadherin and N-Cadherin, to more migration permissive 
type II cadherins that promote delamination from the neural tube (Pla et al., 
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2001). Both Snail1 and Snail2/Slug have well established roles in EMT and 
regulation of cell adhesion (reviewed in Thiery and Sleeman, 2006). However, 
the involvement of other NC specifier genes during EMT and migration is less 
clear. Consistent with a role for other NC specifier genes in EMT and migration, 
overexpression of Sox10 within the neural tube promoted migration of NC by 
inhibition of N-Cadherin and induction of β1 integrin expression (Cheung et al., 
2005). In a similar manner, overexpression of Foxd3 in chick resulted in loss of 
N-Cadherin and promoted expression of β1 integrin and Cadherin 7, presumably 
promoting NC emigration (Dottori et al., 2001; Kos et al., 2001; Cheung et al., 
2005). Given the complex genetic interactions of NC specifier genes, more 
information is needed to determine direct gene regulation involved in the EMT 
and early migratory events of NC.  
 A unique feature of migrating NC is their ability to undergo “collective 
migration”, forming chains of cells that maintain gap junctions and extensive cell-
cell communication (Lo et al., 1997). In response to both intrinsic cues and 
signals within the local environment, emigrating NC cells coalesce to form 
discrete NC cell migratory streams. During this process, NC cells utilize both 
repulsive and attractive environmental factors as migratory guidance cues 
including Ephrins, Semaphorins and chemokines. The most extensively studied 
of these guidance cues are the Ephrins, which serve as ligands for the Eph 
family of receptor tyrosine kinases (Smith et al., 1997; Mellott and Burke, 2008).  
Experiments in chick, Xenopus and mice have demonstrated that Eph/Ephrin 
signaling is important for repulsion of NC from adjacent tissues and maintenance 
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of NC migratory streams, though specific gene function of individual family 
members is poorly conserved among species (reviewed in Kulesa et al., 2010). 
In addition to Eph/Ephrin mediated repulsive signals, NC migration is also 
controlled by Semaphorins, the best characterized of which are Sema3A and 
Sema3F. Semaphorin signaling occurs through activation of Neuropilin and 
Plexin cell surface co-receptors, which are expressed in migrating NC (Brown et 
al., 2001; Gammill et al., 2006; Toyofuku et al., 2008). Proper patterning and 
migration of NC through the anterior region of the somites is mediated by 
Sema3A expression in the intersomitic space and subsequent repulsion of NC 
into the somites (Eickholt et al., 1999; Roffers-Agarwal and Gammill, 2009). The 
migratory stream of NC is further refined by the combined repulsive action of 
Sema3F, expressed in the posterior half of the somites (Gammill et al., 2006), 
and attraction of NC cells into a ventral pathway beyond the somites by the 
chemokine CXCL12 and its receptor in NC, CXCR4 (Belmadani et al., 2005). 
This elegant example of directed cell guidance provides just a glimpse of the 
complexities and levels of regulation involved in NC migration to target tissues. 
 As they migrate, NC cells follow precise and defined pathways 
characteristic of their axial level of origin. The chick-quail chimera system and 
fate-mapping studies in chick and mouse have been instrumental in identification 
of distinct NC populations, migratory patterns and ultimate location of NC-derived 
cells in the embryo (Le Douarin and Teillet, 1973; Le Douarin and Kalcheim, 
1999; Chai et al., 2000; Jiang et al., 2000). Consequently, the NC can be 
subdivided into at least five overlapping but functionally distinct heterogeneous 
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axial populations: cranial, cardiac, vagal, trunk, and sacral (see drawing in Figure 
2A). Each population contributes to specific cell and tissue types for every axial 
level (Le Douarin and Kalcheim, 1999). Here, a basic introduction to these axial 
populations of NC is provided. 
 
Cranial neural crest 
 While NC cells from all populations form neurons, glia and melanocytes, a 
defining property of cranial NC is their generation of both cartilage and bone 
derivatives in vivo. The cranial NC arises in the neural folds anterior to the otic 
placode (Figure 2A, orange) and gives rise to osteoblast and chondrocyte 
progenitors (which form the facial skeleton), and the majority of the vascular 
smooth muscle cells (VSMCs) and connective tissues of the head and neck (Le 
Lievre and Le Douarin, 1975; Etchevers et al., 2001). In addition to these 
mesenchymal cell types, cranial NC also generates dorsal-lateral migrating 
melanocytes of the skin, and neurons and glia in cranial sympathetic ganglia (Le 
Douarin and Kalcheim, 1999). This multipotent population of cells migrates into 
the frontonasal process and the first, second, and third pharyngeal arches 
(Figure 2A). After migration, cranial NC-derived ectomesenchyme proliferates 
and, through interactions with the surface ectoderm, mesoderm and endoderm, 
differentiates into pericytes and VSMCs, or initiates either endochondral or 
intramembranous bone formation (Kulesa et al., 2010). During this process, 
mesenchymal NC differentiation is determined by expression of the transcription 
factors Sox9, which specifies an osteo-chondro progenitor fate (Spokony et al., 
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2002; Mori-Akiyama et al., 2003), and Runx2, which promotes differentiation into 
osteoblasts (Komori et al., 1997). Defects in cranial NC migration, proliferation, 
differentiation, and survival are directly associated with craniofacial defects 
including Velocardiofacial Syndrome and Treacher Collins Syndrome (TCS) 
(Cordero et al., 2010; Trainor, 2010). 
 
Cardiac neural crest 
 The heart initially forms as a simple tube derived from bilateral fields of 
mesoderm that fuse at the midline. Through a complex series of morphogenetic 
events that include rightward looping, chamber specification, and valve 
formation, this simple tube becomes a four-chambered heart. During the latter 
stages of this process, the separation of the single cardiac OFT into distinct 
pulmonary and systemic circulatory systems, in addition to morphogenesis of the 
associated great vessels, requires direct contribution by the cardiac NC.  
 Cardiac NC cells emigrate from the neural tube between the level of the 
mid-otic placode and the fourth somite to populate the posterior (third, fourth and 
sixth) pharyngeal arches and the OFT of the developing heart (Le Lievre and Le 
Douarin, 1975; Kirby et al., 1983) (Figure 2A, red). Cardiac NC generates 
mesenchymal cell types, including VSMCs, which are required for remodeling of 
the bilaterally symmetrical pharyngeal arch arteries (PAAs) into a left-sided aortic 
arch with proper branching of the brachiocephalic, carotid and subclavian arteries 
(Le Lievre and Le Douarin, 1975; Bockman et al., 1987). During septation of the 
OFT, NC cells form an aorticopulmonary septation complex that invades the 
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fusing endocardial cushions (Kirby et al., 1983; Jiang et al., 2000). Failure to 
septate the OFT results in persistent truncus arteriosus (PTA), a congenital heart 
defect in which a single vessel provides both systemic and pulmonary circulation 
from the heart. In chick and mouse, ablation of cardiac NC results in a variety of 
cardiovascular defects including PTA, malpositioning of the great vessels, and 
PAA patterning defects that include interruption of the aortic arch and ventricular 
septal defects (Kirby et al., 1983; Bockman et al., 1987; Porras and Brown, 
2008). In humans, the congenital defects associated with Velocardiofacial 
Syndrome and DiGeorge syndrome are consistent with defects in cardiac NC 
function (reviewed in Brown and Baldwin, 2006).  
 In addition to VSMCs, cardiac NC also forms neural derivatives including 
the phrenic nerves that innervate the diaphragm, the parasympathetic cardiac 
ganglia (Kirby and Stewart, 1983), enteric neurons and glia, and melanocytes in 
the skin (Yntema and Hammond, 1954; Le Douarin and Teillet, 1973; Barlow et 
al., 2008). Thus the term "cardiac” NC refers to the unique requirement for this 
population to mediate cardiovascular patterning and does not infer that all cells 
arising within this domain are restricted to a cardiovascular fate. 
 
Vagal neural crest 
 Partially overlapping with the cardiac NC, vagal NC cells arise from the 
level of somites one to seven (Figure 2A, blue), migrate through the developing 
gut and generate the vast majority of the enteric nervous system (ENS) (Yntema 
and Hammond, 1954; Le Douarin and Teillet, 1973). Distinct from other PNS 
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derivatives, the ENS is able to function relatively autonomously to regulate 
gastric motility, enzyme secretion and blood flow in the gastrointestinal (GI) tract. 
After entry into the foregut, vagal NC-derived cells migrate in a rostrocaudal 
wave to colonize the entire length of the GI tract and differentiate into numerous 
neural and glial lineages (Young et al., 1998; Natarajan et al., 1999). While there 
are no known molecular markers distinguishing cardiac NC from vagal NC, this 
axial population of premigratory NC is uniquely required for innervation of the 
digestive tract. Classic heterotypic grafting experiments in chick revealed that 
other axial levels of NC, including cranial, trunk, and sacral were not able to 
generate a complete ENS (Le Douarin and Teillet, 1974; Ziller et al., 1979; Burns 
and Le Douarin, 2001). 
 Hirschsprung’s disease, a disorder characterized by failure of NC 
progenitors to complete migration through the gut and the absence of enteric 
ganglia in a variable portion of the distal hindgut, is associated with defects in 
migration, proliferation, survival and function of neural crest stem cells (NCSCs). 
Members of the GDNF and Endothelin 3 signaling pathways, and Sox10 are 
associated with Hirschsprung’s disease and Shah-Waardenburg syndrome 
(Baynash et al., 1994; Hosoda et al., 1994; Schuchardt et al., 1994; Enomoto et 
al., 1998; Southard-Smith et al., 1998; Barlow et al., 2003). 
 
Trunk neural crest 
 Trunk NC cells arise from the neural tube at levels posterior to somite 
seven (Figure 2A, green) and primarily migrate along at least two independent 
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pathways reflecting the timing of their delamination and their eventual fate (Thiery 
et al., 1982; Erickson, 1985).  Trunk NC cells colonize their target tissues 
sequentially in a ventral to dorsal order to generate diverse lineages including 
sympathetic and sensory neurons and glia of the PNS, chromaffin cells within the 
adrenal gland, and melanocytes in the skin (Le Douarin and Teillet, 1974). The 
earliest emigrating cells preferentially migrate in a segmented manner ventrally to 
form neurons and glia of the sympathetic ganglia, followed by migration to the 
ventral root, and dorsal root ganglia (DRG), respectively. Later emerging trunk 
NC cells migrate along a dorsolateral pathway under the epidermis and generate 
the majority of melanocytes (Bronner-Fraser and Fraser, 1989; Henion and 
Weston, 1997; Krispin et al., 2010). Interestingly, a recent study suggested that 
initially ventrally migrating NC-derived glia contribute to some melanocytes in the 
skin (Adameyko et al., 2009), suggesting that the initial migratory pathway of NC 
does not completely determine its ultimate fate. 
 Thus, trunk NC gives rise to both sensory and sympathetic neurons, glia, 
adrenal chromaffin cells and melanocytes. Normally, trunk NC cells do not 
generate VSMCs, cartilage or bone. However, lineage tracing studies in mouse 
using the Wnt1-Cre and R26R reporter system revealed that trunk NC cells 
generated some mesenchymal derivatives including endoneurial fibroblasts 
within peripheral nerves (Joseph et al., 2004). It is currently unclear if this 
fibroblast cell type is generated by cells initially expressing glial markers, similar 
to nerve-derived melanocytes, or if endoneurial fibroblasts represent a novel 
derivative of mammalian NC.  
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Sacral neural crest 
 Sacral NC, a subpopulation of trunk NC cells, forms part of the neural and 
glial cell populations that constitute the ENS within the distal hindgut (Burns and 
Le Douarin, 1998; Burns et al., 2000). Located posterior to somite 28 in chick (Le 
Douarin and Teillet, 1973) and somite 24 in mouse (Serbedzija et al., 1991), 
sacral NC cells contribute a small number of ENS progenitors that migrate in a 
caudorostral direction in the colon, opposite the direction of vagal NC cells 
(Burns and Le Douarin, 1998; Burns et al., 2000). Although the precise 
contribution of sacral NC to ENS development is somewhat controversial, data 
from chick-quail chimeras and transgenic mouse models suggest a conserved 
contribution of sacral NC progenitors that is primarily limited to the hindgut (Le 
Douarin and Teillet, 1973; Burns and Le Douarin, 1998; Kapur, 2000; 
Druckenbrod and Epstein, 2005). In chick-quail chimeras, sacral NC formed 
~17% of enteric neurons present in the distal colon (Burns and Le Douarin, 
1998), but their contribution in mammals has not been quantified. Prior to their 
entry into the GI tract, sacral NC cells form neurons and glia that innervate the 
kidney, bladder, and lower urogenital tract where they form the pelvic plexus 
ganglia. After formation of pelvic ganglia, sacral NC transiently pause their 
migration and do not begin colonization of the adjacent distal colon until after 
vagal NC-derived cells are present (~13.5-14.5 dpc in mice) (Kapur, 2000; 
Druckenbrod and Epstein, 2005). The signaling cues underlying this complex cell 
migration behavior are not well understood. 
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Figure 2. NC axial populations and derivatives.  (A) NC cells contribute to 
specific cell and tissue types characteristic of their axial level of origin. Cranial 
NC (orange) populates the head and PA 1, 2, and 3 to generate cartilage and 
bone of the facial skeleton and cranial ganglia. Cardiac NC (red) migrates from 
the neural tube between the level of the mid-otic placode and the 4th somite to 
generate VSMCs in PA 3, 4, and 6 and cardiac OFT and parasympathetic 
cardiac ganglia during heart development. Vagal NC (blue), from the level of 
somites 1-7, partially overlaps with cardiac NC, and migrates through the 
developing gut to generate the ENS. Trunk NC (green) emigrates at levels 
posterior to somite 7 to forms sensory and sympathetic ganglia, endoneurial 
fibroblasts within peripheral nerves, epinephrine-producing cells of the adrenal 
gland and melanocyte precursors. Sacral NC (light blue) is a subpopulation of 
trunk NC that arises at levels posterior to somite 24. Sacral NC generates 
neurons and glia in the pelvic ganglia and ENS derivatives in the distal colon. (B) 
Illustration depicting the neural and mesenchymal cell types produced from 
multipotent NCSCs. NCSCs from all axial populations form neurons, glia and 
melanocytes, whereas only cranial and cardiac NC differentiate into VSMCs, 
cartilage or bone in vivo. OP, otic placode; PA, pharyngeal arch; S, somite, SG, 
sympathetic ganglia.  
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Neural Crest Stem Cells 
 As highlighted above, NC cells give rise to diverse cell types throughout 
the embryo, but the precise mechanisms by which NC accomplish this feat is still 
the subject of intense investigation. Two models have been proposed to explain 
the diversity of cell fates generated by NC cells. The first model suggests that all 
NC cells are initially multipotent NCSCs, and subsequent signals in the local 
environment specify progressive cell fate restrictions in migrating NC. The 
second model suggests that NC cell fates are pre-determined prior to NC 
migration from the neural tube and as such, they are a mixture of fate-restricted 
progenitors. It is likely both models are correct and NC is a heterogeneous 
population of multipotent and fate-restricted progenitor cells. NCSCs can be 
isolated from all axial regions and defined functionally as having two features of 
stem cells; 1) self-renewal, the ability generate another stem cell after cell 
division, and 2) multipotency, the ability to give rise to multiple differentiated cell 
types from their progeny (illustration in Figure 2B). Here, I discuss previous 
characterizations of multipotency and self-renewal in NC progenitors (reviewed in  
Crane and Trainor, 2006; Teng and Labosky, 2006; Delfino-Machin et al., 2007) 
and address known mechanisms controlling cell fate specification and self-
renewal in NC. 
 NC multipotency was first identified by in vitro cell culture of avian trunk 
NC (Cohen and Konigsberg, 1975). By culturing individual NC cells derived from 
neural tube explants and observing their clonal expansion and differentiation, it 
was demonstrated that NC cells form colonies containing either melanocytes or 
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neurons, or colonies containing both melanocytes and neurons (Cohen and 
Konigsberg, 1975; Sieber-Blum and Cohen, 1980). Bronner-Fraser and 
colleagues expanded on these findings by demonstrating that injection of 
cultured NC from multipotent colonies into the migratory pathway of a host chick 
embryo resulted in their contribution to multiple NC derivatives (Bronner-Fraser 
et al., 1980), indicating that multipotency of NC is maintained in vivo. Additionally, 
labeling of individual premigratory trunk NC cells with rhodamine-conjugated 
dextran resulted in identification of NC progeny in single and multiple NC-derived 
tissues, including sensory and sympathetic neurons, glia, and adrenal chromafin 
cells (Bronner-Fraser and Fraser, 1988a). These data provided compelling in vivo 
demonstration that at least some trunk NC cells are multipotent and 
substantiated findings of NC multipotency in vitro.  
 Similar to trunk NC, individual cranial and cardiac NC cells also generate 
multiple differentiated cell types. Clonal analysis of either cranial or cardiac NC 
revealed several different colony types, including multipotent colonies containing 
neurons, glia, and melanocytes as well as mesenchymal cell types including 
smooth muscle cells and chondrocytes (Baroffio et al., 1991; Ito and Sieber-
Blum, 1991). Interestingly, only a small proportion of colonies contained all cell 
types, and the majority of colonies contained derivatives of only one or two 
lineages. In these experiments, the presence of NC progenitors restricted to a 
single lineage suggested that prior to migration, NC is a heterogeneous mix of 
cells with different lineage potentials including various restricted progenitor 
populations and a sub-population of multipotent NCSCs. Taken together, these 
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clonal analyses clearly demonstrated that different axial populations contain a 
unique mixture of progenitors. However, little is known about the molecules that 
regulate NC progenitor cell identity, self-renewal and differentiation, and this is a 
subject of my thesis work. 
 Using rat neural tube explants, Stemple and Anderson isolated an 
enriched population of trunk NCSCs by fluorescence activated cell sorting 
(FACS) using an antibody to the low-affinity nerve growth factor receptor (p75) 
(Stemple and Anderson, 1992). In addition to generating neurons, glia, and non-
neural cells, primary NC colonies contained cells that retained the ability to self-
renew in vitro. Serial passages of primary NC colonies revealed that more than 
half of the primary NC colonies generated secondary colonies that contained 
both neurons and glia (Stemple and Anderson, 1992). Thus, p75 can be used to 
prospectively identify a sub-population of NC that is enriched in multipotent and 
self-renewing NCSCs. The functional role of p75 in NCSCs is not currently clear.  
 Clonal culture or in vivo labeling of early migrating NC cells has generally 
supported the view that some individual NC cells are initially multipotent. More 
recent studies revealed that multipotent NCSCs persist throughout development 
into late gestation and even adulthood, well beyond the initial specification and 
migration of the NC. For example, post-migratory NCSCs have been identified in 
the fetal sciatic nerve (Morrison et al., 1999), adult DRG (Li et al., 2007), fetal and 
adult ENS (Kruger et al., 2002), adult heart (Tomita et al., 2005), and fetal and 
adult skin (Toma et al., 2001; Fernandes et al., 2004; Sieber-Blum et al., 2004). 
Interestingly, in comparison with fetal ENS-derived NCSCs, adult ENS NCSCs 
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had reduced self-renewal capacity and more limited differentiation (Kruger et al., 
2002). Furthermore, in ovo transplantation of gut and sciatic nerve derived 
NCSCs suggested that distinct populations of NCSCs have intrinsic differences 
in their migration and ability to generate PNS derivatives (Mosher et al., 2007). 
Despite the temporal and regional differences in post-migratory populations of 
NCSCs, their identification and characterization represent a significant step 
forward towards the possible use of NCSCs for tissue repair or regeneration in 
treatment of disease. 
 
Regulation of Multipotency and Self-Renewal 
 Relatively little is known about the molecular regulation of multipotency 
and self-renewal in NCSCs. Signals that function during specification of NC 
progenitors also instruct NCSC differentiation. For example, Wnt signaling 
promotes differentiation of NC towards a sensory neuron fate (Lee et al., 2004), 
whereas BMP2 signaling induces an autonomic neuron fate in cultured NC (Shah 
et al., 1996). Acting in opposition, transforming growth factor beta (TGFβ) 
signaling promotes smooth muscle differentiation from NCSCs (Shah et al., 
1996; Wurdak et al., 2005). Curiously, the combination of both Wnt and BMP 
signaling does not promote neural differentiation, but instead synergistically 
maintains NCSCs in a multipotent and undifferentiated state, even in the 
presence of normally instructive TGFβ ligands (Lee et al., 2004; Kleber et al., 
2005; Wurdak et al., 2005). The downstream components of this synergistic Wnt 
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and BMP signaling pathway that specifically maintains multipotency of NCSCs 
are currently unknown. 
 Notch signaling, involved in specification of the neural plate border region 
(Glavic et al., 2004), is implicated in the later control of NC fates. The Notch 
pathway plays an instructive role in glial fate determination of NCSCs (Morrison 
et al., 2000b). In vitro, activation of Notch results in an irreversible switch from 
neuron to glial cell fates, such that NCSCs initially cultured in neural-inducing 
conditions and transiently exposed to Notch ligands undergo glial differentiation, 
even if cells are returned to a neuron-inducing environment (Morrison et al., 
2000b). Consistent with its role in specification of glia, Notch signaling is required 
for peripheral glial derivatives of NC in vivo (Wakamatsu et al., 2000; Taylor et 
al., 2007). In addition, Neuregulin 1 (Nrg1) signaling, mediated by its receptor in 
NC cells, Erbb3, also inhibits neuronal differentiation of NCSCs and promotes 
glial cell fates (Shah et al., 1994). In vitro culture of NCSCs with Nrg1 prevents 
expression of the autonomic neuron marker Mash-1, and in contrast to Notch 
signaling, it is not clear if Nrg1 functions instructively to directly promote 
gliogenesis or non-instructively, promoting glial fates indirectly by allowing 
NCSCs to maintain an undifferentiated state prior entering the glial lineage.  
 Prior to my thesis work, the only transcription factor definitively linked to 
multipotency of NC progenitors was the HMG-box protein Sox10 (Kim et al., 
2003). As mentioned previously, Sox10 is initially expressed in NC cells during 
specification and expression is maintained in early migratory NC and 
differentiated glial cells, though expression is generally downregulated in most 
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other cell types as they differentiate (Kuhlbrodt et al., 1998). In mouse embryos 
homozygous for a dominant-negative mutation in the Sox10 gene (Sox10Dom/Dom), 
increased apoptosis is detected throughout NC, consistent with early loss of 
progenitors, and remaining NC cells show absence of glial differentiation 
(Southard-Smith et al., 1998). In an elegant in vitro study, Kim and colleagues 
demonstrated that overexpression of Sox10 is sufficient to inhibit overt neuronal 
and mesenchymal differentiation in NC, thus preserving glial cell fates (Kim et al., 
2003). This work further suggested that self-renewal and multipotency of NCSCs 
might be maintained as part of a “default” glial fate, in which Sox10 
simultaneously provides “an extended window of opportunity” for neuronal 
differentiation and permissively promotes gliogenesis (Kim et al., 2003). 
 Self-renewal is a unique form of cell division in which stem cells generate 
identical daughter cells to expand the pool of multipotent stem cells. This process 
is likely to involve genes that function to maintain stem cell identity by the 
suppression of overt differentiation and distinct gene functions to control the cell 
cycle and maintain proliferative capacity, inhibit cell death, promote DNA damage 
responses and maintain an epigenetic state characteristic of multipotency. Very 
few genes have been assigned to these functions in NCSCs. 
 The molecules known to control NCSC self-renewal play similar roles in 
other embryonic and adult stem/progenitor cell populations. The polycomb gene 
family transcriptional repressor, Bmi1, has been implicated in self-renewal of 
several stem cell populations including neural stem cells (NSCs), hematopoetic 
stem cells (HSCs), intestinal crypt stem cells, as well as NCSCs (Molofsky et al., 
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2003; Park et al., 2003; Fasano et al., 2007; Sangiorgi and Capecchi, 2008). 
Bmi1-/- mice show progressive growth retardation and have significant defects in 
self-renewal of NSCs isolated from the sub-ventricular zone, and severe loss of 
self-renewal in neurospheres isolated from post-migratory NC derivatives 
(Molofsky et al., 2003). Importantly, the reduced self-renewal in Bmi1 mutant 
cells did not represent a general defect in multipotency or cell proliferation; 
expansion of existing multipotent cells was specifically altered while restricted 
progenitor proliferation was unaffected. Further, Molofsky and colleagues 
indentified the cyclin-dependent kinase (CDK) inhibitors p16Ink4a and p19Arf as 
downstream targets of Bmi1 in adult NSC self-renewal (Molofsky et al., 2003). A 
subsequent study suggested that expression of an alternative CDK inhibitor, p21, 
is regulated by Bmi1 during embryonic NSC self-renewal (Fasano et al., 2007). 
More recently, Hmga2, a chromatin-associated protein, was found to play a 
similar role in self-renewal of NSCs and NCSCs (Nishino et al., 2008). Like Bmi1, 
Hmga2 is required to maintain self-renewal by inhibition of p16Ink4a and p19Arf 
expression, but is not required for proliferation of progenitors restricted to 
neuronal or glial fates (Nishino et al., 2008). Together, these studies demonstrate 
that self-renewal is regulated, in part, by unique mechanisms of cell cycle control 
that are specific for multipotent cells in several progenitor populations, including 
NCSCs. 
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Foxd3 Maintains Stem Cell Properties in Multiple Progenitor Populations 
 Foxd3 is a member of the winged helix or “forkhead” family of transcription 
factors, which are characterized by a 100 amino acid DNA-binding domain and 
either transcriptional activation or repression domains (Kaufmann and Knöchel, 
1996; Wijchers et al., 2006). Although primarily characterized as a transcriptional 
repressor, Foxd3 has been shown to have both activator and repressor activity, 
depending upon its cellular context (Sutton et al., 1996; Guo et al., 2002; Lee et 
al., 2006; Steiner et al., 2006; Yaklichkin et al., 2007). Originally named 
“Genesis”, Foxd3 was first characterized based on its expression in embryonic 
carcinoma cells and embryonic stem cells (ESCs) (Sutton et al., 1996). More 
recently, Foxd3 expression has been characterized in several other progenitor 
cell types, including pluripotent cells within the mouse epiblast, extraembryonic 
trophoblast cells, pancreatic endocrine cells, adult NSCs, and NC progenitors 
(Labosky and Kaestner, 1998; Hanna et al., 2002; Tompers et al., 2005; Perera 
et al., 2006). Below, I will discuss previous characterizations of Foxd3 function in 
several of these progenitor populations and specifically address the possible 
cellular functions for Foxd3 within NC progenitors. 
 Previous studies in our laboratory demonstrated that Foxd3 functions as 
an essential regulator of stem cell properties in multiple progenitor populations 
during development, providing evidence that molecular control of self-renewal 
and multipotency may be conserved among divergent cell types (Hanna et al., 
2002; Tompers et al., 2005; Liu and Labosky, 2008). In the early blastocyst-stage 
mouse embryo, Foxd3 is expressed in two distinct progenitor populations: in cells 
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of the inner cell mass (ICM) and in the surrounding trophectoderm (Labosky, 
unpublished data). The ICM gives rise to the epiblast, and is the source from 
which ESCs are derived. This pluripotent cell population generates all cell types 
within the embryo proper (Beddington and Robertson, 1989). The trophectoderm 
gives rise to extraembryonic ectoderm and forms the fetal components of the 
placenta. Trophectoderm progenitors can be maintained in vitro as trophoblast 
stem cells (TSCs), which retain the ability to differentiate into multiple 
extraembryonic cell types (Tanaka et al., 1998).  
 To determine the role of Foxd3 during early embryogenesis, our laboratory 
generated the Foxd3 null alleles, Foxd3tm1.Lby (Foxd3-) and Foxd3tm2.Lby 
(Foxd3GFP), in which the entire coding region of Foxd3 was removed (Hanna et 
al., 2002). Foxd3-/- embryos die at 6.5 days post coitum (dpc), shortly after 
implantation, and show extensive apoptosis in epiblast cells and expansion of 
extraembryonic tissues (Hanna et al., 2002). Surprisingly, Foxd3-/- blastocysts 
maintain expression of other stem cell genes, including Oct4 and Sox2, and 
appear morphologically normal. However, pluripotent epiblast cells were not 
maintained in vivo and ESC lines could not be established in vitro from Foxd3-/- 
blastocysts (Hanna et al., 2002). Further studies of a tamoxifen-inducible deletion 
of Foxd3 in ESCs resulted in aberrant differentiation towards multiple cell 
lineages, including mesendoderm and trophoblast lineages, and increased cell 
death (Liu and Labosky, 2008), demonstrating a requirement for Foxd3 in the 
maintenance of multipotency and self-renewal of ESCs. Introduction of wildtype 
ESCs into Foxd3-/- blastocysts rescued the Foxd3-/- epiblast phenotype (Hanna et 
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al., 2002), but revealed defects in trophoblast lineages resulting in lethality at 9.5 
dpc (Tompers et al., 2005). Furthermore, multipotent TSCs could not be derived 
from mutant embryos, and extraembryonic tissues differentiated preferentially 
into trophoblast giant cells and failed to form labyrinth or spongiotrophblast cell 
types (Tompers et al., 2005). Together, these studies demonstrate a requirement 
for Foxd3 to maintain self-renewal and repress differentiation of ESCs and TSCs, 
supporting the notion of a conserved role for Foxd3 in stem cell self-renewal and 
multipotency. 
 
Foxd3 Regulation of Neural Crest Progenitors 
 In situ hybridization and antibody staining demonstrated that Foxd3 is one 
of the earliest markers of the NC lineage and is expressed in premigratory NC 
cells at 8.0 dpc and in later migratory progenitors (Labosky and Kaestner, 1998; 
Teng et al., 2008). Foxd3 expression is decreased as cells differentiate into most 
derivatives (Dottori et al., 2001), suggesting a link between Foxd3 expression 
and an undifferentiated NC state. Foxd3 expression is not detected in 
melanocyte precursors (Kos et al., 2001), but expression is maintained in glial 
cells within PNS derivatives (Dottori et al., 2001) and in NC that form the ENS 
(Teng et al., 2008). Although the precise cell lineages that express Foxd3 and 
the timing of its expression in postmigratory NC are not completely clear, these 
expression data are consistent with the hypothesis that Foxd3 plays distinct 
context-dependent roles throughout NC development. 
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 Foxd3 has been implicated to various degrees in several aspects of NC 
development, including NC specification, migration, differentiation and survival. 
Consistent with its classification as a NC “specifier” gene, ectopic expression of 
Foxd3 in Xenopus or chick neural tube induces expression of NC markers, 
including HNK1 (Dottori et al., 2001; Kos et al., 2001), Sox10 (Cheung et al., 
2005), AP2α, and Snail2/Slug (Sasai et al., 2001) and thus expands the domain 
of premigratory NC. In Xenopus, expression of a dominant-negative Foxd3 in the 
neural tube results in a loss of NC marker expression, further implicating Foxd3 
in specification and maintenance of NC precursors (Sasai et al., 2001). However, 
the precise cellular functions of Foxd3 in early NC progenitors remain a matter of 
controversy. For example, there is not a consensus view of the role of Foxd3 in 
EMT, migration or differentiation. Overexpression of Foxd3 in the chick neural 
tube results in changes in expression of cell surface adhesion molecules in 
neuroepithelial cells (Dottori et al., 2001; Cheung et al., 2005), but in some 
investigator’s hands, this was not sufficient to induce EMT (Kos et al., 2001; 
Cheung et al., 2005). In addition, ectopic expression of Foxd3 inhibited neural 
and melanocyte differentiation (Dottori et al., 2001; Kos et al., 2001), consistent 
with the hypothesis that Foxd3 represses differentiation of distinct NC lineages 
and maintains an early, uncommitted NCSC state. It has also been suggested 
that Foxd3 may function to maintain proliferation of neural progenitor cells 
independently of differentiation. In an in vitro teratocarcinoma model of retinoic 
acid (RA)–induced neural differentiation, Foxd3 inhibited expression of the CDK 
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inhibitor p21, preventing senescence. However, Foxd3 did not inhibit RA-induced 
expression of neuronal markers (Hromas et al., 1999).  
 Loss-of-function Foxd3 studies in zebrafish demonstrated increased cell 
death and dramatic losses of distinct NC derivatives, suggesting a central role for 
Foxd3 in maintenance of early NC progenitors (Lister et al., 2006; Montero-
Balaguer et al., 2006; Stewart et al., 2006). In contrast to studies in Xenopus 
suggesting Foxd3 is required for NC specification, mutations that affect Foxd3 
expression and morpholino knockdown of Foxd3 in zebrafish have no effect on 
the initial numbers of premigratory NC cells or EMT (Lister et al., 2006; Montero-
Balaguer et al., 2006; Stewart et al., 2006). In these models, zebrafish mutants 
had alterations in NC cell migration and survival that resulted in defects in 
several NC derivatives, including craniofacial defects, and loss of PNS 
derivatives. However, Foxd3 was not absolutely required for NC specification and 
was dispensable in several NC lineages (Lister et al., 2006; Montero-Balaguer et 
al., 2006; Stewart et al., 2006). These studies also suggested that Foxd3 
functions early in NC progenitors to repress distinct cell fates. In contrast to 
severe PNS and cartilage defects, migration and differentiation of two out of 
three pigmented NC lineages in zebrafish, melanophores and xanthophores, 
were unaffected, while a third, iridophores, was reduced in number (Lister et al., 
2006; Montero-Balaguer et al., 2006). Consistent with these findings, several 
studies in chick indicated that Foxd3 functions to inhibit melanogenesis (Kos et 
al., 2001; Ignatius et al., 2008; Thomas and Erickson, 2009). Taken together, the 
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model emerging is of a complex, context-dependent role for Foxd3 both in early 
NC progenitors and in distinct NC derivatives. 
 
Summary 
 NC progenitors generate a diverse array of mesenchymal and neural cell 
types essential for normal vertebrate development. Understanding the molecular 
mechanisms that control NC multipotency, self-renewal and fate will advance 
efforts towards the ultimate goal of manipulating NCSCs for treatment of disease.  
Growing evidence suggests that the transcription factor Foxd3 may be a key 
regulator of NCSC maintenance, multipotency and self-renewal. The next three 
chapters address the expression and function of Foxd3 within distinct populations 
of murine NC progenitors and demonstrate a requirement for Foxd3 in 
maintenance, multipotency and self-renewal of NC. Chapter II presents data 
characterizing cardiac and vagal NC derivatives in a NC-specific deletion of 
Foxd3 in mice. In Chapter III, I present in vivo and in vitro data demonstrating 
that Foxd3 is essential for repression of mesenchymal cell fates and 
maintenance of NCSC multipotency and self-renewal. Finally, in Chapter IV, I 
address the function of Foxd3 in vagal-NC derived progenitors during 
development of the ENS. Together, these data suggest a global role for this 
transcription factor in maintenance of NCSCs within distinct axial levels, and 
support our hypothesis that the function of Foxd3 is conserved in multiple 
progenitor lineages of the mammalian embryo. 
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CHAPTER II 
 
 
CHARACTERIZATION OF CARDIAC AND VAGAL NEURAL CREST 
DERIVATIVES IN FOXD3 NC-MUTANT EMBRYOS  
 
 
The majority of data presented in this chapter was published under the title 
“Requirement for Foxd3 in the maintenance of neural crest progenitors” in 
Development May 1st, 2008 (Teng et al., 2008). Dr. Lu Teng initiated this work 
and I concluded experiments. We are co-first authors on this publication.  
 
Introduction 
 The NC is a multipotent progenitor population that migrates from the 
dorsal neural tube and gives rise to a diverse array of derivatives including the 
neurons and glia of the peripheral nervous system (PNS), bones and cartilage of 
the face, and vascular smooth muscle cells (VSMCs) of the cardiac outflow tract 
(OFT). The fate of NC progenitors depends on their axial level of origin within the 
embryo, and signaling interactions that occur during NC migration to target sites 
of differentiation (Le Douarin and Kalcheim, 1999). NC cells are specified within 
the dorsal neural folds in response to a combination of morphogen signals 
including members of the Wnt, BMP and FGF families of secreted proteins, 
which in turn induce expression of NC-associated transcription factors including 
Foxd3, Pax3, Snail, Snail2/Slug, AP2α, Sox9 and Sox10 (reviewed in Sauka-
Spengler and Bronner-Fraser, 2008; Nelms and Labosky, 2010). These 
transcription factors act synergistically to specify NC, initiate EMT and maintain 
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multipotent NC progenitors. However, the precise cellular functions of individual 
components of this NC gene regulatory network are not yet clear. 
 A growing body of evidence suggests that Foxd3, a transcriptional 
repressor of the Forkhead family of proteins, plays important roles in maintaining 
multipotent progenitors in several distinct embryonic cell types. Our laboratory 
has demonstrated that Foxd3 is required early in mouse embryogenesis; Foxd3-/- 
embryos fail shortly after implantation, cells of the inner cell mass cannot be 
maintained in vitro, and embryonic stem cell (ESC) and trophoblast stem cell 
(TSC) lines cannot be established (Hanna et al., 2002; Tompers et al., 2005). 
Moreover, inducible deletion of Foxd3 in mouse ESCs resulted in precocious 
differentiation, loss of self-renewal, and cell death (Liu and Labosky, 2008). 
Additionally, several lines of evidence suggest that Foxd3 may have similar 
functions within multipotent NC progenitors. In situ hybridization and 
immunohistochemical analyses demonstrated Foxd3 expression in premigratory 
and migratory NC (Labosky and Kaestner, 1998; Teng et al., 2008), and 
expression decreases as cells differentiate into most derivatives (Dottori et al., 
2001). Ectopic expression of Foxd3 in the chick neural tube induces NC fates 
and maintained expression of Foxd3 in migrating NC inhibits cell differentiation 
(Dottori et al., 2001; Kos et al., 2001; Cheung et al., 2005). In Xenopus, 
expression of a dominant negative Foxd3 in the neural tube results in loss of NC 
marker expression (Sasai et al., 2001), further implicating Foxd3 in specification 
and maintenance of NC progenitors. Additionally, mutations that affect Foxd3 
expression in zebrafish and morpholino knockdown of Foxd3 result in loss of NC 
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marker expression and defects in divergent NC derivatives (Lister et al., 2006; 
Montero-Balaguer et al., 2006; Stewart et al., 2006). However, prior to our work, 
a requirement for Foxd3 in mammalian NC had not been examined. 
 In the remaining sections of this introduction to Chapter II, I present data 
generated by previous members of the Labosky laboratory who used Cre-loxP 
technology to conditionally delete the Foxd3 coding region within the murine NC 
and demonstrated a requirement for Foxd3 in maintenance of NC progenitors. 
These data are presented here in Figures 3-6, and they provide the starting point 
for my thesis work. My work focused on characterizing cardiac NC derivatives 
and temporal apoptosis of NC in Foxd3flox/-; Wnt1-Cre (NC-mutant) embryos 
compared to controls (Figures 7-10). Together, this body of work was published 
in the journal Development (Teng et al., 2008). I also examined whether Foxd3 is 
required for a subpopulation of vagal NC that innervates the pancreas (Figures 
11-12), and these data were part of a collaborative project in the Labosky 
laboratory to investigate the role of NC during pancreatic development (Plank et 
al., 2011).  
 
Requirement for Foxd3 in the maintenance of NC progenitors 
 Because global deletion of Foxd3 results in early embryonic lethality 
precluding analysis of NC (Hanna et al., 2002), we employed the Cre-lox system 
to delete the Foxd3 coding region specifically in NC. The endogenous Foxd3 
allele was targeted by homologous recombination in ESCs such that the single-
exon coding region of Foxd3 was flanked by loxP recognition sequences (Figure 
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3 A-B). Mice were generated that carry the conditional allele Foxd3tm3.Lby (called 
Foxd3flox) and homozygous mice (Foxd3flox/flox) were viable and showed no 
phenotype (genotyping shown in Figure 3C). The Wnt1-Cre transgenic line 
(Danielian et al., 1998) was used to conditionally delete the Foxd3 coding region 
in NC by mating Foxd3flox/flox to Foxd3+/-; Wnt1-Cre mice to obtain Foxd3flox/+; 
Wnt1-Cre (control) and Foxd3flox/-; Wnt1-Cre (mutant) offspring. 
Immunohistochemical analysis of Foxd3 expression in control and mutant 
embryos demonstrated loss of Foxd3 in the mutant NC cells undergoing EMT in 
the headfold region of a 4-somite stage embryo (8.0 dpc) (Figure 3 D-E). Further 
experiments revealed that, in contrast to control embryos, Foxd3 expression was 
not detected in dorsal root ganglia (DRG) from mutant embryos at 9.5 dpc, or 
within cranial ganglia or the gastrointestinal (GI) tract at 13.5 dpc (Figure 3 F-K). 
These data confirm the Wnt1-Cre mediated deletion of the Foxd3flox allele in NC. 
 
Craniofacial defects in Foxd3flox/-; Wnt1-Cre mice and embryos 
 In the pharyngeal arches (PAs) and head, cranial NC cells generate 
cartilage and bone of the developing facial skeleton and accordingly, disruption 
of NC has profound effects on craniofacial development. Our laboratory 
demonstrated that NC-specific deletion of Foxd3 in mice resulted in severe 
defects in NC derivatives including craniofacial and PA defects. Consistent with 
defects in cranial NC progenitors, most Foxd3flox/-; Wnt1-Cre mice died perinatally 
and showed a severe cleft face (Figure 4 A). Skeletal staining with alizarin red 
(labeling bone) and alcian blue (cartilage) demonstrated the severity of 
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Figure 3. NC-specific deletion of Foxd3.  (A) Foxd3 locus, targeting vector and 
resulting alleles. Purple box indicates the single coding exon and orange 
triangles indicates flanking loxP sequences. (B) Southern blot analysis using 3’ 
probe shown in A (pink box below the endogenous allele) with BamH1 digested 
genomic DNA. The 6.5kb wildtype band and correctly targeted 4kb band are 
indicated. (C) Genotyping mice with PCR primers (black arrows in A). PCR 
product from Foxd3flox allele is 220 bp, wildtype allele 130 bp. (D-K). Foxd3 
immunohistochemistry. In a control embryo, NC expressed Foxd3 at 8.0 dpc in 
the headfolds (D), at 9.5 dpc in migrating NC (F) (black arrow), at 13.5 in cranial 
nerves (H) (white arrow) and in the gut coils (J) (white arrow).  In E, Foxd3 
protein was detected in a few cells in the headfolds of a mutant 8.0 dpc embryo 
(black arrow). In contrast, no Foxd3 expression was detected at 9.5 dpc in the 
trunk of a mutant embryo (G) or in the cranial nerves (I) or gut coils (K) at 13.5 
dpc. Foxd3-expressing ventral interneurons were detected in the neural tube of 
control and mutant embryos (red arrows in F and G), serving as an internal 
control. bp, base pairs ; olf, olfactory epithelium. 
 
Data generated by Lu Teng, Qiaohong Wang, Audrey Frist and Patricia Labosky.
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craniofacial defects and revealed complete loss of the frontalnasal bone and 
nasal cartilage, and hypoplasia of numerous facial bones (Figure 4 B). Although 
NC-derived cartilage and bones were present in mutant mice, many structures 
had significant morphological defects; notable were the shortened and thickened 
maxillary and mandibular bones, which normally fuse at the midline during 
development of the first PA to form the upper and lower jaw. Defects in mutant 
PAs were obvious by 10.5 dpc (data not shown) and resulting facial defects were 
readily detected in mutant embryos by midgestation stages (Figure 4 C).  
 To indelibly label NC cells and their all their derivatives, the R26RlacZ Cre-
activatible reporter allele (Soriano, 1999) was introduced into the genetic 
background so that expression of Wnt1-Cre activated transcription of the lacZ 
gene. This allowed us to examine NC fate and make direct comparisons between 
control and Foxd3 NC-mutant embryos. X-gal histochemical detection of β-
galactosidase activity demonstrated that NC-derived cells were present in the 
facial mesenchyme of control and mutant embryos indicating that NC cells 
contribute to craniofacial structures despite loss of Foxd3 (Figure 4D). All cranial 
ganglia and nerves were present, but were mispatterned in Foxd3 NC-mutant 
embryos (data not shown, Teng et al., 2008), suggesting defects in formation of 
cranial PNS derivatives that derive from both NC and ectodermal placode-
derived cells. 
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Figure 4.  Craniofacial dysmorphogenesis, skeletal abnormalities and 
pharyngeal arch malformations in Foxd3flox/-; Wnt1-Cre mice and embryos.  
(A) Newborn mutant mice were found with a severe cleft face and palate. (B) 
Alizarin Red and Alcian Blue staining of the head skeleton and cartilage, lateral 
and dorsal views. The frontal bone and nasal capsule were missing in mutants 
and the parietal and interparietal bones were greatly reduced in size. The 
basioccipital bone and premaxila were present but smaller and the mandible was 
shortened and thickened. (C) Side and front view of embryos at 16.5 dpc shows 
these defects at late gestation. (D) Side view of lineage labeled (Wnt1-Cre; 
R26RlacZ) embryos showing the contribution of NC to the face at 13.5 dpc in 
control and mutant embryos. bo, basioccipital bone; fb, frontal bone; ip, 
interparietal bone; md, mandible; mx, maxilla; n, nostrils; nb, nasal bone; nsc, 
nasal capsule; md, mandibular prominence of pharyngeal arch 1; mx, maxillary 
prominence of pharyngeal arch 1; pb, parietal bone; pmx, premaxilla; t, tongue; 
wp, whisker pads. 
 
Data generated by Lu Teng Qiaohong Wang, and Patricia Labosky. 
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PNS defects in Foxd3 mutant embryos  
 In the PNS, NC cells generate sensory and sympathetic neurons and 
associated satellite glia, Schwann cells and endoneurial fibroblasts (Le Douarin 
and Kalcheim, 1999; Joseph et al., 2004). Fate-mapping analysis of Foxd3 NC-
mutant embryos demonstrated a severe reduction or loss of trunk NC cells that 
form the PNS. X-gal staining in control embryos at 14.5 dpc shows NC in the 
cutaneous and sciatic nerves in the hindlimb, and in the segmented spinal nerves 
emerging from the DRG (Figure 5 A, C). In contrast, NC-derived cells were 
absent from the mutant hindlimb and spinal nerves were not detected in mutant 
embryos. However, some NC-derived cells were able to contribute to a 
rudimentary PNS in mutant embryos (Figure 5 B, D). DRG were present in Foxd3 
NC-mutants, but severely reduced in size. Immunohistochemical analysis 
indicated that both control and mutant DRG contained differentiated neurons and 
glia at 14.5 dpc as indicated by TUJ1 and Fabp7 expression (data not shown) 
(Teng et al., 2008), indicating that Foxd3 mutant trunk NC retained the ability to 
differentiate into neurons and glia in DRG, but showed limited capacity to form 
other PNS derivatives. The ENS is a subdivision of the PNS that controls motility 
in the GI tract and is primarily formed from vagal NC that arise from the neural 
tube at the level of somites one through seven (Yntema and Hammond, 1954). 
Sacral NC progenitors (posterior to somite 24) also contribute a small number of 
cells to the ENS in the distal bowel (Burns and Le Douarin, 1998). One of the 
most striking phenotypes of Foxd3 NC-mutant embryos is the complete loss of 
the ENS. X-gal staining in control embryos revealed NC-derived ENS progenitors 
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throughout the length of the intestine (Figure 5 E, G). In contrast, NC was absent 
from the entire GI tract in Foxd3 NC-mutant embryos (Figure 5 F, H). Analysis of 
PGP9.5 expression, a marker of neurons, confirmed the complete loss of the 
enteric neurons in mutant embryos (Figure 5 I, J), and fate mapping at 9.5 dpc 
demonstrated that mutant vagal NC cells failed to enter the foregut (data not 
shown) (Teng et al., 2008). Together, these data demonstrated a requirement for 
Foxd3 in establishment of the ENS and suggested that Foxd3 is globally required 
to maintain PNS progenitors during embryogenesis.  
 
Initial analysis of cardiac NC in Foxd3 mutant embryos 
 Cell transplantation and ablation studies in chick embryos, along with fate 
mapping experiments in the mouse, identified a subpopulation of NC that arise 
between the level of the mid-otic placode and the fourth somite, termed the 
cardiac NC (Kirby et al., 1983; Kirby and Waldo, 1990; Jiang et al., 2000; Chan et 
al., 2004). Cardiac NC cells are key mediators of PAA patterning and outflow 
tract (OFT) septation during cardiovascular development. Similar to other NC 
populations, cardiac NC progenitors were also severely diminished in Foxd3flox/-; 
Wnt1-Cre embryos (Figure 6). R26R fate-mapping analysis of 9.5-10.5 dpc 
control embryos showed X-gal-positive cells entered into PAs 3, 4, and 6 and the 
cardiac OFT, and transverse sections through the heart confirmed NC 
contribution to PAAs and endocardial cushions of the OFT (Figure 6 A-C). In 
Foxd3 mutant embryos, cardiac NC cells were present, but strikingly decreased 
in number in the PAs and OFT at 9.5-10.5 dpc (Figure 6 D-F), demonstrating a 
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role for Foxd3 in early cardiac NC progenitor maintenance. Interestingly, initial 
analysis of 17.5 dpc embryos suggested normal morphology of the aortic arch 
and great vessels (data not shown) indicating that mutant cardiac NC mediated 
OFT septation.  
 
Pressing questions 
 The overlapping cardiac and vagal NC populations perform two major 
roles in the embryo: they migrate to the foregut to eventually innervate the entire 
GI tract and they also populate the PAAs and cardiac OFT, contributing smooth 
muscle during patterning of the great vessels and forming the aorticopulmonary 
septation complex. Therefore, this region of NC must negotiate fate decisions 
about whether to contribute to the developing heart or the developing ENS. NC-
specific, Wnt1-Cre-mediated deletion of Foxd3 in mice resulted in severe defects 
in NC derivatives including craniofacial and PA defects, and complete loss of the 
ENS. Although cardiac and vagal NC cell numbers were reduced in mutant 
embryos, NC cells were present in the developing heart. In contrast, ENS 
progenitors were unable to enter the foregut. These data suggested intrinsic 
differences among NC progenitors in these initially overlapping populations with 
respect to loss of Foxd3.  
 The severe reduction of mutant cardiac NC at 9.5-10.5 dpc appeared 
similar to other mouse models of cardiac NC dysfunction that resulted in severe 
OFT defects. These include persistent truncus arteriosus (PTA), aortic arch 
interruptions, inappropriate branch points or any of a large spectrum of 
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Figure 5.  Peripheral and Enteric Nervous System Defects in Foxd3flox/-; 
Wnt1-Cre embryos.  (A-H) Beta-galactosidase activity detected by X-gal 
staining in control and mutant embryos. A-B. Lateral view of hindlimbs of 14.5 
dpc embryos. In control embryos, development of cutaneous nerves was obvious 
and the developing sciatic nerve was visible (A).  None of these structures were 
seen in mutant embryos (B). C-D. Dorsal view of the trunk a control embryo at 
14.5 dpc shows the segmented development of spinal nerves radiating out from 
the developing spinal cord (C). This was not seen in mutant embryos (D). E-F. 
Lateral view of a 14.5 dpc embryo shows coils of the developing gastrointestinal 
tract. In the control embryo, cells of the ENS stain blue on the outside of the gut 
coils (E). In the mutant embryo no blue staining of the ENS was visible and the 
absence of cutaneous peripheral nerves was apparent (F). G-H. Dissected GI 
tracts from 17.5 dpc embryos. In the control, the entire extent of the gut was 
ensheathed in NC-derived cells making up the ENS (G). In the mutant, there 
were no X-gal positive cells around the outside of the gut (H). Blue staining inside 
the lumen was background (arrowhead). (I-J) Immunofluorescence for PGP9.5, a 
protein enriched in neurons, showed location of the ENS neurons in cross 
sections of the intestine in the control embryo (I) while no PGP9.5 signal was 
detected in the mutant (J). PGP9.5 signal is red, sections were counterstained 
with DAPI in blue to reveal nuclei. cn, cutaneous nerves; ENS, enteric nervous 
system; sc, sciatic nerve; sn, spinal nerves; st, stomach 
 
Data generated by Lu Teng and Patricia Labosky. 
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Figure 6.  Reduction of cardiac NC in Foxd3flox/-; Wnt1-Cre embryos. (A-F) 
Beta-galactosidase activity as detected by X-gal staining in control and mutant 
embryos at 9.5-10.5 dpc. At 9.5 dpc, PA 1 and 2 were present but smaller in 
mutants and there was a paucity of cells migrating into PA 3-4 and into the 
developing cardiac region (red arrowheads) (A, D). A section through a 9.5 dpc 
lineage-labeled control embryo shows NC entering the developing heart (arrows) 
(B). Location of the inset is indicated by the black box. In a control embryo at 
10.5 dpc, NC were located in PA 3 and 4 (arrow) and have migrated into the 
heart (between arrowheads in C). At 9.5 dpc, a section through a mutant embryo 
shows NC entering the developing heart (arrows in E). Asterisk marks blood 
inside the heart. In a mutant embryo at 10.5 dpc, very few NC migrated into the 
heart (arrowhead in F) and very little NC was detected in PA 3 and 4 (arrow). 
 
Data generated by Lu Teng and Patricia Labosky. 
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anomalies (Epstein et al., 2000; Feiner et al., 2001; Kaartinen et al., 2004; 
Richarte et al., 2007). Yet, analysis of late gestation Foxd3 NC-mutant embryos 
showed normal function of cardiac NC during cardiovascular morphogenesis. 
These results set the stage for my thesis work. Are more subtle cardiac NC 
defects present in Foxd3 NC-mutant embryos? Do cardiac NC progenitors 
undergo increased proliferation leading to a compensatory response in NC-
mutant embryos? Of particular interest are the cellular functions of Foxd3 within 
distinct NC progenitors: why are initially indistinguishable subpopulations such as 
vagal NC derivatives more severely affected by loss of Foxd3 than the cardiac 
NC? 
 In contrast to data in Xenopus and chick suggesting a role for Foxd3 in NC 
specification (Dottori et al., 2001; Sasai et al., 2001), Foxd3 was not required for 
initial specification of NC in mice. NC marker and R26R fate-mapping analysis of 
Foxd3flox/-; Wnt1-Cre embryos indicated that NC cells were present, but greatly 
reduced in number (Teng et al., 2008). Analysis of apoptosis in 9.5 dpc Foxd3 
NC-mutant embryos revealed increased cell death in the dorsal neural tube at 
trunk NC levels (data not shown); suggesting that reduced numbers of NC in 
mutant embryos may be due, at least in part, to increased NC apoptosis. 
However, it was unclear if Foxd3 was required for survival in all NC progenitor 
populations, including cranial, cardiac and vagal NC.  
 The answers to these questions will increase our understanding of the 
precise cellular functions of Foxd3 in the mammalian NC.  
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Experimental Procedures 
 
Mouse lines and generation of Foxd3 NC null embryos 
 As described above, the Foxd3 conditional allele Foxd3tm3.Lby (called 
Foxd3flox) (Teng et al., 2008) was used for tissue specific deletion in combination 
with Foxd3 null alleles Foxd3tm2.Lby or Foxd3tm1.Lby (called Foxd3- throughout) 
(Hanna et al., 2002). The transgenic line Tg(Wnt1-Cre)11Rth (called Wnt1-Cre) 
(Danielian et al., 1998) was used to delete Foxd3flox in NC progenitors and for 
fate-mapping experiments using reporter strains Gt(ROSA)26Sortm1Sor (called 
R26RLacZ) and Gt(ROSA)26Sortm1(EYFP)Cos (called R26RYFP) (Soriano, 1999; 
Srinivas et al., 2001). Foxd3flox/flox and Foxd3+/-; Wnt1-Cre mice were mated to 
generate Foxd3flox/+; Wnt1-Cre (control) and Foxd3flox/-; Wnt1-Cre (mutant) 
embryos. For timed pregnancies, dams were checked for the presence of a 
vaginal plug and noon of the plug day considered 0.5 dpc. For DNA extraction, 
extraembryonic tissues or tail biopsies were isolated and digested overnight at 
55°C in 500 µl of buffer containing 0.3 mg/ml Proteinase K, 100 mM NaCl, 10 
mM Tris pH 8.1, 10 mM EDTA pH 8.0, 0.5% SDS, followed by phenol/chloroform 
extraction and ethanol precipitation of genomic DNA. DNA pellets were 
resuspended in 100-200 µL of TE, and 1 µL of DNA was used for PCR reactions 
to amplify fragments from the Foxd3-, Foxd3flox or wildtype alleles (Hanna et al., 
2002; Teng et al., 2008) and Wnt1-Cre transgene (Danielian et al., 1998); with 
genotyping performed as described. All mouse lines were on a mixed genetic 
background (CD-1, 129S6, and C57BL/6) and maintained according to protocols 
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approved by the Vanderbilt University Institutional Animal Care and Use 
Committee (IACUC). 
 
Corrosion casting 
 To examine the three-dimensional structure of the cardiac OFT and aortic 
arch arteries, corrosion casting was performed as described (Feiner et al., 2001) 
by injecting the left ventricle of embryonic or newborn hearts first with PBS and 
then with methyl methacrylate polymer containing red pigment using gentle 
pressure (Polysciences #07349). Polymer containing blue pigment was injected 
into the right ventricle to monitor for possible ventricular septal defects (VSD). 
The casts cured overnight at 4 °C and surrounding tissue was macerated 
(Polysciences #07359) at 50 °C for 6–8 hours. Resin casts were then washed in 
H2O and imaged using a Nikon SMZ-U stereomicroscope and Q-Imaging 
Micropublisher camera. 
 
Histology and immunohistochemistry 
 Lineage labeled embryos were fixed, permeabilized and stained for beta-
galactosidase activity in wholemount with 5-bromo-4-chloro-3-indolyl-D-
galactoside (X-gal) following standard techniques (Nagy, et al., 2003). For high-
resolution analysis of proliferation and beta-galactosidase expression patterns, 
X-gal stained embryos were processed, paraffin embedded and sectioned 
following standard procedures (Presnell and Schreibman, 1997), using Histoclear 
in place of Xylenes to minimize loss of X-gal labeling in tissue. Transverse 
 45 
sections were dewaxed, rehydrated and subjected to high pH antigen retrieval 
(Vector Laboratories, H-3301) at 95°C for 45 minutes (min). Slides were 
permeabilized in 0.2% Triton X-100 in PBS for 15 min, incubated in 3% H2O2 for 
10 minutes, blocked in 5% normal donkey serum and 1% bovine serum albumin 
(BSA), and incubated in rabbit anti-phospho-histone H3 (pH3) (1:200, Upstate 
Biotechnology) overnight at 4°C. pH3-expressing cells were detected with a 
donkey anti-rabbit biotin-conjugated secondary antibody (1:1000, Jackson 
ImmunoResearch Laboratories) and the Vectastain ABC kit (Vector 
Laboratories). Slides were counter-stained with Nuclear Fast Red (Sigma) and 
coverslips placed with Aqua PolyMount (PolySciences).  
 For wholemount immunohistochemistry, 9.5 to 10.5 dpc embryos or the 
pancreas and duodenum from 16.5 dpc embryos were dissected and fixed in 4% 
paraformaldehyde (PFA) in PBS for 4 hours, or overnight, and then 
permeabilized in 0.5 % Triton X-100 at room temperature for 30 minutes. Non-
specific antibody binding was minimized by blocking in 1% BSA, 10% normal 
donkey serum and 0.1% Triton X-100 in PBS. After blocking, tissue was 
incubated in primary antibodies at dilutions given below, washed in PBS with 
0.1% Triton X-100, incubated with secondary antibodies and washed, with each 
step performed overnight at 4°C. The hindlimb and surface ectoderm were 
removed from embryos and the gut tube separated from the neural tube to 
facilitate imaging. For imaging, embryos or tissues were positioned flat on glass 
slides and cover-slipped with Aqua PolyMount (PolySciences). 
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 The following antibodies were used: chicken anti-GFP to detect yellow 
fluorescent protein (YFP) expression from the activated R26RYFP allele (1:500, 
Abcam), guinea pig anti-Pdx1 (1:250) gift from Dr. Christopher Wright), mouse 
anti-β-III Tubulin (1:500, Covance, TUJ1), rabbit anti-Glucagon (1:500, Millipore) 
and rabbit anti-phospho-histone H3 (pH3) (1:200, Upstate Biotechnology). 
Secondary antibodies were: donkey anti-rabbit-biotin, donkey anti-chick-Cy2, 
donkey anti-guinea pig-Cy3, donkey anti-mouse-Cy5 and donkey anti-rabbit-Cy5 
(Jackson ImmunoResearch Laboratories). 
 
Quantification of proliferation in cardiac and cranial NC 
 Serial sections were processed for phospho-histone H3 
immunohistochemistry as described above. Images of matched serial sections 
encompassing the entire OFT were captured with a Zeiss Axio Observer A1 
microscope and AxioCam MRc5 camera and the area of X-gal positive tissue 
was measured in duplicate by two blind observers using Image J software. X-
gal/pH3 double-positive cells were counted for each section and statistics 
calculated using Excel software.   
 
Wholemount LysoTrackerTM staining 
 For wholemount LysoTrackerTM staining, 8.5-10.5 dpc embryos were 
dissected in Hanks’ balanced salt solution (HBSS), and incubated in 5 µM 
LysoTracker RedTM (Molecular Probes) at 37oC for 1 hour. Embryos were then 
washed in HBSS and fixed in 4% paraformaldehyde (PFA) in PBS overnight, 
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washed in PBS and dehydrated in methanol before imaging with a Leica 
fluorescent stereoscope.  
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Results 
 
Deletion of Foxd3 in the NC results in a low occurrence of cardiac NC-
related defects 
 In the mouse embryo, cardiac NC cells mediate remodeling of the OFT 
and PAAs from 10.5 dpc to 12.5 dpc, separating the OFT into the ascending 
aorta and pulmonary trunk and forming a normal left-sided aortic arch with 
appropriate branching of the brachiocephalic, carotid and subclavian arteries 
(Hiruma et al., 2002; Brown and Baldwin, 2006). Previous to my thesis work, the 
analysis of cardiac NC derivatives in Foxd3 NC-mutant embryos showed a 
severe loss of cardiac NC in embryos 10.5 dpc and younger, but surprisingly 
normal morphology of the aortic arch and great vessels during late gestation. 
However, it was possible that rare or subtle cardiac NC defects were not 
detected in these analyses of mutant embryos. To investigate development of the 
cardiac NC in Foxd3 NC-mutant embryos in a more three dimensional manner, 
we examined aortic arch patterning and OFT morphology using corrosion casting 
(Figure 7 A-D). We observed normal patterning of the aortic arch in the majority 
of Foxd3 NC-mutants (13/17, 76%) between 15.5 dpc until birth. However, in 3 
out of 17 Foxd3 NC-mutant embryos examined, we observed a duplication of the 
left common carotid artery (Figure 7 C and C’). One mutant embryo had severe 
cardiac NC defects, including type A2 persistent truncus arteriosus (PTA) (Van 
Praagh and Van Praagh, 1965), in which the septation of the OFT did not occur 
and the ductus arteriosus was absent (Figure 7 D-D’). Prior histological analysis 
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of eight mutant and control littermates was performed and ventricular septal 
defects (VSDs) were not detected (data not shown), however, while in the 
process of performing resin casts, one Foxd3 NC-mutant embryo showed a VSD 
(the sample shown in Fig. 7D). 
 In a separate set of experiments to examine gross morphology of the OFT 
and aortic arch, we monitored cardiovascular defects in an additional 55 Foxd3 
mutant embryos and mice (from 14.5 dpc to birth). These analyses confirmed 
that there were no cardiovascular patterning defects in the majority of Foxd3 NC-
mutant embryos (45 out of 55). Consistent with results from resin casts, we 
detected a low penetrance of cardiovascular defects including: PTA (4 out of 55, 
7.3%), double outlet right ventricle, (DORV, 3 out of 55, 5.5%) interruption of the 
aortic arch (IAA, 2 out of 55, 3.6%) and duplication of the left common carotid 
artery (DCA, 2 out of 55, 3.6%). This low frequency of cardiac defects is 
consistent with genetic background effects that may influence cardiac NC 
phenotypes in Foxd3 NC-mutant embryos. Examples of a normal aortic arch from 
a postnatal control mouse and a rare Type B IAA defect present in a Foxd3 
mutant mouse are shown in Figure 7 E, F. Together with our previous resin cast 
data, our results indicate that 93% (67/72) of Foxd3 mutant embryos showed 
normal septation of the cardiac OFT into an ascending aorta and pulmonary 
trunk and 81% (58/72) showed no cardiovascular defects. 
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Foxd3 mutant NC cells show normal proliferation during cardiac 
development 
 NC must maintain a delicate balance of proliferation and migration in order 
to properly contribute to embryonic tissues. We observed greatly reduced 
numbers of cardiac NC within PAs and OFTs of Foxd3 NC-mutant embryos at 
stages prior to OFT septation and aortic arch patterning (9.5-10.5 dpc) (Figure 6). 
Curiously, cardiac NC-derived structures were normal in the overwhelming 
majority of Foxd3 mutants at late gestational stages, suggesting specific recovery 
of this NC population in mutant embryos. To determine if cardiac NC progenitors 
undergo increased proliferation as part of a compensatory response in Foxd3 
NC-mutant embryos, we analyzed cell proliferation in the cardiac NC using a 
combination of lineage labeling and immunohistochemistry for phosphorylated 
histone H3 (pH3) protein indicating cells in the G2 to M phases of mitosis. OFT 
septation is complete by 13.0 dpc (Hiruma et al., 2002), so we chose to examine 
embryos at 11.5-12.5 dpc. Despite near-complete or complete separation of the 
OFT and pulmonary artery in all embryos examined (n= 4 mutants and 4 
controls), numbers of cardiac NC cells remained greatly reduced and obvious 
changes in proliferation were not detected. To investigate the distribution and 
proliferation of the cardiac NC in more detail, we quantified the NC area and 
numbers of pH3/X-gal-positive cells in matched serial sections through the entire 
OFT for one control and one mutant embryo. Representative sections of 12.5 dpc 
control and mutant embryos are shown in Figure 8 A-D, clearly demonstrating 
the paucity of NC present in the OFT at all rostral and caudal levels. The 
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Figure 7.  Deletion of Foxd3 in the NC results in low penetrance 
cardiovascular defects. (A-D) Corrosion casts of 16.5 dpc cardiac OFT and 
associated vessels.  A’-D’ show corresponding traces. The majority of mutants 
(13 of 17) were indistinguishable from controls (A-B). A few mutants had a 
duplicated left carotid artery (3 of 17) (C) and one mutant had a PTA (D). (E, F) 
Gross examination of cardiac NC derivatives. Control mice showed normal 
septation of the OFT and arrangement of the great vessels (E). The ductus 
arteriosus appeared closed as these preparations were postnatal. Newborn 
mutant mice died at birth without overt cardiovascular defects. Additional analysis 
of cardiovascular morphology in Foxd3 NC-mutant embryos from 14.5 dpc to 
birth revealed that the majority of NC-mutants (45 of 55) showed no defects and 
were identical to controls. However, rare OFT and PAA defects including 
interruption of the aortic arch (2 of 55) (F) were detected. Ao, aorta; bca, 
brachiocephalic artery; dAo, dorsal aorta; DCA, duplicated carotid artery, IAA, 
interruption of the aortic arch; lca, left carotid; lsa, left subclavian artery; PT, 
pulmonary trunk; PTA, persistent truncus arteriosus; rca, right carotid artery; rsc, 
right subclavian artery; * denotes the ductus arteriosus. 
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proportion of pH3-positive NC cells was not different between controls and 
mutants (Figure 8 E), suggesting that initial numbers of cardiac NC were 
reduced, but these cells maintained normal levels of proliferation throughout OFT 
septation. Analysis of proliferation in another mesenchymal NC population, the 
cranial NC, also revealed equivalent numbers of pH3/X-gal-double-positive 
proliferating NC in control and mutant embryos (Figure 8 F-H), indicating Foxd3 
is not required for proliferation of cranial or cardiac NC. 
 
Distribution of Foxd3 mutant cardiac NC cells 
 Our results were inconsistent with the hypothesis that cardiac NC 
underwent compensatory proliferation and “recovery” in Foxd3 NC-mutant 
embryos. By measuring the area of NC in serial sections through the entire OFT, 
the total volume of NC within the OFT in a 12.5 dpc control embryo was 
calculated to be 4 mm3 and a mutant was 0.7 mm3 (Figure 9 A-C). Although loss 
of Foxd3 resulted in this dramatic reduction in the overall amount (or volume) of 
cardiac NC, these cells were still able to pattern the OFT. Morphometric analysis 
of NC lineage cells in matched serial sections revealed that Foxd3 mutant NC 
cells occupied a reduced area when compared to control cells in every region of 
the OFT. Interestingly, mutant cardiac NC cells were located primarily between 
the aorta and pulmonary artery (Figure 9 B) and were detected in 32 of 37 
sections that spanned the OFT (Figure 9 D). These data indicate that reduced 
numbers of mutant NC migrated and populated caudal levels within the OFT 
cushions in a manner comparable to control. 
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Figure 8.  Proliferation of cardiac NC in Foxd3flox/-; Wnt1-Cre embryos. (A-E) 
Matched sections from control and mutant rostral (A and C) and caudal (B and D) 
OFT with lineage label (blue) and pH3 immunostaining (brown) showed a 
reduced amount of NC in the mutant OFT. The box indicates area of the inset. X-
gal and pH3 double-positive cells were counted for each section and proliferation 
in cardiac NC quantified as the average number of pH3/X-gal-double-positive 
cells per area of cardiac NC (E). No difference was detected in the ratio of 
proliferating NC in control versus mutant embryos. (F-H) X-gal staining and 
immunohistochemistry for phospho-histone H3 in transverse sections through the 
facial mesenchyme of control (F) and Foxd3 mutant (G) R26RlacZ lineage labeled 
12.5 dpc embryos. (H) Quantification of proliferation in cranial NC-derived 
mesenchyme. Similar to cardiac NC, proliferation was unchanged in the facial 
mesenchyme of 12.5 dpc embryos. Arrowheads indicate X-gal/pH3 double-
positive cells. Error bars were calculated as s.e.m. for all sections containing X-
gal positive cells. 
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Figure 9.  Morphometric analysis of Foxd3 mutant cardiac NC.  
(A,B) Screen capture of matched sections from control and mutant OFTs with the 
X-gal-positive area outlined in yellow with Image J software. (C) The volume of 
cardiac NC was greatly reduced in a mutant embryo (0.7 mm3) compared to a 
littermate control (4.0 mm3). (D) Histogram showing area of NC along the rostral 
to caudal extent of the OFT. Mutant NC were detectible throughout the length of 
the OFTs and migrated to caudal levels comparable to control embryos. Cardiac 
defects were not present in the mutant embryos analyzed, suggesting that 
reduced NC can mediate aorticopulmonary septation if the level of migration is 
normal. Error bars represent the SD between areas calculated by two unbiased 
observers. * indicates the caudal-most section in which X-gal-positive cells were 
detected in the mutant OFT. 
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Foxd3 is required for survival of early NC progenitors 
 Our results indicate that virtually all NC lineages are adversely affected by 
the loss of Foxd3 supporting the hypothesis that Foxd3 function is required for 
maintenance of NC progenitors. However, it was still unclear if reduced numbers 
of mutant NC cells are associated with increased cell death throughout NC axial 
populations. Previous data from our laboratory demonstrated increased 
apoptosis, as determined by terminal deoxynucleotidyl transferase (TUNEL) 
labeling, in the dorsal neural tube from the trunk of 9.5 dpc embryos with a NC-
specific deletion of Foxd3 (Figure 10 A-B). This raised the question of whether 
Foxd3 is similarly required to maintain survival in other populations of NC. To 
address this question, I evaluated apoptosis in control and Foxd3 NC-mutant 
embryos with LysoTracker RedTM dye at 8.5-10.5 dpc. 
 At 8.5-9.0 dpc, wholemount analysis with LysoTrackerTM Red showed 
increased apoptosis in migrating NC in the hindbrain of mutant embryos (n= 7 
mutant embryos, 15 controls) and in the neural tube (Figure 10 C-D, arrowheads) 
at levels caudal to the otic placode. This suggested increased apoptosis in 
mutant NC cells within cranial, cardiac and vagal NC domains. At 9.5 dpc 
apoptotic cells were detected at trunk NC levels (data not shown), and by 10.5 
dpc, apoptosis was more pronounced in the posterior tail of the embryo (Figure 
10 E-F, arrows). The absence of apoptosis in distal PAs of mutant embryo at 
10.5 dpc (Figure 10 E, arrowhead) is likely due to the large deficit in NC cell 
numbers within the PAs. These data demonstrate a rostral to caudal “wave” of
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Figure 10.  Foxd3 is required for survival of NC progenitors.  
(A-B) Marked changes in apoptosis, as measured by TUNEL analysis, occured 
in the dorsal neural tube from the trunk of 9.5 dpc mutant embryos (arrows). (C-
D) Whole 9.0 dpc embryos incubated in LysoTrackerTM Red to indicate dying 
cells. Note pronounced cell death in the mutant hindbrain and migrating NC 
(arrowheads). (E-F) At 10.5 dpc, mutant embryos had fewer apoptotic cells in the 
distal region of the PAs (arrowheads), but increased apoptotic cells in the tail 
(arrows). The overall loss of PA tissue is apparent (E-F). n=5 control and 5 
mutant embryos examined at 9.0 dpc and 5 control and 2 mutant embryos at 
10.5 dpc. 
 
Data in A-B generated by Lu Teng. 
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apoptosis in Foxd3 mutant NC that occurred in both premigratory and migratory 
NC.  
 
Timing of vagal NC migration into the pancreatic primordium 
 Although Foxd3 is required for survival and maintenance in all NC 
populations, our results suggest different requirements for Foxd3 in some NC 
populations. Many neural derivatives including ENS progenitors were completely 
absent in Foxd3 NC-mutant embryos. This loss of specific NC populations may 
have far-reaching developmental effects on target tissues; it is well established 
that interactions between NC cells and mesoderm or endoderm-derived cells are 
required for proper organogenesis of multiple tissues during development 
(Bockman and Kirby, 1984; Farrell et al., 2001; Nekrep et al., 2008; Knox et al., 
2010). Previous reports have suggested that a subpopulation of vagal NC-
derived ENS progenitors that colonize the pancreas primordium as early as 12.5 
dpc (Jiang et al., 2003; Nekrep et al., 2008) are required for normal development 
of pancreatic beta cells (Nekrep et al., 2008). This NC population functions in the 
pancreas to control proliferation of insulin-expressing cells to limit initial beta cell 
mass (Nekrep et al., 2008). However, the timing of interactions between NC and 
the pancreatic primordium had not yet been examined in detail. The dorsal and 
ventral pancreatic buds emerge from the endoderm-derived gut epithelium at 
approximately 8.5-9.0 dpc. Signals from the adjacent mesoderm-derived 
pancreatic mesenchyme regulate branching morphogenesis of the pancreatic 
epithelium (Golosow and Grobstein, 1962; Gittes et al., 1996), but other cell 
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types that function within the pancreatic primordium are not well characterized. 
To determine the timing of vagal NC-derived progenitor migration into the 
pancreatic primordium, we analyzed the NC lineage in Wnt1-Cre; R26RYFP/+ 
(control) embryos from 9.5 dpc-10.5 dpc. At the 26 somite stage (9.5-10.0 dpc), 
YFP-expressing NC cells had invaded the anterior foregut (Figure 11 A) but were 
not in contact with the Pdx1-positive pancreatic epithelium (Figure 11 D). 
However, beginning at the 27 somite stage (Figure 11 B, E, G), NC cells were 
present within the pancreatic mesenchyme adjacent to the epithelium, indicating 
that NC cells reach the pancreatic primordium between the 26 and 27 somite 
stages (approximately 10.0 dpc). Our experiments indicated that NC cells 
entered the mesenchyme surrounding the dorsal pancreas prior to the ventral 
pancreas; YFP-positive NC cells were present in the mesenchyme surrounding 
the dorsal pancreas by the 27 somite stage (Figure 11 B, E) but were not 
detected adjacent to the ventral pancreatic bud until the 28 somite stage (Figure 
11 C, F, H). This timing confirms that NC progenitors were present within the 
pancreatic primordium at very early stages of pancreatic lineage segregation and 
development, much earlier than previously thought (Percival and Slack, 1999; 
Horb and Slack, 2000). 
 
Foxd3 is required for establishment of NC within the developing pancreas 
 A previous study demonstrated that Phox2b-/- embryos lack NC 
progenitors within the pancreas, resulting in loss of neurons and glial cells and a 
profound increase in beta cell proliferation (Nekrep et al., 2008). Because 
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Figure 11. NC cells enter the pancreatic primordium between the 26 and 27 
somite stages. (A-C) Wholemount immunofluorescence in Wnt1-Cre; R26RYFP 
control embryos for Pdx1, marking the pancreatic epithelium (red), and YFP, 
marking NC cells (green), illustrates the path and timing of NC migration. NC 
cells have not reached the pancreatic primordium by the 26 somite stage (A), by 
the 27 somite stage (B) migrating NC cells had just reached the pancreatic 
epithelium, and at the 28 somite stage (C), the leading edge of the NC migratory 
stream was past the pancreatic primordium. (D-F) Higher magnification of the 
dorsal and ventral pancreatic buds illustrate that the YFP-positive NC cells have 
not reached the dorsal bud at the 26 somite stage (D) but have arrived at the 
dorsal bud at the 27 somite stage (E) and the ventral bud at the 28 somite stage 
(F). (G-H) Higher magnification images of the ventral bud demonstrate no YFP-
positive NC cells present near the ventral bud at the 27 somite stage (G) but NC 
are at the ventral bud at the 28 somite stage (H). The cartoon illustrates the 
orientation of the embryos with the boxed region corresponding to the area 
shown in A-C. n=2-3 embryos per somite stage. VP, ventral pancreas; DP, dorsal 
pancreas; *, sympathetic ganglia.  
 
Figure from (Plank et al., 2011). Immunohistochemistry in A-G by Jennifer Plank with 
imaging by Nathan Mundell. 
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Phox2b is expressed in both NC-derived and ectodermal placode-derived 
neurons (reviewed in Brunet and Pattyn, 2002), it was unclear if disruption of 
pancreatic development in the global null Phox2b-/- embryos was entirely due to 
disruption of NC. It was also possible that Foxd3 NC-mutant embryos would have 
a more severe phenotype with regard to pancreatic development. While both 
Foxd3 NC-mutant and Phox2b-/- embryos lack ENS, Foxd3 mutant NC do not 
enter the GI tract (Teng et al., 2008), whereas Phox2b-/- NC cells initially migrate 
into the anterior foregut, but are not maintained (Pattyn et al., 1999). Our 
previous data suggested that Foxd3 might be specifically required in sub-
lineages of NC: for vagal NC cells that innervate the GI tract, but not for cardiac 
NC-mediated OFT septation. To further test this hypothesis, we characterized 
neuronal derivatives of the vagal NC within the pancreas in Foxd3flox/-; Wnt1-Cre 
mutant embryos. Analysis of the NC lineage with R26RYFP in paraffin sections 
(Figure 12 A, B) and in wholemount (Figure 12 C, D) demonstrated that, in 
contrast to controls, mutant NC cells were not detected adjacent to the 
pancreatic primordium at 10.5 dpc. These data confirm a cell-autonomous 
requirement for Foxd3 within vagal NC fated to enter the pancreas. To further 
determine whether entry of NC progenitors was delayed or if non-NC-derived 
neurons or glia were present in the pancreas of mutant embryos at later 
developmental stages, we examined the pancreas from control and mutant 
embryos at 15.5 dpc. Sections through a control pancreas show YFP-positive NC 
cells interspersed between clusters of Pdx1-positive cells, while, in contrast, NC 
cells remained absent from the pancreas in Foxd3 mutant embryos at 15.5 dpc 
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(Figure 12 E, F). Immunohistochemistry for Pdx1 (marking pancreatic 
epithelium), neuronal β-III tubulin (TUJ1, marking neurons), and fatty acid binding 
protein 7 (FABP7, marking glia) at 15.5 dpc suggested that pancreatic neurons 
and glia were completely absent in Foxd3 mutant embryos (Figure 12 G, H). 
These data support our earlier observations that Foxd3 is required for 
maintenance of vagal NC progenitors that enter the GI tract (Teng et al., 2008), 
including NC derivatives in the pancreas.  
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Figure 12: NC cells do not populate the pancreas in the absence of Foxd3. 
(A-D) Immunofluorescence in embryonic sections (A, B) or wholemount (C, D) 
demonstrated that YFP-positive NC (green) were adjacent to Pdx1-positive (red) 
and Glucagon-positive (blue) cells in the pancreatic epithelium at 10.5 dpc in 
control embryos (A, C), but were not present in the pancreatic primordium in 
mutant embryos (B, D). (E-F) At 15.5 dpc, control YFP-positive NC (arrows) were 
intermingled with branching pancreatic epithelium and were closely associated 
with cells expressing higher levels of Pdx1 (E). In contrast, YFP-positive cells 
were not detected in the pancreatic primordium of mutant embryos (F). (G-H) 
Immunofluorescence at 15.5 dpc showed that TUJ1-positive neurons (red) and 
FABP7-positive glia (blue) were present within the pancreas from a control 
embryo (G). In mutant embryos, pancreatic neurons and glia were not detected 
(H). Scale bar =50 µm. n=3-4 embryos in each group.  
 
Data in A, B, E-H generated by Jennifer Plank and Audrey Frist. 
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Discussion 
 Our data demonstrate that Foxd3 is globally required in the NC throughout 
all axial levels to maintain NC progenitors, but suggest different requirements for 
Foxd3 in specific subpopulations of NC, including in the overlapping cardiac and 
vagal subpopulations. During heart development, cardiac NC cells migrate into 
PA 3, 4 and 6, eventually contributing to the PAAs and cardiac aorticopulmonary 
septum (Kirby et al., 1983). Initially indistinguishable from cardiac NC 
progenitors, vagal NC migrate from the neural tube ventrally along a path later 
followed by the vagus nerve, and accumulate in the posterior PAs prior to 
invasion of the foregut and generation of the ENS (Tucker et al., 1986; Baetge 
and Gershon, 1989). Although both cardiac and vagal NC cell numbers were 
reduced in mutant embryos, lineage analysis demonstrated that NC cells were 
able to migrate ventrally and caudally in the developing heart, and even though 
fewer NC cells were present, this reduced amount of NC effectively septated the 
OFT in most (93%) cases. In contrast, vagal NC cells failed to enter the gut, and 
the ENS was not established in any region of the GI tract. 
 A study examining cardiac NC ablation in mouse suggested that the 
severity of NC-associated cardiovascular defects is directly proportionate to the 
amount of cardiac NC within the developing heart (Porras and Brown, 2008). 
However, the precise threshold of NC needed for PAA remodeling and cardiac 
OFT septation had not been established. Our analysis of cardiac NC derivates in 
Foxd3 mutant embryos suggested novel concepts regarding the levels of cardiac 
NC contribution and migration that are required for heart development. Our fate 
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mapping data were inconsistent with our hypothesis that Foxd3 mutant cardiac 
NC underwent compensatory proliferation and “recovery” in order to mediate 
morphogenesis of the PAAs and OFT. The volume of mutant NC in the septating 
OFT remained decreased and we did not observe alterations from wildtype levels 
of proliferation in NC during critical stages of cardiovascular development (11.5-
12.5 dpc). Additionally, despite the greatly decreased volume of NC migrating 
into the developing heart (mutants contained 17.5% the volume of NC in the OFT 
compared to controls by lineage label), these cells were able to migrate to an 
appropriate caudal level within the endocardial cushions and mediate septation 
of the OFT. This indicates that the critical variable of NC contribution during OFT 
septation is not the absolute number of cardiac NC, but instead it is the caudal 
extent of their migration in the conotruncus that is crucial for the function of 
cardiac NC.  
 Our results demonstrate that, in contrast to normal migration of cardiac 
NC, vagal NC progenitors did not migrate into the GI tract in Foxd3 mutant 
embryos, resulting in complete loss of the ENS as well as the ENS-derived NC 
that innervate the pancreas. Our fate-mapping experiments precisely defined the 
timing of NC migration into the pancreatic primordium and verified findings from 
previous studies suggesting that NC is the primary contributor of pancreatic 
neurons (Kirchgessner et al., 1992; Jiang et al., 2003; Nekrep et al., 2008). Our 
results indicated that NC cells were proximal to the pancreatic epithelium 
beginning at the 26-27 stage (~10.0 dpc), significantly earlier than previous 
characterizations of NC migration into the pancreas in chick, rat and mouse 
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embryos (Kirchgessner et al., 1992; Jiang et al., 2003; Nekrep et al., 2008), and 
well in advance of endocrine and exocrine cell differentiation. Our findings 
contradict previous studies that suggested only mesoderm and endoderm-
derived tissues were present in pancreatic buds prior to 11.5 dpc (Percival and 
Slack, 1999; Horb and Slack, 2000). Further experiments by our laboratory 
demonstrated that loss of vagal NC-derived neurons and glia in Foxd3 NC-
mutant embryos increased the proliferation of pancreatic insulin-expressing cells, 
while at the same time inhibited maturation of these cells. Therefore, without NC, 
insulin-expressing cells did not develop into mature beta cells (Plank et al., 
2011).  
 There are several possibilities for the different requirements for Foxd3 in 
cardiac versus vagal NC. One hypothesis is that expression of other genes in NC 
may function to specifically maintain sufficient numbers of cardiac but not vagal 
NC progenitors in Foxd3flox/-; Wnt1-Cre embryos. In support of this hypothesis, a 
recent study from our laboratory demonstrated a genetic interaction between 
Foxd3 and the transcription factor Pax3 within the cardiac NC (Nelms et al., 
2011). In contrast to Foxd3flox/-; Wnt1-Cre embryos which had a low occurrence 
of cardiovascular defects and survive until birth, compound mutant embryos that 
were homozygous for a Wnt1-Cre mediated NC-specific deletion of Foxd3 and 
heterozygous for Pax3 had severe cardiac NC defects including midgestation 
lethality and 100% penetrance of PTA. Thus, expression levels of the 
transcription factor Pax3 are critical for maintenance of cardiac NC in the 
absence of Foxd3 (Nelms et al., 2011).   
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 A second hypothesis is that ENS progenitors underwent selective cell 
death, whereas NC cells that were specified to populate the heart were 
selectively maintained. Consistent with the notion that Foxd3 functions to 
maintain survival of NC progenitors, our wholemount LysoTrackerTM analysis of 
Foxd3 NC mutant embryos suggests that depletion of the progenitor pool was 
likely due to apoptosis within the premigratory and early migrating mutant NC, 
which were depleted in a rostral to caudal progression. Although the precise 
cause of cell death in Foxd3 mutant NC has not been established, it is possible 
that inappropriate NC differentiation and/or loss of multipotency may underlie 
apoptosis in mutant NC, resulting in loss of specific NC subpopulations. Although 
a large proportion of Foxd3 mutant NC cells die in the dorsal neural tube, our 
results indicate that apoptosis was not limited to premigratory NC, suggesting 
that apoptosis is not caused by global defects in EMT. Our results do not rule out 
the possibility that the vagal NC progenitors fated to generate the ENS were 
unable to delaminate from the neural tube resulting in cell death. Molecular 
markers that distinguish between cardiac and vagal lineages prior to emigration 
have not been identified, so we are unable to test this hypothesis directly. 
However, our experiments presented below in Chapter III suggest that in vitro 
inhibition of apoptosis in Foxd3 mutant NC was not sufficient to rescue 
expression of markers associated with both neural crest stem cells (NCSCs) and 
ENS progenitors (Mundell and Labosky, 2011). 
 Since both cardiac and vagal progenitors were depleted in Foxd3 NC 
mutant embryos, it is perhaps more likely that cell death in the dorsal neural tube 
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represents loss of NC cells that had not yet acquired a distinct cell fate. 
Therefore a general loss in NC progenitors might affect the establishment of the 
ENS more severely. The complete loss of ENS progenitors in Foxd3 NC-mutant 
embryos is consistent with previous work suggesting that a “critical mass” of 
vagal NC is required prior to their entry into the gut mesenchyme (Barlow et al., 
2008).  
 A final possibility is that Foxd3 mutant ENS progenitors did not acquire 
appropriate cell fates and therefore were not competent to enter the gut 
mesenchyme. This is consistent with the hypothesis tested throughout my thesis 
work that Foxd3 is required for multipotency and self-renewal of all NC 
progenitors; however this requirement has varied effects on specific 
subpopulations of NC. For example, within the cardiac and vagal domains, 
cardiac progenitors may be less susceptible to loss of multipotency than cells 
restricted to enteric fates due to accumulation or persistence of vascular smooth 
muscle cell (VSMC)-restricted progenitors in Foxd3 mutant embryos that may not 
require maintenance of multipotency for proper cardiovascular remodeling. Our 
results suggest that Foxd3 mutant NC were able to undergo normal 
differentiation into cardiovascular lineages including VSMCs. The roles of Foxd3 
in NC cell fate potential and self-renewal are discussed in Chapter III. In addition, 
the hypothesis that Foxd3 is required throughout development of the ENS is 
examined in Chapter IV. 
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CHAPTER III 
 
NEURAL CREST STEM CELL MULTIPOTENCY REQUIRES FOXD3 TO     
MAINTAIN NEURAL POTENTIAL AND REPRESS MESENCHYMAL FATES 
 
The majority of this chapter was published under this title in the journal 
Development in the February 15th, 2011 issue (Mundell and Labosky, 2011).   
 
Introduction 
 At the onset of their migration from the neural tube, neural crest (NC) cells 
are a heterogeneous pool of multipotent neural crest stem cells (NCSCs) and 
fate-restricted progenitors that give rise to a wide variety of cell types including 
neurons, glia, melanocytes, vascular smooth muscle cells (VSMCs), 
chondrocytes and osteoblasts (Le Douarin and Kalcheim, 1999). In vitro clonal 
analyses and in vivo cell transplantation and labeling experiments established 
that NC is both multipotent and self-renewing (Bronner-Fraser et al., 1980; 
Sieber-Blum and Cohen, 1980; Bronner-Fraser and Fraser, 1988b; Baroffio et al., 
1991; Ito and Sieber-Blum, 1991; Trentin et al., 2004). NCSCs can be isolated 
from neural tube explants or embryonic and postnatal NC derivatives including 
fetal peripheral nerves, heart, skin, and the adult enteric nervous system (ENS) 
(reviewed in Crane and Trainor, 2006; Teng and Labosky, 2006; Delfino-Machin 
et al., 2007). Additionally, NCSCs can be isolated by flow cytometry based on 
their expression of the low-affinity nerve growth factor receptor, p75NTR (Stemple 
and Anderson, 1992). Combinatorial Wnt and bone morphogenic protein (BMP) 
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signaling synergistically maintains NCSC multipotency in vitro by suppressing 
differentiation (Kleber et al., 2005), and overexpressing the HMG-box 
transcription factor Sox10 in NC maintains multipotency by preserving gliogenic 
potential and inhibiting neural differentiation (Kim et al., 2003). Despite these 
significant advances in characterization of NCSCs, relatively little is known about 
the molecules required for establishing and controlling their self-renewal and/or 
multipotency.  
 NCSCs may share common transcriptional mechanisms controlling self-
renewal and multipotency with other embryonic progenitor populations. Our 
earlier work established that Foxd3 functions in embryonic stem cells (ESCs) and 
trophoblast stem cells (TSCs) to maintain self-renewal and repress 
differentiation, supporting the notion of a conserved role for Foxd3 in stem cell 
self-renewal and multipotency (Hanna et al., 2002; Tompers et al., 2005; Liu and 
Labosky, 2008). In the NC, Foxd3 is expressed in pre-migratory and early 
migrating cells, and its expression decreases as cells differentiate into most 
derivatives, suggesting a link between Foxd3 expression and multipotency 
(Labosky and Kaestner, 1998). Ectopic expression of Foxd3 in avian NC inhibited 
neural differentiation (Dottori et al., 2001), supporting the hypothesis that Foxd3 
largely maintains an early, uncommitted NCSC state. Loss-of-function studies in 
Xenopus laevis, zebrafish and mice demonstrate dramatic losses of distinct NC 
derivatives and suggest a central role for Foxd3 in early NC maintenance (Sasai 
et al., 2001; Lister et al., 2006; Montero-Balaguer et al., 2006; Stewart et al., 
2006; Teng et al., 2008). A NC-specific deletion of murine Foxd3 caused severe 
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defects in most NC derivatives; however, this requirement was not identical 
throughout the NC; although Foxd3 is required for establishment of the ENS, it is 
dispensable for cardiac OFT septation (Teng et al., 2008). This lead us to 
hypothesize that intrinsic differences between these overlapping NC populations 
may reflect divergent molecular requirements controlling multipotency and 
lineage commitment. However, direct roles for Foxd3 in NCSC multipotency and 
self-renewal, or the extent to which Foxd3 controls lineage allocation of NC has 
not been directly examined.  
 To address these unanswered questions, we combined a NC-specific 
deletion of Foxd3 with in vivo lineage mapping and in vitro clonal analysis of 
isolated NC to demonstrate a cell-autonomous requirement for Foxd3 in NC self-
renewal and multipotency. In vivo, the NC-specific deletion of Foxd3 resulted in 
loss of neural derivatives of the cranial, vagal and cardiac NC, with aberrant 
differentiation of mesenchymal NC derivatives and ectopic expansion of the NC-
derived VSMC domain. In single-cell analyses of multipotency, Foxd3 played a 
crucial role in negatively regulating myofibroblast differentiation, thereby 
maintaining newly generated NCSCs in an uncommitted multipotent state. We 
therefore provide the first genetic identification of a specific gene requirement for 
both self-renewal and multipotency of NC. Together with published findings, we 
describe a model in which Foxd3 maintains NCSCs by inhibiting non-neural 
differentiation, drawing important gene-regulatory parallels between disparate 
stem and progenitor cell populations.  
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Experimental Procedures 
 
Mouse lines 
 The Foxd3 null alleles Foxd3tm1.Lby and Foxd3tm2.Lby (called Foxd3- 
throughout) were used interchangeably in combination with Foxd3tm3.Lby, the 
Foxd3 conditional allele (Foxd3flox). These alleles were described previously 
(Hanna et al., 2002; Teng et al., 2008). The Wnt1-Cre transgenic line (Danielian 
et al., 1998) was used to delete Foxd3flox and to lineage-map NC using reporter 
strains Gt(ROSA)26Sortm1Sor (called R26RLacZ) and Gt(ROSA)26Sortm1(EYFP)Cos 
(called R26RYFP) (Soriano, 1999; Srinivas et al., 2001). The ubiquitously 
expressed tamoxifen-inducible Cre transgenic line (CAGG Cre-ERTM) (Hayashi 
and McMahon, 2002) was used for inducible deletion of Foxd3. All lines are on a 
mixed genetic background and maintained in accordance with protocols 
approved by the Vanderbilt University Institutional Animal Care and Use 
Committee (IACUC). 
 
Histology  
 Embryos were fixed in 4% paraformaldehyde (PFA) in PBS for 4 hours or 
overnight, and histology was performed using standard procedures (Presnell and 
Schreibman, 1997). Wholemount immunostaining (Wall et al., 1992) and 5-
bromo-4-chloro-3-indolyl-D-galactoside (X-gal) staining (Nagy et al., 2003) were 
performed as described. The following antibodies were used: chicken-anti-green 
fluorescent protein (GFP) to detect yellow fluorescent protein (YFP) expression 
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from the activated R26RYFP allele (1:500, Abcam), goat-anti-Sox10 (1:20, Santa 
Cruz), goat-anti-smooth muscle 22 alpha (SM22α) (1:200, Abcam), mouse-anti-
Neurofilament (2H3, 1:1000, Developmental Studies Hybridoma Bank), mouse-
anti-β-III Tubulin (1:500, Covance, TUJ1), mouse-anti-α-smooth muscle actin 
(SMA) (1:200, Sigma), mouse-anti-glial fibrillary acidic protein (GFAP) (1:200, 
Sigma), rabbit-anti-Foxd3 (1:500, (Tompers et al., 2005), rabbit anti-smooth 
muscle myosin heavy chain (SM-MHC) (1:200, Biomedical Technologies), rabbit 
anti-Sox9 (1:500, Chemicon), rabbit anti-Runx2 (1:500, (Yang et al., 2004), 
rabbit-anti-cleaved Caspase3 (1:200, Cell Signaling), rabbit-anti-p75NTR (1:200, 
Promega), rabbit anti-Peripherin (1:1000, Chemicon). Secondary antisera were 
purchased from Jackson ImmunoResearch and 4', 6-diamidino-2-phenylindole 
DAPI (1:5000, Molecular Probes) was used to detect nuclei. For sequential 
detection of Foxd3 and p75NTR, anti-Foxd3 and Cy3-conjugated secondary 
antibody labeled sections were incubated in unconjugated anti-rabbit IgG (1:15) 
prior to immunodetection of p75NTR. The Vectastain ABC kit (Vector Laboratories) 
was used for colorimetric immunohistochemical experiments. Terminal 
deoxynucleotidyl transferase (TUNEL) analysis was performed using the In Situ 
Cell Death Detection Kit (Roche). 
 
NC explant culture 
 Cardiac/vagal neural tube (from mid-otic placode to somite four) and trunk 
neural tube segments (from somites 16 to 22) of embryos 9.0-9.5 dpc were 
isolated by microdissection and dissociated from surrounding tissues with 
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collagenase/dispase (Roche), using procedures modified from Stemple and 
Anderson (Stemple and Anderson, 1992). Explants were cultured in wells coated 
with 30 µg/ml Fibronectin (Gibco) in self-renewal medium containing Dulbecco’s 
modified Eagle’s medium (DMEM) with low glucose (Invitrogen), 30% neurobasal 
medium (Invitrogen), 15% chick embryo extract (CEE), 2% B27 (Invitrogen), 1% 
N2 (Invitrogen), 117 nM retinoic acid (Sigma), 50 µM β-mercaptoethanol (Sigma), 
20 ng/ml insulin-like growth factor (IGF) 1 and 20 ng/ml basic fibroblast growth 
factor (bFGF) (R&D Systems) using procedures modified from Morrison et al. 
(Stemple and Anderson, 1992; Morrison et al., 1999). All cultures were 
maintained in hypoxic conditions within a sealed incubator chamber (Billups-
Rothenberg) flushed every 48 hours with a gas mixture containing 1% O2, 6% 
CO2, 93% N2 to achieve 3-6% oxygen and 5% CO2 (Morrison et al., 2000a). After 
48 hours, neural tubes were physically removed. For adherent clonal cultures, 
NC cells were plated at low density (25 cells/cm2) ensuring that individual cells 
formed spatially distinct colonies. After 6 days, medium was changed to 
differentiation-promoting medium (10 ng/ml bFGF and 1% CEE) for 8 days prior 
to analysis of colony composition (Morrison et al., 1999; Mosher et al., 2007). 
Sphere cultures were maintained 8-10 days in low-adherence dishes (Costar) 
undisturbed and at low density (<1 cell per 10 µl of medium) to minimize fusion, 
and dissociated using papain (Worthington) for 30 min at 37°C with gentle 
agitation (Fasano et al., 2007). All statistics were mean ± standard error of the 
mean (s.e.m.) and p values calculated with Student’s t-test. 
 
 75 
Results 
 
Foxd3 expression is maintained in neural derivatives and downregulated in 
ectomesenchymal derivatives of NC 
 Vagal NC (from somites one to seven) and cardiac NC (from the mid-otic 
placode to somite four) are initially overlapping cell populations that innervate the 
digestive tract and diaphragm, and function in cardiac development by mediating 
OFT septation, contributing VSMCs to the great vessels and generating 
parasympathetic cardiac ganglia (Allan and Greer, 1997; Young and Newgreen, 
2001; Hutson and Kirby, 2007; Hildreth et al., 2008). Foxd3 is differentially 
required in these NC populations; NC-specific Foxd3-null embryos have no ENS, 
whereas cardiac OFT septation is overtly normal (Teng et al., 2008). This striking 
difference led us to examine temporal expression of Foxd3 in Wnt1-Cre; R26RYFP 
lineage-traced NC from distinct axial origins: cranial, cardiac, vagal and trunk NC. 
Foxd3 expression overlaps with YFP-positive cells in pre-migratory NC at the 
dorsal-lateral most region of the headfolds at 8.0 dpc (four-somite stage) and 
expression was maintained in migratory cranial NC at 8.5 dpc (Figure 13 A, B), in 
agreement with our previous work (Labosky and Kaestner, 1998). At 
vagal/cardiac somite levels, Foxd3 was co-expressed with YFP in ventral 
migrating NC at 8.5 dpc (Figure 14 A). Beginning at 9.0 dpc (14 somites), Foxd3 
expression was extinguished in ventral-most NC cells (Figure 14 B, arrowhead) 
and by 9.5 dpc, Foxd3 expression was restricted to presumptive cranial and 
dorsal root ganglia (DRG), with no expression detected in cranial or cardiac NC 
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Figure 13. Temporal analysis of Foxd3 expression during cranial NC 
development. (A-A'') Sections through the headfold region of a NC lineage 
marked Wnt1-Cre; R26RYFP 8.0 dpc (four-somite stage) embryo show Foxd3 
(red) and YFP expression (green) in premigratory NC. (B-B'') At 8.5 dpc (eight 
somites), Foxd3 expression was maintained in migratory cells in the cranial 
mesenchyme. (C- D'') Foxd3 expression was absent in cranial NC mesenchyme 
beginning at 9.5 dpc (C). Co-expression of Foxd3 and YFP was limited to NC 
cells in cranial ganglia at both 9.5 dpc (C) and 10.5 dpc (D). Yellow arrowheads 
indicate Foxd3/YFP co-expressing cells; white arrowheads indicate YFP-
expressing NC. Abbreviations: md, mandible; nt, neural tube; OFT, outflow tract.  
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Figure 14. Foxd3 expression is selectively maintained in neural derivatives 
and downregulated in mesenchymal derivatives of the NC. (A) Transverse 
sections through the vagal NC level of Wnt1-Cre; R26RYFP (NC lineage marked) 
embryos shows Foxd3 (red) and YFP expression (green) at 8.5 dpc in 
premigratory and ventral migratory NC indicated by yellow arrowheads. (B-C) At 
9.0-9.5 dpc, Foxd3 expression was maintained in dorsal migratory cells (yellow 
arrowheads), but was not detected in ventral NC migrating towards the heart or 
within the pharyngeal arch or outflow tract (white arrowheads). Abbreviations: nt, 
neural tube; PA, pharyngeal arch; OFT, outflow tract. 
 
 79 
 
 
 
 
 
Figure 15. Foxd3 is co-expressed with the NCSC markers p75NTR and 
Sox10. (A-B') Transverse sections through vagal (A, A') and trunk (B, B') levels 
of Wnt1-Cre; R26RYFP (NC lineage marked) embryos shows NC specific co-
expression of Foxd3 (red) and YFP (green, A, B) or Sox10 (green, A', B') in DRG. 
Foxd3 was also expressed in interneurons of the spinal cord (arrows in B). (C-D) 
Foxd3 and p75NTR were co-expressed in NC proximal to the esophagus (yellow 
arrowhead, C) and in cranial ganglia (yellow arrowheads, D). Expression was 
absent in cardiac and cranial NC mesenchyme. Abbreviations: DRG, dorsal root 
ganglia; e, esophagus; nt, neural tube; OFT, outflow tract. 
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mesenchyme (Figure 14 C, and Figure 13 C, D). At 10.5 dpc, Foxd3 was co-
expressed with Sox10, a NCSC and glial marker, in NC at the periphery of vagal 
and trunk DRG (Figure 15 A, B). This expression pattern was similar to 
previously reported co-expression of p75NTR, a NCSC and neuronal progenitor 
marker, and Sox10 (Sonnenberg-Riethmacher et al., 2001), which led us to 
examine expression of Foxd3 and p75NTR. At 10.5-11.5 dpc, Foxd3 and p75NTR 
were co-expressed in NC at the level of the developing esophagus and trachea, 
and in cranial ganglia (Figure 15 C, D). Foxd3 and p75NTR were downregulated in 
cardiac NC prior to entry into the OFT (Figure 15 C) and in cranial NC-derived 
mesenchyme (Figure 15 D). These expression patterns indicate that Foxd3 is 
present in NCSCs and support a role for Foxd3 in segregation of neural, glial and 
ectomesenchymal lineages of the NC. 
 
Foxd3 is necessary for diaphragm and gastrointestinal tract innervation 
and formation of the parasympathetic cardiac ganglia 
 Foxd3 NC-conditional null mice die perinatally, presumably due to 
respiratory failure (Teng et al., 2008). To determine if this lethality is associated 
with defects in NC-mediated diaphragm innervation, we evaluated NC with Wnt1-
Cre activated R26RlacZ and X-gal staining. In Foxd3flox/+; Wnt1-Cre control 
embryos at 16.5 dpc, the phrenic nerves projected to the antral right and left 
leaflets of the diaphragm and elongated dorsally and ventrally through the central 
region of the muscle (Figure 16 A, top). By contrast, only a few NC-derived cells 
were present in a small cluster in the left leaflet of diaphragms from NC-
 81 
conditional nulls (Figure 16 A, bottom). Examination of R26RYFP with 
neurofilament expression (2H3) confirmed a paucity of neurons projecting into 
the diaphragm in mutant embryos (Figure 16 B). Additionally, mutant vagal NC 
were not present in the esophagus (Figure 16 C). These data indicate a vital role 
for Foxd3 in development of neural derivatives of the vagal NC. 
 To determine if Foxd3 is required for normal differentiation of cardiac NC-
derived neuronal lineages, we examined contribution of lineage-traced control 
(Foxd3 heterozygous) and Foxd3 mutant NC to the parasympathetic cardiac 
neurons using β-III tubulin (TUJ1) immunodetection. From 12.5-17.5 dpc, NC 
contributed to the dorsal cardiac ganglia in heterozygous control embryos, but in 
mutants, NC cells were not present in this location (n=12 mutant embryos, Figure 
16 D, E). In Foxd3 mutant embryos, NC did not contribute to parasympathetic 
innervation, and although non-NC neurons (presumably of placodal origin, (Kirby, 
1988)) were present, only rudimentary ganglia formed (Figure 16 E). 
 
Ectopic location of NC-derived VSMCs without Foxd3 
 Our data suggest a model in which Foxd3 is initially expressed in all NC 
but then extinguished in cardiac NC prior to OFT septation, as a requisite step in 
the differentiation and generation of VSMCs in the great vessels. Although 
Foxd3-deficient NC mediate OFT septation, it was unknown whether the normal 
contribution of VSMC progenitors to PAAs required Foxd3 expression in NC 
progenitors. Previous lineage-tracing studies demonstrated that cardiac NC gives 
rise to VSMCs in the aortic arch, but NC-derived cells do not populate the
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Figure 16. Foxd3 is required for neural derivatives of the cranial, vagal and 
cardiac NC. (A) Loss of diaphragm innervation in mutant embryos. Top view of 
diaphragm from a lineage-mapped 16.5 dpc Wnt1-Cre; R26RLacZ (control) 
embryo showed X-gal-positive cells in the phrenic nerves (arrows) that extended 
dorsally and ventrally to the diaphragm muscle leaflets (top panel). In mutant 
embryos, diaphragms were almost completely devoid of NC cells (bottom panel). 
A small cluster of NC cells from the left phrenic nerve (arrow) was present in 5 
out of 6 mutant diaphragms examined. (B) Wholemount immunohistochemistry 
for Neurofilament (2H3) and YFP from the R26RYFP allele identified NC-derived 
neurons (arrowhead) in control embryos at 16.5 dpc (top). The small number of 
mutant NC-derived cells was disorganized and few 2H3-positive neurons were 
detected (bottom). (C) Lineage mapping at 15.5 dpc shows NC cells did not 
innervate the esophagus in Foxd3 mutant embryos (right). Nodose ganglia 
(arrows) were present but smaller in mutants. (D) Cardiac ganglia in control and 
mutant embryos. A NC-derived network of nerve ramifications emanated from the 
parasympathetic cardiac ganglia (arrow) in control X-gal stained hearts at 16.5 
dpc (dorsal view), but this was missing in Foxd3 mutant embryos. Arrows 
indicate position of ganglia. (E) Wnt1-Cre mediated YFP expression from 
R26RYFP and neuronal β-III Tubulin (TUJ1) identified neurons of NC (YFP-
positive) and placodal (TUJ1-positive/YFP-negative) origin in control cardiac 
ganglia (arrows) at 14.5 dpc (top panels). YFP expression was not detected in 
mutant TUJ1-positive cardiac ganglia and neural projections (arrowheads) were 
greatly reduced (bottom panels). Abbreviations: CG, cardiac ganglia; e, 
esophagus; LA, left atria; LL, left leaflet; LV, left ventricle; ML, middle leaflet; NG, 
nodose ganglia; RA, right atria; RL, right leaflet; RV, right ventricle. 
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descending aorta, forming a distinct boundary with mesoderm-derived VSMCs at 
the junction of the left fourth and sixth arch arteries with the dorsal aorta (Le 
Lievre and Le Douarin, 1975; Jiang et al., 2000). To investigate if Foxd3 is 
required for cardiac NC to contribute appropriately to the great vessels, we 
compared distributions of lineage-traced control and conditional Foxd3-null NC in 
the aorta. At 16.5 dpc, NC cells populated the aortic arch of both Foxd3 
heterozygous control and mutant embryos (Figure 17 A, B). The sharp boundary 
between NC- and mesoderm-derived VSMC was apparent at the level of the 
ductus arteriosus in control embryos (Figure 17 A, arrow). However, this border 
was no longer respected in Foxd3 NC-mutant embryos and NC-derived cells 
were detected caudally, throughout the descending aorta, to at least the level of 
the diaphragm. Confocal analysis of the aorta subjected to YFP immunodetection 
co-labeled with smooth muscle 22 alpha (SM22α) or smooth muscle myosin 
heavy chain (SM-MHC) showed Foxd3 mutant NC in the VSMC layer of the 
descending aorta (Figure 17 C-H). Further analysis of VSMC markers in 
transverse sections from lineage-traced 14.5 and 16.5 dpc embryos confirmed 
contribution of mutant NC to VSMCs within the tunica media of the descending 
aorta (Figure 18 F-H and data not shown). The relative contribution of NC cells in 
the descending aorta at 14.5-16.5 dpc was greater at regions proximal to the 
normal NC boundary (average % YFP-positive vascular area = 31% just caudal 
to the ductus arteriosus, n=4) compared with more distal regions (8.2% YFP-
positive, at the diaphragm), demonstrating a rostral-to-caudal gradient of ectopic 
mutant NC. We did not detect any differences in the contribution of cardiac NC 
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Figure 17. Deletion of Foxd3 results in defects in location of NC-derived 
VSMCs. (A, B) Lineage mapping at 16.5 dpc in Wnt1-Cre; R26RLacZ control and 
mutant embryos (dorsal view) showed X-gal-positive NC present in the aortic 
arch (outlined in red) at the normal lineage boundary at the level of the ductus 
arteriosus (arrow) in control embryos. In contrast, mutant NC was present 
throughout the descending aorta (arrowheads in B). Boxes in A, B indicate 
approximate fields in C-F. (C-H) Representative confocal images of Wnt1-Cre; 
R26RYFP NC (green) in the VSMC layer of the aortic arch, determined by Z-stack 
analysis; SM22α (C, D) or SM-MHC (E-H) in red. Control YFP-positive cells 
formed a distinct border at the level of the ductus arteriosus (C, E) and were not 
detected in the descending aorta (G). In contrast, Foxd3 mutant NC (YFP-
positive) was located distal to the border (border marked with arrows, ectopic 
cells indicated with arrowheads in D and F) in the descending aorta (H). Fields in 
G and H depict distal regions of the aorta approximately one third of the distance 
towards the diaphragm. Abbreviations: AoA, aortic arch; da, ductus arteriosus; 
dAo, dorsal aorta; lcc, left common carotid; lsc, left subclavian artery; RV, right 
ventricle. 
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Figure 18. Foxd3 mutant NC gives rise to ectopic VSMCs in the tunica 
media of the descending aorta. (A, E) Transverse sections through the 
ascending aorta of a Foxd3flox/+; Wnt1-Cre; R26RYFP control (A) and a Foxd3flox/-; 
Wnt1-Cre; R26RYFP mutant (E) embryo subjected to immunofluorescence 
analysis revealed SMA (red) and YFP (green) expression in NC derived cells 
(arrows). (B-D, F-H) Further posteriorly, at the level of the apex of the heart, NC 
was not detected within the VSMC layer of the descending aorta of control 
embryos (B-D). By contrast, ectopic mutant NC in the descending aorta partially 
overlapped with SMA (F), SM22α (G) and SM-MHC (H) in adjacent sections. 
Examples of YFP-positive VSMCs are indicated with arrows. (I) Red lines 
indicate the level of sections through the aorta. Normal contribution of NC to the 
aorta is indicated by green shading. Ao, aorta; bc, brachiocephalic artery; da, 
ductus arteriosus; dAo, descending aorta; lcc, left common carotid; lsc, left 
subclavian artery; rcc, right common carotid; rsc, right subclavian artery.  
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Figure 19. Analysis of cardiac NC in wildtype and Foxd3-heterozygous 
embryos. (A, B) Fate-mapping in diaphragms (top view) from a 16.5 dpc 
wildtype (A) and Foxd3+/-; Wnt1-Cre; R26RLacZ (heterozygous) embryo (B) 
showed similar distribution of X-gal-positive NC cells in phrenic nerves (arrows) 
of the diaphragm. (C-F) NC cells formed parasympathetic cardiac ganglia in 
hearts from wildtype (C) and heterozygous (D) embryos, and showed normal 
lineage boundaries in the aortic arch (E, F, arrows). AoA, aortic arch; CG, cardiac 
ganglia; dAo, descending aorta; e, esophagus; LA, left atria; LL, left leaflet; LV, 
left ventricle; ML, middle leaflet; RA, right atria; RL, right leaflet; RV, right 
ventricle. 
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between wildtype and Foxd3-heterozygous control embryos (Figure 19).  
 Our data may indicate that Foxd3 mutant cardiac NC-derived VSMCs are 
unable to maintain their position rostral to this border, or alternatively, other 
initially non-VSMC NC progenitors, presumably from vagal and/or trunk NC, may 
inappropriately acquire VSMC fates and aberrantly contribute to the descending 
aorta. To determine if NC contribution to the PAAs and aorta was disrupted at 
earlier stages, we examined lineage-traced control and Foxd3 NC-mutant 
embryos at 9.5-10.0 dpc (Figure 20, A-D'). At both stages, Foxd3 mutant NC 
were detected in close proximity to the descending aorta at mid-trunk levels 
(Figure 20 B, D), despite formation of a distinct NC boundary at the distal edge of 
the sixth PA (the primordial ductus arteriosus) that was comparable to controls 
(Figure 20, C-D'). Although these experiments were not conclusive with respect 
to identifying the origin of ectopic NC in Foxd3 mutant embryos, our data are 
consistent with the possibility that NC that would normally contribute to vagal 
and/or trunk derivatives precociously acquired a VSMC fate in the absence of 
Foxd3.  
 
Foxd3 regulates mesenchymal differentiation in cranial NC 
The ectopic location of Foxd3 mutant NC-derived VSMCs in the aorta raised the 
question of whether other mesenchymal NC populations were similarly affected 
by loss of Foxd3. Cranial NC generate both neural (cranial ganglia) and 
mesenchymal (facial bone and cartilage) derivatives, therefore we examined 
differentiation and patterning of this NC population. Analysis of TUJ1 expression 
 90 
 
 
 
 
Figure 20. NC cells form a distinct border between PAAs and the 
descending aorta in control and Foxd3 mutant embryos. (A-D) 
Representative confocal images of Wnt1-Cre; R26RYFP lineage mapped NC 
(green) in 9.5-10.0 dpc control (A, C) and mutant (B, D) embryos showed YFP-
positive NC at the normal lineage boundary between the distal edge of the sixth 
PA and descending aorta (yellow arrows) as determined by Z-stack analysis. In 
contrast to controls, mutant NC cells were also detected in close proximity to the 
descending aorta at mid-trunk levels at 9.5-10.0 dpc (B, D, white arrows) (n=5). 
Images in C', D' show higher magnification of NC boundary shown in C, D. 
Normal contribution of NC to the PAAs is indicated by green shading in drawings 
(bottom left). Abbreviations: PA3, third pharyngeal arch; PA4, fourth pharyngeal 
arch; PA6, sixth pharyngeal arch; Ao, decending aorta; * indicates pharyngeal 
arch surface located outside of the focal plane. 
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(neurons) in lineage-traced embryos revealed that, in contrast to control embryos 
(Figure 21 A), mutant NC showed limited contribution to cranial nerves, with co-
expression of TUJ1 and YFP primarily in DRG (Figure 21 B). During early stages 
of endochondrial bone formation (11.5 – 12.5 dpc), chondrogenesis was not 
apparent in control embryos: Runx2, marking osteoblast progenitors, and 
Collagen-II, a chondrocyte marker, were not detected (data not shown). Sox9 
expression (marking osteo-chondroprogenitors) was only faintly detected in the 
mandibular component of the first pharyngeal arch at 11.5 dpc (Figure 21 C).  In 
12.5 dpc control embryos, Sox9 was uniformly expressed in the distal mandibular 
precartilage primordium (Figure 21 E-E”) and this expression domain largely 
overlapped with that of Runx2 (Figure 21 F-F”, arrowheads). In stark contrast, 
mutant NC showed precocious induction of Sox9 at 11.5 dpc (Figure 21 D). By 
12.5 dpc, Sox9 was strongly expressed in the medial region of the developing 
mandible with lower expression at the lateral edges (Figure 21 G-G”, arrow) 
whereas Runx2 was highly expressed at the lateral edges (Figure 21 H-H”, 
arrowheads). Our results indicate that Foxd3-null cranial NC cells preferentially 
formed non-neural lineages and that differentiation of mesenchymal NC lineages 
was accelerated. 
 
Maintenance of NCSC marker expression is dependent on Foxd3 
 The observation that Foxd3 is expressed in early, presumably multipotent, 
NC, and downregulated in later migratory NC, raised the hypothesis that Foxd3 is 
required to maintain the multipotent nature of NC. To address this in a tightly 
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Figure 21. Foxd3 regulates timing of mesenchymal differentiation in cranial 
NC. (A-D) In vivo characterization of cranial NC differentiation in Wnt1-Cre; 
R26RYFP control and mutant embryos. TUJ1 (red) and YFP (green) expression 
identified NC-derived neurons (yellow arrowheads) and non-NC-derived neurons 
(white arrowheads) in transverse sections of 11.5 dpc embryos (A,B). Expression 
of Sox9 (red) in the mandible represents precocious differentiation towards 
mesenchymal NC fates in mutant (D) compared with control (C) embryos. (E-H) 
Sox9 and Runx2 expression at 12.5 dpc.  In near-adjacent sections through the 
mandible of a control embryo, Sox9 expression (E-E”) overlaps extensively with 
the Runx2 expression domain (arrowheads, F-F”). In Foxd3 mutant embryos, 
Sox9 was strongly expressed in a wedge of cells at the center of the mandible 
(arrow) with low levels of expression in adjacent mesenchyme (arrowheads, G-
G”). Runx2-expressing osteoblast progenitors are adjacent to cells expressing 
high levels of Sox9 (H-H”), indicating segregation of osteoblast and chondrocyte 
lineages characteristic of a later developmental stage. Images were captured at 
identical exposures for control and mutant sections and manipulated in a similar 
manner. Small boxes in A and B denote magnified region at the upper right, 
larger boxes denote regions shown in panels C and D. Boxes in E-H indicate 
regions shown in E’-H” to the right. Abbreviations: DRG, dorsal root ganglia; *, 
craniofacial defect. 
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controlled manner, we turned to a culture system in which neural tube-derived 
NCSCs can be maintained as undifferentiated cells (Stemple and Anderson, 
1992). Approximately 96% of cells actively migrating away from neural tube 
explants demonstrated Wnt1-Cre-based reporter activation (Figure 22 A-F). 
Nuclear Foxd3 expression was detected in control NC cultures but undetectable 
in mutant NC (Figure 23 A, B), demonstrating efficient deletion of the coding 
region. Heterozygous control NC cultured for 48 hours in self-renewal medium 
maintained expression of NCSC markers p75NTR and Sox10, and few cells 
expressed smooth muscle α-actin (SMA), a marker of myofibroblast and VSMC 
differentiation (Figure 23 C, E). By contrast, almost all mutant NC cells from both 
vagal and trunk levels were devoid of p75NTR (decreased by 99% in vagal and 
trunk NC cultures (p<0.05), (Figure 23 D, F; Figure 24 A-B''', F-G'''; Figure 25). 
Similarly, p75NTR expression was reduced in vivo in fate-mapped vagal and trunk 
NC in mutant embryos at 9.5 dpc (Figure 24 D-E, I-J), suggesting a role for 
Foxd3 in establishing or maintaining p75NTR -expressing NCSCs. Additionally, 
expression of Sox10, normally detected in NCSCs and differentiated glia, was 
reduced in mutant cultures. The few Sox10-positive cells present did not co-
express p75NTR (Figure 23 F), suggesting differentiation towards the glial lineage. 
Mutant explant cultures contained increased numbers of SMA-expressing cells 
(Figure 23 D), demonstrating that mutant NC differentiate towards the 
myofibroblast lineage under conditions that normally maintain undifferentiated 
NCSC. 
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Figure 22. Neural tube outgrowths are NC derived. (A-F) Wnt1-Cre; Z(eg) (A-
C) and Wnt1-Cre; R26RYFP (D-F) 9.5 dpc neural tubes cultured for 48 hours 
showing most of the cells (91% of Wnt1-Cre; Z(eg) and 96% of Wnt1-Cre; 
R26RYFP) that migrated away from neural tube explants (white outline) were GFP 
or YFP reporter-positive (green) NC cells as lineage mapped with Wnt1-Cre. 
DAPI-stained nuclei are in red. Very few cells were GFP or YFP-negative 
(arrowheads). NC cells were counted from two Wnt1-Cre; Z(eg) and three Wnt1-
Cre; R26RYFP embryos. Neural tubes isolated from 8.5 dpc Wnt1-Cre; R26RYFP 
embryos before the 10-somite stage resulted in variable detection of Wnt1-Cre-
mediated recombination of R26RYFP in outgrowths (data not shown). For this 
reason, all experiments here were performed with later embryos (9-9.5 dpc). 
Scale bars: 100 µm.  
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 To further evaluate if Foxd3 is required to repress differentiation of 
individual NC cells towards multiple lineages, thereby ensuring continued 
multipotency, we performed in vitro culture of NC cells at clonal density (Stemple 
and Anderson, 1992). Individual control NC cells typically proliferated to form 
round, tightly packed colonies whereas the majority of mutant colonies consisted 
of loosely-packed fibroblast-like cells, consistent with the data above that showed 
a tendency for mutant NC to adopt a myofibroblast fate (Figure 23 G, H). To 
examine differentiation status at a molecular level, NC colonies were cultured for 
six days under self-renewing conditions and evaluated for expression of p75NTR 
or markers of neural (Peripherin), glial (glial fibrillary acidic protein (GFAP)), and 
myofibroblast (SMA) differentiation. Control NC colonies expressed p75NTR 
(Figure 23 I), and significant neural, glial, and myofibroblast differentiation was 
not detected (Figure 23 K). In stark contrast to controls, clonally derived mutant 
NC colonies rarely expressed p75NTR (Figure 23 J), and many NC colonies (60-
70%) contained SMA-positive cells, although the remaining non-myofibroblast 
colonies did not exhibit aberrant neural and glial differentiation (Figure 23 L). 
These data indicate that Foxd3 is required to repress myofibroblast differentiation 
and maintain NCSCs in an undifferentiated state. 
 Consistent with increased apoptosis in the neural tube of Foxd3 NC-
mutant embryos (Teng et al., 2008), the loss of p75NTR and Sox10 in mutant NC 
could reflect selective apoptosis of NCSCs. However, apoptosis was only 
modestly increased in Foxd3 mutant NC in vitro, measured by cleaved-Caspase3 
detection or TUNEL assay (Figure 25). Comparison of control and mutant 
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Figure 23. Maintenance of NCSC marker expression is dependent on 
Foxd3. (A, B) Immunocytochemistry revealed nuclear Foxd3 (green) in the 
majority of control NC cells in a 48-hour vagal neural tube explant culture (A). 
Foxd3 expression was undetectable in a Foxd3flox/-; Wnt1-Cre mutant neural tube 
outgrowth (B). (C, D) Immunofluorescence images showing p75NTR (green) and 
SMA (red) in NC explants. Most cells in control cultures were negative for SMA, 
with robust p75NTR expression. Mutant NC outgrowths had reduced p75NTR 
expression and increased numbers of SMA-expressing cells. (E, F) 
Immunocytochemistry for Sox10 (red) and p75NTR (green) in control NC cultures 
showed widespread co-expression of these two NCSC markers (E). Mutant 
outgrowths contained reduced numbers of Sox10-positive cells and p75NTR 
expression was not detected (F). (G-L) Secondary NC cultures at clonal density. 
Control colonies were typically round and contained spindle-like cells (G), 
maintained p75NTR expression (green) (I) and showed little significant 
differentiation into myofibroblasts (assayed by SMA expression, green) (K) after 
6 days of culture. Mutant NC formed irregularly shaped colonies (H), did not 
maintain p75NTR expression (J), and the majority of colonies (approximately 70%) 
contained large, flattened cells expressing SMA (L). Scale bars for all panels = 
100 µm.  
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Figure 24. Foxd3 is required for p75NTR expression in vagal and trunk NC. 
(A-B''') Immunohistochemistry for YFP and p75NTR in primary vagal NC cultures. 
Explant from a Foxd3flox/+; Wnt1-Cre; R26RYFP (control) embryo with lineage-
labeled p75-positive NC cells (A). Very few Foxd3 mutant YFP-positive NC cells 
expressed p75NTR (B). (C) To quantify migration of NC, ImageJ software was 
used to measure the area of NC explants after 48 hours in culture. To control for 
random variations in explant size and shape, the migration index was determined 
by dividing the NC outgrowth area (entire explant area minus the area of the 
neural tube) by the area of the central neural tube. No differences were observed 
in migration between genotypes. Data represent the mean ± s.e.m. for six 
control and mutant explants. (D-E'') In vivo fate-mapping of NC with R26RYFP 
(green) compared to p75NTR expression (red) in migrating vagal NC. Confocal 
images of wholemount staining at 9.5 dpc in a control embryo showed p75NTR-
positive vagal NC migrated into the third and fourth pharyngeal arches (arrows) 
and presumptive foregut. (D-D''). Green box in cartoon (right) indicates the region 
magnified in D-E. Mutant vagal p75NTR-positive NC were reduced compared to 
controls. (F-G''') Cells in control trunk neural tube explants expressed YFP and 
p75NTR (F). By contrast, p75NTR expression was not detected in lineage-labeled 
Foxd3 mutant trunk NC (G). (H) Migration index of trunk neural tube explants. 
Data represent mean ± s.e.m. for three control and mutant littermates and was 
calculated as described above for C. (I-J'') In vivo fate-mapping (R26RYFP) and 
p75NTR expression in migrating trunk NC is shown. Confocal analysis of 
wholemount staining at 9.5 dpc in a control embryo showed p75NTR-positive NC 
migrated into somites at the level of the hindlimb (arrow, I). The green box in 
cartoon (right) indicates region magnified in I-J; anteriormost somites are at top 
of the panels. The few mutant NC cells present in the somites had reduced 
expression of p75NTR (arrow, J). Scale bars: 100 µm.  
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outgrowths showed no significant differences in initial cell numbers or migration 
index despite loss of p75NTR expression (Figure 24 C, H). In a complementary 
approach, we failed to detect restoration of NCSC numbers when neural tube 
explants were exposed to an apoptosis inhibitor (the caspase inhibitor, Z-VAD-
FMK, (Maynard et al., 2000; Uesaka et al., 2007)). Using TUNEL assays to 
detect caspase-dependent and independent apoptosis, Z-VAD-FMK reduced cell 
death in both control and mutant NC, but p75NTR expression was not restored 
(Figure 25). This suggests a direct cell-autonomous role for Foxd3 in maintaining 
NCSC multipotency, rather than simply increasing cell survival. 
 
Reduced self-renewal in Foxd3 mutant NC 
 Self-renewal is a defining characteristic of stem cells, and Foxd3 is crucial 
for this property in ESCs (Hanna et al., 2002; Liu and Labosky, 2008). Therefore, 
to determine if Foxd3 regulates self-renewal in NCSCs we used neurosphere 
culture assays to measure this critical stem cell property. Compared to wildtype 
NC, Foxd3 mutant NC generated smaller neurospheres at much lower frequency 
(Figure 26 A-D). Analysis of secondary neurosphere formation from dissociated 
individual primary neurospheres showed that Foxd3 mutant NC was significantly 
impaired in self-renewal capacity (vagal NC reduced by 64%; trunk NC by 47%, 
Figure 26 E). To control for the smaller size of primary Foxd3 mutant 
neurospheres, we also dissociated pools of primary neurospheres, plated 
equivalent cell numbers, and again observed similar reductions in self-renewal 
from mutant neurospheres (reduced 63% for vagal NC, 55% for trunk NC; Figure  
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Figure 25. Inhibition of caspase-dependent apoptosis in Foxd3 mutant NC.  
(A, B) Apoptotic cells in control (A) and mutant NC (B) cultures labeled using 
immunofluorescence for cleaved-caspase3 (green). (C-F) Immunocytochemistry 
for p75NTR (green) combined with TUNEL assay (red) in vehicle (C,D) and 
caspase-inhibitor (E, F) treated control and mutant explants. Despite a clear 
inhibition of cell death, p75NTR expression was not restored in mutant NC treated 
with 100 mM Z-VAD-FMK. (G) Percentage of cleaved caspase3-positive cells in 
control and mutant outgrowths. NC cells were counted from five control and three 
mutant embryos. (H-I) Percentage of p75NTR -positive (H) and TUNEL-positive (I) 
cells in explant cultures with vehicle and inhibitor treatments. NC cells were 
counted from three vehicle and three inhibitor-treated control embryos and two 
vehicle and four inhibitor-treated mutant embryos. Data shown are mean ± 
s.e.m., *p< 0.05. 
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 26 F-H). Taken together, our findings reveal a conserved role for Foxd3 in both 
NC and ESCs in the maintenance of stem cell self-renewal. 
 
Foxd3 is required for multilineage potential of NC progenitors   
 If Foxd3 plays a role in maintaining multipotency of NCSCs, it is possible 
that individual mutant NC may have a restricted ability to generate progeny 
towards one or more NC lineages. In vivo, Foxd3 mutant NC gave rise to 
mesenchymal lineages, but showed limited capacity to generate neurons 
(Figures 16-21). Similarly, NC contributed some neurons and glia to smaller than 
normal DRG, but derivatives more distal to the neural tube were absent (Teng et 
al., 2008). To directly address whether individual NC cells have reduced lineage 
potential, clonally-derived colonies from vagal and trunk NC were cultured under 
differentiation-promoting conditions, and lineage potency measured by 
immunocytochemistry for differentiation markers as above and scored as 
described (Morrison et al., 1999), (Figure 27 A). Compared to wildtype (or 
heterozygous, Figure 28 C) control cultures, Foxd3 mutant NC had significantly 
reduced numbers of neuron (N)-containing colonies (mutant vagal and trunk N-
containing colonies reduced by 61% and 69%, p<0.001, Figure 28 A, B), 
supporting a role for Foxd3 in maintaining neural potential, consistent with in vivo 
results (Figure 16). Further quantification indicated that individual mutant cells 
had additional defects in potency. For example, a reduced proportion of bi-potent 
cells produced both neurons and myofibroblasts (N+M; Figure 27 B, C). Most 
significantly, mutant NC rarely (1% of vagal NC, 2% of trunk NC, p<0.001) 
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Figure 26. Reduction of self-renewal in Foxd3 mutant NC.   
(A-D) Dissociated vagal and trunk NC were cultured at clonal density in non-
adherent conditions for 10 days. Representative control (A) and mutant (B) 
primary NC neurospheres are shown. Quantification of relative neurosphere 
diameter (C) and percent of dissociated cells that formed primary neurospheres 
(D) demonstrated defects in Foxd3 mutant NC. (E-H) Self-renewal was 
measured from individually isolated primary neurospheres (E) or as the relative 
frequency of secondary sphere formation from pooled primary neurospheres (F). 
Representative fields of control (G) and mutant (H) secondary neurospheres. 
Scale bars = 50 µm. Data represent 3-6 independent experiments with 3 
technical replicates for pooled neurospheres and 8 replicates for individual 
neurospheres for each experiment. All statistics are mean ± s.e.m., *(p< 0.05). 
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formed multipotent (N+G+M) colonies compared to control NC (10% of vagal NC, 
16% of trunk NC). The rare mutant multipotent colonies were significantly smaller 
than controls, and almost always showed a strong differentiation bias towards a 
single fate (N, G, or M), with few cells adopting other fates. Coincident with loss 
of multipotency, mutant clonal cultures displayed an increased incidence of 
myofibroblast (M-only) colonies, but the percent of neural or glial (N-only or G-
only) colonies was unaffected. This altered spectrum of potential in control 
versus mutant NC was similar in vagal and trunk NC, demonstrating that loss of 
multipotency, and an increased bias toward the myofibroblast lineage, is an 
equivalently penetrant phenotype along the anterior-posterior axis (Figure 27 B, 
C). In a complementary approach, inducible deletion of Foxd3 after NC migrated 
from the neural tube resulted in reduction of Sox10 expression, and recapitulated 
these changes in NC potency (loss of N+G+M and bias towards M-only, Figure 
29 A-F). In all the above assays, Foxd3-heterozygous NC were similar to 
wildtype in p75NTR expression, self-renewal and lineage composition of clonal 
cultures (Figure 28 F and data not shown), consistent with absence of NC 
defects in heterozygous embryos or mice. Together, these data clearly 
demonstrate that Foxd3 is required to maintain multipotency in NCSCs, but is not 
required for differentiation to any specific lineage.  
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Figure 27. Foxd3 controls multipotency of individual NC cells.  
(A) NC cells were cultured at clonal density in self-renewal medium for 6 days 
and then differentiation was promoted for 8 days by changing culture medium. 
Immunocytochemical analysis of multilineage differentiation into neurons 
(peripherin), glia (GFAP, red), and myofibroblasts (SMA, green). Images of a 
single field from a control (N+G+M) multilineage containing colony (left), a rare 
Foxd3 mutant (N+G) colony (center) and a more typical (M-only) mutant colony 
(right panels) are shown. Insets show higher magnification of Peripherin-positive 
neurons. (B, C) Quantification of lineage composition of single-cell derived 
colonies. Both vagal and trunk Foxd3 mutant NC formed bi-potent colonies with 
neural potential (N+G and N+M) at reduced frequency and rarely formed 
multipotent colonies compared to control cultures. Mutant clonal cultures 
contained an increased percent of myofibroblast-only (M-only) colonies and were 
unchanged from control NC in establishing restricted progenitor colonies (N-only 
or G-only). Data represent 6 independent experiments with at least 3 technical 
replicates of clonal cultures from 10 mutant and 6 wildtype littermate control 
embryos. All statistics are mean ± s.e.m., *p< 0.05 comparing control to mutant. 
(D). A model of Foxd3 action in multipotent NCSCs. Foxd3 is required for self-
renewal of NCSCs (curved arrows) and for maintenance of the neural lineage 
choice (N). Without Foxd3 (right side of diagram) NCSCs have reduced self-
renewal capacity (dashed ”X”) and preferentially and precociously differentiate 
towards mesenchymal fates. 
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Figure 28. Clonal analysis of differentiation in vagal and trunk NC. (A,B) 
Control and Foxd3 mutant NC clones were cultured in self-renewal conditions for 
6 days, then changed to differentiation-promoting medium for 8 days. 
Composition of vagal (A) and trunk (B) NC colonies were scored based on 
differentiation into (N) neurons (Peripherin), (G) glia (GFAP) and (M) 
myofibroblasts (SMA). (C,D) Plating efficiencies for the vagal and trunk NC 
cultures were calculated as the percentage of plated cells that formed colonies. 
(E) Co-expression of YFP (green), TUJ1 (red) and peripherin (purple) in a control 
(top) and a mutant (bottom) colony. N-containing colonies in Foxd3 mutant 
cultures are derived from founder cells showing Wnt1-Cre activity as assessed 
with YFP expression. These colonies typically contained a reduced number of 
neurons. All statistics are mean ± s.e.m., *p<0.05. (F) The full multipotency 
differentiation profile of NC clones is presented as pooled data from all embryos 
tested and as the mean of biological replicates in Figure 24 B, C. 
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Figure 29. Inducible deletion of Foxd3 in vitro results in reduced Sox10 
expression and loss of NC multipotency. (A) Foxd3flox/flox (control) and 
Foxd3flox/flox; ER-Cre (mutant) NC explants were cultured for 48 hours, then the 
neural tubes were removed and culture medium changed to contain 2 µM 
tamoxifen. After an additional 24 hours, cultures were fixed and analyzed for 
YFP, Foxd3 and Sox10 expression, or littermate cultures were plated for clonal 
culture. In contrast to control explant outgrowths (left), Foxd3 expression was not 
detected and the number of Sox10-expressing cells was greatly reduced in 
mutant cultures. (B) Clonal analysis of multilineage differentiation into neurons 
(Peripherin), glia (GFAP, red), and myofibroblasts (SMA, green). Images of a 
single field from a control (N+G+M) multilineage containing colony (left), and an 
M-only mutant colony (right panels) are shown. Bottom left panel shows SMA-
expressing cells outside of the field at the edge of the control colony. (C-F) 
Composition of vagal (C,E) and trunk (D,F) NC colonies were scored based on 
differentiation into N, G and M. Data represent the mean of biological replicates: 
four mutant and four littermate control embryos (vagal NC cultures) and three 
control and two mutant embryos (trunk NC cultures), with at least three technical 
replicates performed for each embryo. NC cells from all control tamoxifen-treated 
outgrowths generated colonies when plated clonally, whereas inducing Cre 
activity resulted in no colonies in one out of five vagal NC and two out of four 
trunk NC cultures. All statistics are mean ± s.e.m., *p<0.05 comparing control 
with mutant. 
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Discussion 
 Our findings demonstrate a cell-autonomous requirement for the 
transcription factor Foxd3 in maintaining both self-renewal and multipotency of 
NC progenitors. Foxd3 plays a pervasive role in preserving these definitive stem 
cell properties throughout the NC; the conditional inactivation of Foxd3 affected 
cranial, cardiac, vagal and trunk domains similarly. Clonal analyses of Foxd3 
mutant NC indicated a severe reduction in self-renewal and an increased bias 
towards myofibroblast-directed NC, which was associated with an almost 
complete loss of multipotent NCSCs. Overall, neural differentiation was reduced 
in mutant cultures, suggesting that multipotent (neural/glial/myofibroblast, 
N+G+M) cells and neural-containing bipotent cells (neural/myofibroblast, N+M or 
neural/glial, N+G) undergo a selective loss of neural potential, moving towards 
myofibroblast or glial fates. However, the frequency of neural-only or glial-only 
restricted progenitors was not significantly altered, indicating that lineage entry is 
not impaired by loss of Foxd3. Our current model is that Foxd3 permissively 
maintains multipotent NCSCs in an uncommitted state, rather than functioning as 
part of an instructive cue to instill neural or glial competency.  
 Our results support a model in which Foxd3 functions as a gatekeeper in 
multipotent NCSCs to repress mesenchymal lineages and preserve neural fates 
and multipotency (Figure 27 D). NC-specific inactivation of Foxd3 caused 
profound deficits in innervation of several target organs, and NC cells aberrantly 
adopted mesenchymal cell fates. This is consistent with the notion that Foxd3 
functions in opposing programs controlling neural versus mesenchymal potential 
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of NC. Without Foxd3, individual NC cells committed to one of the three major 
lineages (neural, glial, or myofibroblast) may be unaffected, while multipotent and 
bi-potent progenitors destined to more distally located neural and/or glial fates 
are unable to repress differentiation toward mesenchymal lineages. An 
alternative, although not mutually exclusive, explanation is that the progressive 
reduction in mutant NC self-renewal we describe here may selectively exhaust 
the neural-containing progenitor pool, so that by the time NC reach distant 
locations, their overall neural potential is dramatically reduced or absent. In either 
of these possibilities, we suggest that Foxd3 promotes self-renewal and 
multipotency independent of NCSC survival mechanisms because blocking 
caspase activity in Foxd3 mutant NC cultures did not restore expression of 
NCSC-associated proteins. 
 
Foxd3 represses ectomesenchymal cell fates. 
 Distinct NC cell fates are thought to arise via progressive restrictions in 
lineage potential prior to and during NC migration (Young et al., 2003; Krispin et 
al., 2010). Foxd3 is expressed in pre-migratory NC and is maintained in early 
migrating NC progenitors, but is downregulated in cranial and cardiac NC 
mesenchyme well before chondrocyte, osteoblast or VSMC differentiation. Our 
findings demonstrate an early requirement for Foxd3 in repression of 
ectomesenchymal fates shortly after cells leave the neural tube, prior to arrival at 
the pharyngeal arches or cardiac OFT. During craniofacial development, Sox9 is 
required for specification of bi-potent osteochondroprogenitors (Lefebvre et al., 
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1997; Akiyama et al., 2002; Mori-Akiyama et al., 2003) and subsequently, Runx2 
acts as a determining factor for differentiation of osteoblasts (Ducy et al., 1997; 
Komori et al., 1997). Loss of Foxd3 in the NC resulted in ectopic activation of 
both Sox9 and Runx2 in cranial NC, therefore premature endochondrial bone 
and cartilage formation may underlie the severe craniofacial defects observed in 
Foxd3 NC-mutant embryos (Teng et al., 2008).  
 In addition to controlling the timing of cranial NC differentiation, we also 
provide evidence that Foxd3 is required to restrict NC progenitors from VSMC 
and myofibroblast fates. Normally, cardiac NC generates VSMCs in precise 
regions of the aortic arch and great vessels (Le Lievre and Le Douarin, 1975; 
Jiang et al., 2000). The contribution of NC-derived VSMCs extends from the 
ascending aorta caudally to the precise location where the ductus arteriosus 
connects to the aortic arch. Further caudally, VSMCs in the descending aorta are 
derived from mesoderm (Esner et al., 2006; Wiegreffe et al., 2007; Wasteson et 
al., 2008). Our lineage-tracing experiments showed that Foxd3 mutant NC 
extended caudally well past the aortic boundary, but other NC-mesoderm 
boundaries in the pulmonary arteries were still respected (data not shown). In 
multiple locations in vivo and in vitro the neural potential of mutant NC was 
decreased while mesenchymal potential was increased. Therefore, it is tempting 
to speculate that mutant NC located in the distal aorta are derived from cells that 
would normally give rise to neural and/or glial cells in the nearby gastrointestinal 
tract or sympathetic ganglia that underwent an inappropriate lineage decision to 
a mesenchymal fate. Lineage analysis of NC populations captured on the basis 
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of emigration and Foxd3 expression status could begin to define these 
transitional cell states in a prospective manner, and live cell imaging in the whole 
embryo could resolve some of these unanswered questions.  
 
Molecular regulation of progenitor cell multipotency and self-renewal. 
 One surprising discovery we describe here is that Foxd3 functions to 
preserve multi (or bi) potency by maintaining the neural lineage choice open in 
multipotent NCSCs. Therefore, regulation of Foxd3 expression is important with 
respect to the ability of NC to interpret environmental signals effecting lineage 
allocation. Combinatorial Wnt and BMP signaling synergistically maintain NCSC 
multipotency and suppress differentiation (Lee et al., 2004; Kleber et al., 2005; 
Wurdak et al., 2005) and TGFβ signaling promotes non-neural lineage 
differentiation from NCSCs (Shah et al., 1996; Wurdak et al., 2005). Our findings 
here are consistent with the possibility that Foxd3 functions at a critical early step 
in NCSC multipotency and self-renewal by permissively maintaining 
responsiveness to Wnt/BMP signaling and/or functions in opposition to TGFβ 
signaling to promote neural fates. In contrast to factors such as Bmi1 and 
Hmga2, that specifically regulate self-renewal independent of initial NC 
multipotency (Molofsky et al., 2003; Nishino et al., 2008), Foxd3 is required in 
newly generated NC for both multilineage potential and self-renewal. It is likely 
that these properties are intimately coupled by Foxd3; reduced self-renewal of 
mutant NC may be due to increased differentiation and not due to direct cell 
cycle regulation. Proliferation of Foxd3 mutant NC is not reduced in vivo, or in 
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Foxd3 mutant ES cells despite diminished self-renewal and multipotency (Liu and 
Labosky, 2008; Teng et al., 2008).  
 In addition to Foxd3, the only other transcription factor definitively linked to 
multipotency of NC is Sox10, which maintains NCSCs by inhibiting differentiation 
into neural cell fates to allow for gliogenesis (Kim et al., 2003). Heterozygous loss 
of Sox10 results in defects in glial and melanocyte lineages and, similar to Foxd3 
NC-mutant embryos, Sox10 homozygous mutants fail to form the ENS 
(Southard-Smith et al., 1998). Sox10 expression is markedly reduced in both 
Foxd3 mutant embryos (Teng et al., 2008) and NC cultures. While it is possible 
that Foxd3 may regulate Sox10 expression and vice versa, it is also likely that 
they are coordinately regulated (Drerup et al., 2009). Sox10 preservation of glial 
fates may act in synchrony with Foxd3-mediated maintenance of neural 
competency within NCSCs to ensure multipotency. Future studies will address 
whether these two transcription factors act in a single common pathway or in 
parallel to regulate NCSC multipotency.  
 The precise molecular mechanisms by which Foxd3 controls self-renewal 
and multipotency are incompletely understood, but presumably involve direct 
regulation of gene transcription and/or regulation of chromatin modifications (Xu 
et al., 2009; Liber et al., 2010). Although primarily characterized as a 
transcriptional repressor, Foxd3 has both activator or repressor activity, 
depending upon the cellular context (Sutton et al., 1996; Guo et al., 2002; Lee et 
al., 2006; Steiner et al., 2006; Yaklichkin et al., 2007). A distinct possibility is that 
interactions with differentially expressed co-factors modulate Foxd3 function. 
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Consistent with this idea, Foxd3 mediates repression of Mitf (thereby inhibiting 
melanocyte cell fate) via a protein-protein interaction with Pax3, and not by direct 
effects on the Mitf cis-regulatory sequences (Thomas and Erickson, 2009). 
Together with our previous findings, the model emerging is of a complex, 
context-dependent role for Foxd3 as a multifunctional protein regulating gene 
expression in distinct cellular programs. A further possibility is that Foxd3 
controls multipotency and self-renewal of NC by its central participation in the 
overall repression of gene regulatory networks promoting NC differentiation to 
non-neural lineages. 
 Our work now adds NCSCs to ESCs and TSCs as multipotent progenitor 
pools with a strict requirement for Foxd3 in maintaining multipotency and self-
renewal (Hanna et al., 2002; Tompers et al., 2005; Liu and Labosky, 2008). This 
molecular conservation of function suggests that Foxd3 may be a fundamental 
integrator and/or effector of the upstream pathways modulating “stemness”. 
Determining if Foxd3 regulates common target genes or signaling pathways in 
these divergent progenitor populations could lead to a clearer fundamental 
understanding of the levels of regulation involved in multipotency, and assist with 
development of methods for accessing control of populations for use in stem cell-
based therapies; these will be important future directions.   
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CHAPTER IV 
 
ENTERIC NERVOUS SYSTEM SPECIFIC DELETION OF FOXD3 DISRUPTS 
GLIAL CELL DIFFERENTIATION AND ACTIVATES COMPENSATORY 
ENTERIC PROGENITORS 
 
Introduction 
 The enteric nervous system (ENS) is a large and complex network of cells 
that regulates motility, secretion and blood flow in the gastrointestinal (GI) tract. 
Within the gut muscle wall, interconnected ganglia, containing a diverse array of 
neurons and glia, are organized into the myenteric and submucosal plexi 
(Gershon et al., 1993; Gershon, 2010). The cells that comprise the ENS are 
derived from neural crest (NC) progenitors that arise from the dorsal neural tube 
at both vagal and sacral levels during early embryonic development (Le Douarin 
and Kalcheim, 1999). The vast majority of the ENS is generated from vagal NC 
cells, which emigrate from the level of somites 1-7 (Yntema and Hammond, 
1954; Le Douarin and Teillet, 1973). In mice, vagal NC enter the foregut at ~9.0 
dpc, migrate in a rostrocaudal wave along the entire length of the GI tract to 
generate both neural and glial lineages (Young et al., 1998; Natarajan et al., 
1999). During this process, NC progenitors at the most caudal end of the 
migration wavefront have not initiated expression of lineage-specific markers and 
undergo extensive proliferation, whereas cells rostral to the wavefront show 
various stages of differentiation (Young et al., 1999; Simpson et al., 2007). In the 
hindgut, sacral NC, originating posterior to somite 24, contributes a smaller 
number of ENS progenitors that migrate in a caudorostral direction (Burns and Le 
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Douarin, 1998; Burns et al., 2000). Although sacral NC cells are responsible for 
innervation of the kidney, bladder, and reproductive organs, in the wildtype 
situation these cells halt migration after formation of the pelvic plexus ganglia and 
do not colonize the distal colon until vagal NC derived cells are present (~13.5-
14.5 dpc) (Kapur, 2000; Druckenbrod and Epstein, 2005).  
 Several signaling pathways converge to control cellular functions of 
multipotent NC progenitors during development of the ENS. Members of the 
GDNF family of ligands signal through the receptor tyrosine kinase Ret and its 
co-receptor GFRα1 to regulate the migration, proliferation, survival and neural 
differentiation of ENS progenitors. The effect of GDNF/Ret on ENS progenitors is 
modulated, in part, by Endothelin 3 signaling mediated by the G-protein coupled 
receptor Endothelin Receptor B (Ednrb). Specifically, Ednrb signaling maintains 
GDNF-driven proliferation (Barlow et al., 2003) and along with the transcription 
factor Sox10, inhibits differentiation of enteric neurons (Hearn et al., 1998; Wu et 
al., 1999; Bondurand et al., 2006), thus maintaining multipotent enteric neural 
crest stem cells (NCSCs) in an uncommitted, self-renewing state.  
 Hirschsprung’s disease, a congenital disorder characterized by failure of 
NC progenitors to completely colonize the gut and absence of enteric ganglia in 
the colon, is directly linked to defects in neural crest stem cell (NCSC) function 
(Iwashita et al., 2003). Both humans and rodents deficient for several genes 
including Sox10, and members of the GDNF and Endothelin 3 signaling 
pathways, suffer from aganglionosis of the distal colon and a megacolon 
phenotype (Baynash et al., 1994; Hosoda et al., 1994; Schuchardt et al., 1994; 
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Enomoto et al., 1998; Southard-Smith et al., 1998; Barlow et al., 2003). Because 
of the severity of aganglionosis in Hirschsprung’s disease patients, many ENS 
studies have focused on this disease, however, other abnormalities of the GI 
tract, including chronic constipation and functional bowel disorders are likely to 
be caused by developmental defects in ENS progenitors. NCSCs can be isolated 
from the ENS throughout embryogenesis and into postnatal life, and it is possible 
that ENS-derived NCSCs may be a source of neurons and glia for regeneration 
or repair of ENS disorders (Kruger et al., 2002; Kruger et al., 2003). 
 During ENS generation, multipotent NCSCs co-exist with fate-restricted 
NC, but mechanisms coordinating proliferation and neural versus glial 
differentiation of these separate progenitor pools are not completely understood. 
Markers of neuronal differentiation are readily observed soon after enteric NC 
initially invades the gut. In contrast, glial differentiation is first detectable well 
behind the initial wavefront of migrating NC, indicating differentiation of glia lags 
significantly behind differentiation of neurons (Heanue and Pachnis, 2007; Young 
et al., 2005). While much is known about molecules required for differentiation of 
enteric neurons, relatively little is understood about how enteric gliogenesis 
occurs. An emerging concept is that genes that initially function to maintain 
multipotency in NCSCs also play additional context-dependent roles in later cell 
fate decisions. For example, enteric NC progenitors entering the foregut can be 
identified by Sox10 or Phox2b expression (Kuhlbrodt et al., 1998; Natarajan et 
al., 1999; Young et al., 1999; Britsch et al., 2001), both of which are individually 
required for formation and establishment of the ENS (Southard-Smith et al., 
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1998; Pattyn et al., 1999). Sox10 maintains multipotency of NCSCs by inhibiting 
neural cell fates (Kim et al., 2003) and its expression is downregulated is 
differentiating neurons but maintained in glia (Kim et al., 2003; Deal et al., 2006). 
Together with Notch signaling, Sox10 is required for enteric gliogenesis (Taylor 
et al., 2007; Okamura and Saga, 2008). Conversely, Phox2b expression levels 
are decreased in glia (Pattyn et al., 1997; Young et al., 1998; Corpening et al., 
2008) and maintained expression of Phox2b is required for developing neurons 
(Pattyn et al., 1999).  
 The forkhead transcription factor Foxd3 is one of the earliest genes 
expressed in NC progenitors and this expression is maintained as NC begin 
populating the GI tract (Labosky and Kaestner, 1998; Perera et al., 2006; Teng et 
al., 2008). Our earlier work showed that Foxd3 is required to repress 
ectomesenchymal differentiation and preserve neural fates and multipotency of 
NCSCs (Mundell and Labosky, 2011). A NC-specific deletion of Foxd3 in mice 
resulted in perinatal lethality and severe defects in most NC derivatives, including 
complete loss of the ENS (Teng et al., 2008; Mundell and Labosky, 2011). 
Although Foxd3 is required for early NC development and establishment of ENS 
progenitors, its expression and cellular functions at later stages of ENS 
development have not been examined. 
 Here, we comprehensively map Foxd3 expression during murine ENS 
development and demonstrate that Foxd3 is initially expressed in enteric 
progenitors and subsequently maintained in differentiated glia. Using a novel 
Ednrb-iCre transgene, we specifically delete Foxd3 in vagal NC-derived ENS 
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progenitors to determine the functions of Foxd3 during late ENS development, 
after vagal NC progenitors colonize the proximal GI tract. Our in vivo lineage-
mapping experiments demonstrate that Foxd3 functions cell-autonomously to 
maintain both proliferation and glial differentiation of ENS progenitors. In addition, 
we have discovered a sub-population of Foxd3-expressing ENS progenitors that 
become activated in response to ENS defects, undergo regulative proliferation 
and differentiation, and compensate for initial disruption of ENS development due 
to loss of Foxd3 in vagal NC-derived cells.  
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Experimental Procedures 
 
Mouse lines 
  Foxd3 alleles were described previously (Hanna et al., 2002; Teng et al., 
2008). The Foxd3 null allele Foxd3tm2.Lby harboring a GFP-fusion protein (called 
Foxd3GFP) was used for some expression analyses, while an alternative null 
allele, Foxd3tm1.Lby, (called Foxd3- throughout) was used in combination with 
Foxd3tm3.Lby, the Foxd3 conditional allele (called Foxd3flox) for tissue specific 
deletion. The Ednrb-iCre transgenic line was generated by standard 
microinjection techniques (Nagy et al., 2003). The Ednrb ENS-specific enhancer 
was described in (Zhu et al., 2004) and consists of a genomic fragment (-1.2 kb 
to -160 bp) upstream of the Ednrb start site. This element was linked to an hsp68 
minimal promoter to direct expression of a codon-improved Cre recombinase 
(iCre) (Shimshek et al., 2002) in ENS progenitors. DNA for genotyping was 
obtained from embryonic yolk sac or tail biopsies, and the presence of the Ednrb-
iCre transgene was detected by genotyping for iCre with primers (5’-
GACAGGCAGGCCTTCTCTGAA-3’) and (5’-CTTCTCCACACCAGCTGTGGA-3’) 
that amplify a 522 bp fragment. The PCR conditions were 30 cycles of 94°C, 
58°C, and 72°C, each for 45 seconds, followed by 72°C for 10 min. Genotyping 
for Foxd3 alleles was as described (Hanna et al., 2002; Teng et al., 2008). 
Mouse lines were interbred to generate Foxd3flox/-; Ednrb-iCre (mutant) and 
Foxd3flox/+; Ednrb-iCre (littermate control) embryos or mice. For lineage analyses, 
the reporter strains Gt(ROSA)26Sortm1Sor (called R26RlacZ) and 
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Gt(ROSA)26Sortm1(EYFP)Cos (called R26RYFP) were included in the genetic 
background (Soriano, 1999; Srinivas et al., 2001). In some experiments, the 
Wnt1-Cre transgenic line (Danielian et al., 1998) was used to lineage-map NC. 
All lines were on a mixed genetic background (CD-1, 129S6, and C57BL/6) and 
maintained in accordance with protocols approved by the Vanderbilt University 
Institutional Animal Care and Use Committee (IACUC).  
 
Embryonic dissections and enteric muscle strip preparations 
 For timed pregnancies, females were checked daily for the presence of a 
vaginal plug, and noon on the day of plug designated 0.5 days post coitum (dpc). 
GI tracts (esophagus to anus) were dissected from 10.5-16.5 dpc embryos in ice 
cold PBS, mesentery was removed, and tissue fixed in 4% paraformaldehyde 
(PFA) in phosphate buffered saline (PBS) for 4 hours or overnight and washed in 
PBS. For muscle strips, the GI tract was dissected from postnatal (P11-P14) or 
adult mice (2-3 months old) and fixed for 6-8 minutes in ice cold neutral buffered 
formalin. After initial fixation, the intestine was further dissected into segments 
corresponding to the duodenum and the proximal and distal halves of the colon. 
The inner and outer muscle layers, containing the myenteric plexus, were 
separated from the submucosa of the gut and fixed in 4% PFA for 4 hours on ice. 
 
Histology and Immunohistochemistry  
 For wholemount immunohistochemistry, tissues were fixed as described 
above, permeabilized in 0.5 % Triton X-100 at room temperature for 30 minutes 
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and blocked for 4 hours or overnight at 4°C in 1% BSA, 10% normal donkey 
serum and 0.1% Triton X-100 in PBS. After blocking, tissue was incubated in 
primary antibodies at dilutions given below, washed in PBS with 0.1% Triton X-
100, incubated with secondary antibodies and washed, with each step performed 
overnight at 4°C. For imaging, GI tracts and muscle strips were positioned flat on 
glass slides and cover-slipped with Aqua PolyMount (PolySciences). For 
immunohistochemistry on paraffin sections, 10.5 dpc embryos were fixed in 4% 
paraformaldehyde (PFA) in PBS overnight, and processing and histology 
performed using standard procedures (Presnell and Schreibman, 1997). The 
following primary antibodies were used: chicken-anti-GFP to detect green 
fluorescent protein (GFP) from the Foxd3GFP allele and also for yellow fluorescent 
protein (YFP) expression from the activated R26RYFP allele (1:500, Abcam), 
mouse-anti-β-III tubulin (1:500, Covance, TUJ1), mouse-anti-glial fibrillary acidic 
protein (GFAP) (1:500, Sigma), rabbit-anti-Foxd3 (1:500, Tompers et al., 2005), 
rabbit anti-fatty acid binding protein 7 (Fabp7) (1:500, gift from Dr. Thomas 
Muller), rabbit-anti-p75 (1:200, Promega), rabbit anti-protein gene product 9.5 
(PGP9.5) (1:1000, AbD Serotec), rabbit anti-S100b (1:500, Dako), and goat-anti-
Sox10 (1:20, Santa Cruz). Secondary antisera were purchased from Jackson 
ImmunoResearch: Cy2 donkey anti-chicken (1:500), DyLightTM 488 donkey anti-
chicken (1:500), Cy3 donkey anti-mouse (1:700), Cy3 donkey anti-rabbit (1:700), 
Cy3 donkey anti-goat (1:700), Cy5 donkey anti-mouse (1:500), Cy5 donkey anti-
rabbit (1:500), Cy5 donkey anti-goat (1:500). 4,6-diamidino-2-phenylindole, 
dihydrochloride (DAPI, 1:5000, Molecular Probes) was used to detect nuclei. 
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Immunohistochemical experiments were imaged using either an Olympus 
FV1000 laser scanning confocal microscope or a Zeiss Axio Observer A1 
fluorescence microscope and AxioCam MRc5 camera. 5-bromo-4-chloro-3-
indolyl-β-D-galactoside (X-gal) reactions (Nagy et al., 2003) and wholemount 
acetylcholinesterase (AChE) enzyme histochemistry (Enomoto et al., 1998) were 
performed as described and imaged with a Nikon SMZ-U stereomicroscope and 
Q-Imaging Micropublisher camera. 
 
Quantification of enteric cell types 
 To quantify proliferation in cells with Ednrb-iCre activity, GI tracts from 
14.5 dpc R26RYFP fate-mapped embryos were isolated, subjected to 
immunofluorescence for YFP and phospho-Histone H3 (pH3), and stained with 
DAPI as described above. Confocal images of non-overlapping fields were 
captured with a 40x objective, corresponding to ~0.1 mm2 per field (x,y) with an 
optical thickness (z) of 0.75 µm. The z-dimension image from each field that 
contained the highest number of YFP-expressing cells and therefore was 
presumably focused on the myenteric plexus, was digitally analyzed using 
MetaMorphTM software to determine the total number of YFP, pH3 or DAPI-
positive cells. Three random fields containing a minimum of 3000 cells were 
quantified in the duodenum and six semi-contiguous fields containing at least 
6000 cells were scored in the distal colon from each sample. To quantify enteric 
glia in adult gut muscle strips, the total number of S100b-positive cells and 
S100b and YFP-expressing glia were counted in 4-5 random 20x fields of the 
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duodenum from 3 control and 5 mutant animals and the distal half of the colon 
from 3 control and 4 mutant mice. Images were quantified using Photoshop 
software to compare YFP and S100b signals in individual and merged channels 
by two blind observers and are presented as the average percent of S100b-
positive cells that co-expressed YFP. Statistics were calculated as mean + 
standard error of the mean (s.e.m) and significance determined with a two-tailed 
Student’s t-test. 
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Results 
 
Foxd3 is expressed in enteric progenitors and progressively restricted to 
glia during ENS development 
 During early NC development (8.0-10.5 dpc), Foxd3 is initially expressed 
in all NC progenitors, but expression is extinguished in cranial and cardiac NC 
progenitors prior to their differentiation into mesenchymal lineages (Labosky and 
Kaestner, 1998; Mundell and Labosky, 2011). Although Foxd3 expression has 
been reported in the ENS at 10.5-13.5 dpc (Labosky and Kaestner, 1998; Perera 
et al., 2006; Teng et al., 2008), its expression during ENS development had not 
been investigated in detail or characterized with cell-type specific markers. 
Therefore, we examined Foxd3 expression in Wnt1-Cre; R26RYFP lineage-traced 
NC progenitors after their initial colonization of the foregut. At 10.5 dpc, Foxd3 
protein expression is detected in the nucleus of YFP-positive cells in the proximal 
GI tract (Figure 30 A-A”), consistent with its expression in nearly all NC 
progenitors at early stages of ENS development. To avoid difficulties inherent 
with antibodies generated from the same species and to label Foxd3-expressing 
cells throughout the cytoplasm, we examined immunohistochemical co-
localization of Foxd3 with GFP from the Foxd3GFP allele using cell-type specific 
markers. We used this approach previously to co-label Foxd3-expressing cells in 
the pancreas (Perera et al., 2006). To confirm that GFP from the Foxd3GFP allele 
precisely replicated endogenous Foxd3 expression, we examined GFP and 
Foxd3 protein expression with confocal microscopy during late ENS development  
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Figure 30. Foxd3 is expressed throughout ENS development.   
(A) Transverse sections through the proximal foregut of a Wnt1-Cre; R26RYFP 
(NC fate-mapped) embryo show co-labeling of YFP (green) and Foxd3 (red) 
expression at 10.5 dpc (A-A”, white arrowheads). (B-C) Confocal images of 
wholemount 16.5 dpc GI tract (B-B”) and postnatal day 14 gut muscle strips from 
the duodenum (C-C”) of Foxd3GFP embryos and mice showed expression of GFP 
from the Foxd3GFP allele (green) filling the cytoplasm of ENS cells with Foxd3 
protein (red) in nuclei. At both stages, Foxd3 protein expression largely 
overlapped with GFP-expressing cells (yellow arrows), and few cells expressed 
only GFP (white arrowheads) or Foxd3 protein (red arrowheads). Images in B-C'' 
were captured with a 40x oil objective. Scale bars = 100 µm.  
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in 16.5 dpc embryos and in gut muscle strips from postnatal day 14 (P14) 
animals. At both stages, Foxd3 protein was co-expressed in the nuclei of GFP-
positive cells throughout the ENS (Figure 30 B-B”, C-C”) indicating that Foxd3 
was expressed in ENS progenitors during and after enteric neuron and glial 
lineage segregation. We detected very few GFP-positive cells that lacked 
staining for Foxd3 protein, indicating the high fidelity of GFP expression in 
Foxd3-expressing cells. (Figure 30 B-C”). It is possible that Foxd3 expression is 
dynamically restricted within ENS lineages and rare Foxd3-negative, GFP-
positive cells represent a cell population that recently extinguished Foxd3 protein 
but have residual GFP expression. 
 To establish the identity of Foxd3-expressing cells within enteric ganglia 
we examined immunohistochemical co-localization of GFP with markers for NC 
progenitors, neurons and glia. Consistent with a role for Foxd3 in enteric 
neural/glial progenitors, at 16.5 dpc, GFP expression largely overlapped with 
expression of the low-affinity nerve growth factor receptor (p75NTR), a NC 
progenitor marker (Figure 31 A-A”). In addition to GFP/p75NTR double-positive 
cells, we detected a small population of GFP-positive cells that did not express 
p75NTR, suggesting they may have initiated differentiation (Figure 31 A-A”). At 
16.5 dpc, examination of GFP expression and the enteric neuron marker PGP9.5 
demonstrated that Foxd3-expressing cells were primarily located adjacent to 
neurons and very few GFP-positive cells co-expressed PGP9.5 (Figure 31 B-B”), 
indicating that Foxd3 was not expressed in differentiating neurons. A small 
number of GFP and PGP9.5 co-expressing cells were detected that displayed 
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Figure 31. Foxd3 is expressed in ENS progenitors but downregulated in the 
majority of enteric neurons. (A) Immunohistochemical detection of GFP from 
the Foxd3GFP allele (green) together with p75NTR (red) revealed expression of 
Foxd3 in enteric neural progenitors in the duodenum from 16.5 dpc embryos (A-
A”, yellow arrows) and in additional cells that did not express p75NTR (white 
arrowheads). (B-C) GFP expression in combination with PGP9.5 (red) 
demonstrated that Foxd3 protein was largely absent from most PGP9.5-
expressing enteric neurons in the duodenum at 16.5 dpc (B-B”). Yellow arrows 
identify a small population of cells that co-expressed GFP and PGP9.5 and white 
arrowheads indicate cells that expressed only PGP9.5. In postnatal gut muscle 
strips Foxd3 was expressed in cells adjacent to neurons, but was not detected in 
the majority of PGP9.5-expressing neurons (C-C”, white arrowheads). Images 
were captured with a 40x oil objective. Scale bars = 100 µm.  
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lower levels of GFP expression, consistent with the possibility that Foxd3 was 
recently downregulated in those cells. Further analysis of postnatal enteric 
ganglia confirmed absence of Foxd3 expression in neurons but confirmed Foxd3 
expression in cells closely associated with PGP9.5-positive (Figure 31 C-C”) or 
β-III tubulin (TUJ1) -positive neurons (Figure 33 B-B''').  
 The morphology and location of Foxd3-expressing cells was highly 
suggestive of an enteric glial identity. To address this possibility and determine 
whether Foxd3 expression is detected in differentiating glial cells, we examined 
co-immunodetection of the glial cell markers Sox10 and S100b with GFP from 
the Foxd3GFP allele at embryonic and postnatal stages. At 16.5 dpc, nearly all 
NCSCs and glia, marked by Sox10, were co-labeled with GFP (Figure 32 A-A'), 
demonstrating that Foxd3 is maintained in enteric progenitors and glia. By P14, 
co-localization of GFP and Sox10 indicated that Foxd3 expression is maintained 
in mature enteric glial cells (Figure 32 B-B’). Further immunohistochemical co-
labeling of GFP and the mature glial marker S100b also showed almost complete 
overlap with GFP expression from the Foxd3GFP allele at 16.5 dpc and P14 
(Figure 32 C, D). In addition, immunodetection with FABP7, a marker of 
immature and mature glia, and TUJ1, a neuronal marker, revealed a similar 
pattern of co-expression with Foxd3 in FABP7-positive glia but not neurons 
(Figure 33 A-A''', B-B'''). Together, these expression patterns demonstrated that 
Foxd3 was broadly expressed in enteric progenitors, progressively 
downregulated as cells underwent neuronal differentiation, and maintained in 
differentiated glia.  
 133 
 
 
 
 
 
 
 
 
Figure 32. Foxd3 expression is maintained in glia during ENS development.  
(A-B) GFP from the Foxd3GFP allele (green) was extensively co-localized with 
Sox10 (red) in glial cells at 16.5dpc (A-A”) and in postnatal gut muscle strips (B-
B”). Yellow arrows indicate cells with GFP and Sox10 co-expression. A small 
population of Foxd3-expressing cells did not co-express Sox10 (white 
arrowheads). (C-D) 16.5 dpc GI tracts from Foxd3GFP embryos (C-C”) and gut 
muscle strips from postnatal day 14 mice (D-D”) stained with antibodies to GFP 
(green) and S100b (red) confirmed Foxd3 expression in glial cells during 
specification of enteric lineages. Examples of cells that co-expressed GFP and 
S100b are indicated with yellow arrows. Red arrowheads indicate S100b-positive 
cells that did not show GFP expression. Images were captured with a 40x oil 
objective. Scale bars = 100 µm.  
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Figure 33. Characterization of Foxd3 expression with neural and glial 
lineage markers.  (A-B) Localization of GFP from the Foxd3GFP allele (green) 
with FABP7 (red) and TUJ1 (blue) demonstrated that Foxd3 was primarily 
expressed in FABP7-positive glial cells in the duodenum at 16.5 dpc (A-A’”). 
Similar restriction of Foxd3 expression in enteric glia (white arrowheads in B-B”’) 
was detected in postnatal gut muscle preparations from Foxd3GFP mice. Images 
captured with a 40x oil objective. Scale bars = 100 µm.  
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Spatiotemporal characterization of Ednrb-iCre activity 
 Previous tissue-specific deletion of Foxd3 within early, and presumably 
uncommitted, NC progenitors with Wnt1-Cre or Pax3Cre resulted in a complete 
loss of enteric progenitors (Teng et al., 2008; Nelms et al., 2011). Foxd3 
maintains neural potency of early NC by repression of mesenchymal 
differentiation (Mundell and Labosky, 2011); but it is not known whether Foxd3 is 
required in the sublineage of NC cells specified to generate enteric neurons 
and/or glia. The expression of Foxd3 we defined above led us to hypothesize that 
Foxd3 has later roles in ENS development, specifically within ENS progenitors 
and glia. To conditionally delete Foxd3 after specification of enteric NC and initial 
entry of vagal-derived cells into the GI tract, we obtained a transgenic mouse 
line, Ednrb-iCre from Dr. Myung Shin (Merck) through Dr. John Burke, then at 
Fox Chase Cancer Center, in which expression of Cre-recombinase is directed 
by an ENS-specific enhancer of Ednrb (diagram shown in Figure 34 A). This ~1 
kb enhancer is active after NC colonization of the foregut and small intestine 
(Zhu et al., 2004). The tissue specificity of Cre activity from this transgene was 
verified by breeding Ednrb-iCre mice with R26RlacZ or R26RYFP reporter mice in 
which Cre expression results in excision of a stop codon and expression of lacZ 
or YFP. In wholemount analysis of Ednrb-iCre; R26RlacZ embryos X-gal staining 
was faintly detected in the developing GI tract when ENS progenitors are 
approaching the cecum at 11.0 dpc (40-42 somite stage), and was not detected 
in embryos 10.5 dpc or younger (Figure 34 B-C’). Later, at 11.5 dpc, Cre activity 
was detected in developing ENS progenitors populating the GI tract from the 
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esophagus to the cecum (Figure 34 D-E’). Cre activity was also detected in 
discrete domains within the neural tube (Figure 34 F, G) as expected; however, 
activity within NC progenitors was limited to the GI tract and was not detected in 
other NC derivatives including NC in the OFT of the heart, skin, cranial ganglia or 
DRG (Figure 34 C-G).  
 
Ednrb-iCre activity is specific to vagal NC-derived cells 
 To determine if Foxd3 is expressed in cells with Ednrb-iCre mediated Cre 
activity, we evaluated Foxd3 protein expression in the duodenum versus colon 
from Ednrb-iCre; R26RYFP lineage-traced embryos. At 15.5 dpc, the vast majority 
of Foxd3-expressing cells in the duodenum show YFP expression (Figure 35 A) 
indicating Cre activity in enteric progenitors and differentiating glia. This 
expression pattern was similar to previously reported co-expression of this 
enhancer with Sox10 in vagal NC-derived progenitors (Zhu et al., 2004). 
Examination of Foxd3 and YFP expression at higher magnification revealed that 
a small fraction of Foxd3-expressing cells did not exhibit Cre activity (Figure 35 
A’), suggesting that a unique sub-population of Foxd3-expressing enteric 
progenitors did not activate the Ednrb enhancer.  At this stage, sacral NC-derived 
ENS progenitors are present in the distal colon and in the adjacent pelvic 
ganglia. While Ednrb expression has been reported in sacral NC (Delalande et 
al., 2008), it was unclear if the 1 kb enhancer region is expressed in both vagal 
and sacral ENS progenitors. Analysis of YFP and Foxd3 expression in the colon 
revealed two distinct populations of Foxd3-expressing cells: a predominant cell 
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Figure 34. Temporal activity of Cre-recombinase in Ednrb-iCre; R26RlacZ 
embryos during ENS development.  (A) Diagram of the construct used to 
generate Ednrb-iCre transgenic mice, details in Experimental Procedures 
section. (B-E) At 10.5 dpc, X-gal-positive cells were not detected in the GI tract 
from Ednrb-iCre; R26RLacZ embryos (B). Beginning at 11.0 dpc (40-42 somite 
stage), X-gal-positive cells were detected in the neural tube and faint beta 
galactosidase activity was observed in enteric NC progenitors (C, C’, arrow). At 
11.5 dpc, Ednrb-iCre is fully activated and Cre activity is detected in ENS 
progenitors throughout the GI tract to the level of the cecum (D, E, E’). Boxes in 
C and E shows field for C’ and E’ turned at 90° counterclockwise. (F, G) 
Dissection of neural tube and DRG from 11.5 dpc embryos show X-gal positive 
cells detected in distinct domains in the neural tube. X-gal positive cells were not 
detected in DRG (arrows in F, G). G is transverse view of neural tube shown in F. 
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Figure 35. Ednrb-iCre is active in vagal NC but not sacral NC during ENS 
development. (A-B) Wholemount immunohistochemistry at 15.5 dpc revealed 
that Foxd3 expression (red) in the duodenum overlapped extensively with Ednrb-
iCre mediated YFP expression (green) from the R26RYFP allele (yellow 
arrowheads in A, A’). Overlap of Foxd3 and YFP expression was reduced in the 
colon (B, B’) compared to the duodenum (A, A’) indicating increased numbers of 
Foxd3-expressing cells lacking Ednrb-iCre activity (white arrows A’, B’). (C-C’) 
Wholemount immunohistochemistry of a 14.5 dpc colon and lower urogenital 
tract for p75NTR (C) and Wnt1-Cre mediated YFP expression from R26RYFP (C’) 
identified NC-derived cells in both the proximal colon and pelvic ganglia (arrow). 
(D-D’) In Endrb-iCre; R26RYFP embryos, p75NTR expression labels sacral NC cells 
within the pelvic ganglia (arrow in D). Ednrb-iCre mediated YFP expression was 
not detected in p75-positive sacral NC cells in the pelvic ganglia (arrow in D’) but 
was present in vagal NC derived cells in the colon (D’). (E). Drawing illustrates 
orientation of the GI and urogenital tracts shown in C-D’. Red oval in drawing 
indicates location of sacral NC-derived cells in the pelvic ganglia and gray 
shading indicates vagal NC migration towards the terminal colon. b, bladder; dc, 
distal colon; PG, pelvic ganglia; pu, pelvic urethra; pc, proximal colon. 
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population co-expressing both Foxd3 and YFP, and a smaller population of 
Foxd3-positive cells lacking Cre activity (Figure 35 B-B'). The decreased overlap 
of Foxd3 and YFP expression observed in the colon versus the duodenum 
suggests two non-exclusive possibilities: that Ednrb-iCre activity is specific to 
vagal NC derived ENS progenitors and is not present in sacral NC, or a 
significant number of Foxd3-expressing cells do not express Cre and/or have 
delayed activation of the transgene. To determine if Cre activity was present in 
sacral NC derivatives, we examined expression of p75NTR in the sacral NC-
derived pelvic plexus and compared this to activation of the R26RYFP reporter 
with the NC-specific Wnt1-Cre transgene versus with Ednrb-iCre.  At 14.5 dpc, 
Wnt1-Cre fate mapped YFP-expressing sacral NC-derived cells were present 
within pelvic ganglia as marked by p75NTR (arrow, Figure 35 C-C'). In stark 
contrast, Ednrb-iCre mediated expression of YFP was not detected in pelvic 
ganglia, although YFP-expressing cells are detected within the colon in the same 
embryos (Figure 35 D-D'). These data suggest that Ednrb-iCre expression is 
limited to vagal NC derived ENS progenitors, and highlight the utility of this Cre 
transgene to label and examine the function of Ednrb-expressing vagal NC 
progenitors after their initial population of the GI tract independent from the sacral 
NC.  
 
Effect of deleting Foxd3 in ENS progenitors using Ednrb-iCre 
 Foxd3 is required for NC colonization of the GI tract and establishment of 
all ENS progenitors (Teng et al., 2008), but its role in later ENS development has 
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not been explored. To selectively delete Foxd3 within the vagal NC-derived ENS, 
we mated Foxd3flox/flox and Foxd3+/-; Ednrb-iCre mice to obtain Foxd3flox/+; Ednrb-
iCre (control) and Foxd3flox/-; Ednrb-iCre (mutant) mice (Figure 36). Embryos and 
mice were found in expected ratios for each genotype at all stages during 
development and as adults suggesting no lethality was caused by loss of Foxd3 
in the Ednrb-iCre lineage. Litters were monitored for general health and 
appearance of ENS disruptions including distal megacolon phenotypes. Foxd3 
ENS-mutant mice survive well into adulthood with overtly normal morphology of 
the entire GI tract. There were no differences in weight of control and mutant 
littermates (data not shown), suggesting little or no defects in nutrition, overall 
growth and general health of mutant mice.  
 To determine if enteric neurons were disrupted in postnatal (P11) or adult 
(6 week old) mice we performed wholemount analysis of cholinergic neurons 
labeled by acetylcholinesterase (AChE) activity. Cholinergic neurons were 
present in enteric ganglia throughout the GI tracts from control and mutant mice 
(Figure 37 A, B). While the AChE staining pattern revealed that the ENS formed 
in both control and mutant mice, the patterning of ganglia appeared to be slightly 
irregular in the mutant ENS, with larger spacing between ganglia. These findings 
are consistent with the possibility that subtle changes in distribution of AChE-
stained neurons could reflect developmental defects in ENS progenitors (Gianino 
et al., 2003). To better understand this result and verify that Foxd3 was absent in 
ENS-mutant Cre-expressing cells, we used wholemount immunodetection of 
Foxd3 and YFP expression in isolated GI tracts from 16.5 dpc embryos carrying 
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the R26RYFP reporter allele. In controls, the majority of Foxd3-expressing cells in 
both the duodenum and colon showed co-labeling with Foxd3 and YFP (Figure 
37 C, D, left panels), though a significant population of Foxd3-expressing cells 
did not show Cre activity. Surprisingly, in ENS-mutant embryos, we detected the 
emergence of a distinct Foxd3-positive ENS population that did not express Cre; 
despite the reduced number of YFP-expressing cells in GI tracts from mutant 
embryos, overall, numbers of Foxd3-expressing cells were similar between 
control and mutants in both the duodenum and colon (Figure 37 C, D). The 
normal numbers of Foxd3-expressing cells in mutants was not due to failure to 
delete Foxd3 in the Ednrb-iCre lineage; Foxd3 expression was not detected in 
YFP-expressing cells in the duodenum and only a few cells showed co-labeling 
in the colon, indicating efficient deletion of the Foxd3flox allele by Ednrb-iCre. 
These curious results suggested a cell-autonomous role for Foxd3 during ENS 
development (as indicated by reduced YFP expression) but also implied that a 
sub-population of Foxd3-expresssing ENS progenitors that does not express 
Ednrb-iCre may be expanding and compensating for the apparent reduction in 
Ednrb-iCre lineage cells. 
 
Foxd3 is required to maintain ENS progenitors during development 
 Because Foxd3 plays a prominent role in early NC development, and it 
appeared that although the ENS was functionally intact, there were patterning 
irregularities observed, we focused our analysis of Foxd3 ENS-mutant embryos 
to examine earlier developmental stages. To determine if Foxd3 is required for 
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Figure 36. Breeding strategy to generate mice with an ENS-specific deletion 
of Foxd3. Fate mapping was performed using either the R26RYFP allele or 
R26RlacZ allele to label Ednrb-iCre lineage cells in control and ENS mutant 
embryos and mice. Drawing by Jean-Pierre Saint-Jeannet, (University of 
Pennsylvania).
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Figure 37. Effect of deleting Foxd3 in ENS progenitors using Ednrb-iCre. 
(A-B) Wholemount acetylcholinesterase (AChE) histochemical staining of 
postnatal day 11 GI tracts revealed enteric ganglia in the duodenum (A) and 
colon (B) from both Foxd3flox/+; Ednrb-iCre (control, left panels) and Foxd3flox/-; 
Ednrb-iCre (mutant, right panels) mice. Mutant mice were viable and had normal 
gross morphology of the GI tract. (C-D) In control embryos at 16.5 dpc, Foxd3 is 
expressed in both YFP-positive Ednrb-iCre activated cells (yellow nuclei, 
indicated with yellow arrows) and in a smaller population of YFP-negative cells 
(red nuclei, indicated with red arrows) (C-D, left panels) in the duodenum and 
colon. In mutant embryos, Foxd3 expression is not detected in the majority of 
YFP-expressing cells (C-D, right panels). However, Foxd3 expression (red) was 
not reduced in the duodenum (C) or distal colon (D), despite severe reduction in 
the number of Ednrb-iCre-expressing (YFP+) cells (C, D), suggesting that a 
subpopulation of Foxd3-expressing ENS progenitors that does not activate 
Ednrb-iCre expression compensated for the loss of ENS progenitors in the distal 
colon. Scale bars = 50 µm. 
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proper migration, distribution, and patterning of vagal NC-derived ENS 
progenitors, we evaluated GI tracts from control and mutant embryos with Ednrb-
iCre activated R26RlacZ and X-gal staining from 11.5 dpc -15.5 dpc. After initial 
expression of Cre at 11.5 dpc in Foxd3flox/+; Ednrb-iCre (control) embryos, many 
X-gal positive cells were detected on the surface of the proximal GI tract to the 
level of the cecum-hindgut boundary, consistent with their identity as ENS 
progenitors (Figure 38 A, inset).  In Foxd3flox/-; Ednrb-iCre (mutant) embryos at 
11.5 dpc, X-gal staining was initially modestly reduced and X-gal positive cells 
were detected at caudal levels in the cecum similar to controls (Figure 38 B).  In 
contrast, direct comparison of X-gal labeling in Foxd3 mutant and littermate 
controls at 13.5 dpc demonstrated a pronounced decrease in the density of NC 
cells in the GI tract from mutant embryos compared to controls (Figure 38 C, D). 
Control vagal NC progenitors had migrated through the proximal half of the 
hindgut at 13.5 dpc (Figure 38 C). Despite their decreased numbers, Foxd3 
mutant cells migrated to a comparable level in the colon (Figure 38 C, D). By 
15.5 dpc, when control vagal NC cells have completed colonization of the GI tract 
to the distal end of the colon (Figure 38 E, E’), mutant X-gal labeled cells were 
severely reduced throughout the gut (Figure 38 F) and were not detected in the 
distal colon (arrow in Figure 38 F’). These data demonstrated a progressive 
reduction of ENS progenitors in mutant embryos that is more severe at caudal 
levels of the GI tract, and suggested a prominent role for Foxd3 in maintaining 
vagal NC-derived progenitors during ENS development. 
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Figure 38. Ednrb-iCre-expressing ENS progenitors were severely reduced 
in GI tracts from Foxd3 mutant embryos. (A-F) Lineage labeling in control 
Foxd3flox/+; Ednrb-iCre; R26RlacZ (A, C, E) and Foxd3flox/-; Ednrb-iCre; R26RlacZ 
mutant embryos (B, D, F) demonstrated that the density of Foxd3 mutant Cre-
expressing cells was progressively reduced throughout the GI tract from 11.5-
15.5 dpc. At 11.5 dpc, control NC populated the GI tract to the level of the cecum 
(A, inset arrowhead), and were located in the proximal colon at 13.5 dpc (C, 
arrow). At both 11.5 and 13.5 dpc, fewer Foxd3 mutant Ednrb-iCre lineage cells 
migrated to a similar caudal level in the GI tract compared to control embryos 
(arrowheads in inset for A, B, arrows in C, D). In control embryos, X-gal-positive 
cells colonized the distal colon at 15.5 dpc (E, E’, arrow). Foxd3 mutant ENS 
progenitors were reduced in number throughout the GI tract and were not 
present in the distal colon (F, F’). Arrows in E’, F’ indicate caudal extent of X-gal-
positive cell colonization in the distal colon. 
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Patterning and distribution, but not differentiation, of enteric neurons is 
disrupted in Foxd3 mutant ENS  
 Our previous work demonstrated that Foxd3 preserves neural potency of 
early NC progenitors (Mundell and Labosky, 2011). However, it was unknown 
whether Foxd3 maintains neural potency after cells are specified as ENS 
progenitors. The decrease in the number of Foxd3 mutant cells within the GI tract 
of Foxd3flox/-; Ednrb-iCre embryos and the irregular patterning of AChE staining in 
the GI tracts of postnatal mutant mice may indicate a similar role for Foxd3 in 
maintenance of enteric neurons. To examine the effect of the ENS-specific loss 
of Foxd3 on patterning and differentiation of enteric neurons during development, 
we used wholemount immunohistochemistry for R26RYFP and PGP9.5 in 14.5 
dpc embryos. Confocal analysis of GI tracts from control embryos revealed a 
dense meshwork of tightly packed PGP9.5-positive neurons present in the 
duodenum (Figure 39 A-A”). PGP9.5-expressing cells showed extensive but not 
complete overlap with YFP expression, suggesting that the majority of vagal NC-
derived enteric neurons arise from Ednrb-iCre-expressing cells (Figure 39 A-A”). 
In stark contrast, reduced numbers of YFP-expressing cells in the duodenum 
from Foxd3 mutant embryos was associated with alterations in the density and 
distribution of enteric neurons (Figure 39 B-B”). Similar expression patterns of 
YFP and PGP9.5 were detected in the colon from control and mutant embryos 
(Figure 39 C, D). Interestingly, despite a 48% reduction of YFP-positive cells in 
the duodenum (Figure 39 E) and a 72% reduction in the colon (Figure 39 F), the 
majority of mutant YFP-positive cells showed co-labeling with PGP9.5, 
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suggesting that neuronal differentiation was not overtly impaired by loss of 
Foxd3. This is perhaps not surprising, considering the restriction of Foxd3 
expression from differentiating neurons in control GI tracts described above 
(Figure 31), although these results support a different role for Foxd3 in ENS-
committed NC versus early multipotent NC progenitors (Mundell and Labosky, 
2011).  At 15.5 dpc, analysis of YFP and TUJ1 expression in control and mutant 
ENS confirmed defects in ENS patterning, and demonstrated a paucity of TUJ1-
expressing neurons in the duodenum (Figure 39 G, H). These data were 
consistent with the possibility that Foxd3 is required within Ednrb-iCre expressing 
cells for initial neuronal patterning during development. 
 
ENS progenitors require Foxd3 for proper glial cell differentiation and/or 
maintenance 
 Our data demonstrate that Foxd3 is initially expressed in ENS progenitors 
and expression is selectively maintained in differentiated glia during late ENS 
development, suggesting lineage-specific roles for Foxd3. Although Foxd3 ENS-
mutant mice show defects in patterning of enteric ganglia, differentiation of 
neurons was not overtly impaired. To investigate if Foxd3 was required for 
differentiation of ENS progenitors towards glial lineages, we examined 
expression of glial markers (S100b and Sox10) in Foxd3 ENS-mutant embryos 
and mice. At 16.5 dpc, analysis of S100b expression in the duodenum of lineage 
traced embryos revealed that, in contrast to control embryos (Figure 40 A-C), 
mutant Ednrb-iCre lineage (YFP-positive) cells showed limited
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Figure 39. Foxd3 is required for patterning and distribution but not 
differentiation of enteric neurons. (A-B) Characterization of neuronal 
differentiation in Endrb-iCre, R26RYFP fate mapped control (A-A”) and Foxd3 
mutant (B-B”) GI tracts. Confocal images of wholemount immunohistochemistry 
for YFP (green) and PGP9.5 (red) identified two populations of enteric neurons in 
control embryos: Ednrb-iCre derived neurons (yellow cells in A, yellow 
arrowheads) and a relatively smaller population of neurons that did not show Cre 
activity (red cells, red arrowheads). Both Ednrb-iCre derived and YFP-negative 
neurons organized into a regular meshwork pattern of developing ganglia in the 
duodenum from 14.5 dpc control embryos (A-A”). In Foxd3 mutant embryos, ENS 
patterning was dramatically disrupted and included areas of thin projections from 
fewer enteric neurons (B-B”). In the GI tract from mutant embryos, YFP-positive 
cells show extensive overlap with PGP9.5 (yellow cells n B), but the majority of 
enteric neurons do not show Ednrb-iCre activity (red cells in B). (C-D) Expression 
of YFP (green) and PGP9.5 (red) in the colon from 14.5 dpc control (C) and 
Foxd3 ENS mutant (D) embryos shows reduced numbers of YFP-expressing 
cells in the colon from mutant embryos. Most mutant YFP-positive cells were co-
expressing PGP9.5 (yellow arrowheads in D). In contrast to controls, very few 
YFP-positive and PGP9.5-negative cells were detected; indicating increased 
neuronal differentiation of mutant cells. (E-F) Quantification of YFP-expressing 
cells in the duodenum (E) and colon (F) from 14.5 dpc control and mutant 
embryos. Data represent confocal analysis of 3 (duodenum) or 6 (colon) non-
overlapping adjacent fields from 3 mutant and 3 littermate control embryos. All 
statistics are mean ± SEM, *(p< 0.05) comparing control to mutant. (G-H) 
Expression of YFP (green) and TUJ1 (blue, neurons) in control (G) and mutant 
(H) enteric ganglia within the duodenum from 15.5 dpc embryos showed similar 
neural patterning differences. Scale bars = 100 µm. 
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differentiation into enteric glia (Figure 40 D-F). At this stage, glial differentiation is 
not complete in the distal GI tract and S100b expression was only faintly 
detected in the colon of control embryos, so further analysis of glial differentiation 
in the colon was completed in adult ENS. Co-labeling of Sox10 with YFP in gut 
muscle preparations from the duodenum and distal colon of adult (2-3 month old) 
control and mutant mice showed that, in comparison to controls, numbers of 
Sox10/YFP double-positive cells were reduced in both duodenums (Figure 40 G, 
H) and colons (data not shown) from mutant mice compared to controls. 
Quantification of enteric glia, labeled by S100b expression, and YFP-expressing 
cells in the duodenum (n= 3 control and 5 mutant mice) and colon (n=3 control 
and 4 mutant mice) confirmed severely reduced numbers of differentiated glia in 
mutant Ednrb-iCre lineage cells compared to controls (Figure 40 I-L): S100b/YFP 
positive cells were reduced by 78% in duodenum (Figure 40 K) and 84% in the 
colon (Figure 40 L). Despite greatly reduced numbers of glia generated by the 
Ednrb-iCre lineage in mutants, the overall numbers of S100b-positive glia was 
similar to controls (Figure 40 I, J), consistent with our hypothesis that an 
independent population of ENS progenitors was somehow compensating for the 
loss of the Ednrb-expressing cells. Our results indicate that Foxd3 is required cell 
autonomously for proper differentiation and/or maintenance of enteric glia.  
 
Foxd3 is required cell autonomously for proliferation of ENS progenitors 
 During colonization of the GI tract, vagal NC progenitors proliferate 
extensively in order to generate the progenitor pool needed to complete their 
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Figure 40. Analysis of glial differentiation during ENS development in 
mutant and control embryos and mice. (A-F) YFP (Ednrb-iCre activity, green), 
and S100b (glia, red) expression in control (A-C) and Foxd3 mutant (D-F) 
duodenum at 16.5 dpc. Co-localization of S100b and YFP (yellow arrows) is 
diminished in mutant ENS. Red arrowheads indicate glia that do not express 
YFP. (G-H) Immunodetection of YFP (green) with Sox10 expression (glia) in the 
duodenum from adult control (G) and Foxd3 mutant (H) mice at postnatal day 14 
show reduced numbers of Ednrb-iCre lineage glia. Yellow arrows indicate co-
expression of Sox10 and YFP. (I-L) S100b/YFP double-positive enteric glia 
(yellow arrows) were depleted in the mature ENS from mutant mice (I) compared 
to controls (J). Data in K and L represent 3 independent experiments in which 
S100b-positive glial cells were counted in random fields from the duodenum (n= 
3 control and 5 mutant mice) and the colon (n= 3 control and 4 mutant mice).  
Scale bars = 50 µm. All statistics are mean ± s.e.m., *(p< 0.05). 
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migration through the gut (Simpson et al., 2007). The severe reduction of Ednrb-
iCre lineage cells we observed in mutant embryos may reflect a requirement for 
Foxd3 in proliferation and/or survival of ENS progenitors. To investigate the 
possibility that Foxd3 is required for proper expansion of the ENS progenitor 
pool, we monitored proliferation in the duodenum and colon from R26RYFP fate-
mapped control and mutant embryos using immunohistochemistry for phospho-
histone H3 (pH3), which labels cells during mitosis (Figure 41 A, D, G). In 
confocal images through the developing enteric plexus, all YFP-positive cells 
were scored as either pH3-positive or negative and ENS progenitor proliferation 
was calculated as the percent of Ednrb-iCre lineage cells that were also pH3-
positive. Additionally, the total number of proliferating cells in each field was 
determined by calculating the number of pH3-positive cells divided by the total 
number of DAPI-positive nuclei. At 14.5 dpc, proliferation of mutant YFP-positive 
cells in the duodenum was significantly reduced by 36% compared to control 
embryos (Figure 41 A, B, p=0.047). Despite reduced proliferation of YFP-positive 
cells, the overall percent of pH3-positive cells in each field was slightly increased 
in mutant embryos (Figure 41 C) due to increased numbers of proliferating cells 
that did not express Ednrb-iCre. This suggests that in mutants, non-Ednrb-iCre 
cells may compensate by increasing proliferation compared to control embryos. 
Analysis of proliferation in the colon at 14.5 dpc revealed that proliferation of 
YFP-expressing cells was decreased by 46% in mutants (Figure 41 D, E, 
p=0.046), while the overall percentage of proliferating cells in control versus 
mutant embryos was unchanged (Figure 41 F), supporting the hypothesis that a 
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sub-population of the ENS undergoes expansion to compensate for the loss of 
Cre-expressing Foxd3 mutant cells. As expected, the overall number of 
proliferating cells was increased in the colon versus the duodenum (Figure 41 B, 
C, E, F), likely due to increased numbers of uncommitted ENS progenitors in 
distal locations. Additional quantification of proliferation in the colon at 16.5 dpc 
showed a similar decrease in pH3- and YFP-expressing cells (Figure 41 G, H) 
and a slight, but not statistically significant, increase in the overall numbers of 
proliferating cells (Figure 41 I). These data demonstrate that Foxd3 is required at 
later stages to maintain proliferation of ENS progenitors and further suggests 
continued proliferation of non-Ednrb-iCre ENS cells. To determine if Foxd3 is 
required to maintain cell survival in ENS progenitors, we examined apoptosis 
with wholemount LysoTrackerTM Red staining in fate-mapped control and mutant 
embryos at 12.5 dpc. Although mutant Ednrb-iCre lineage cells were reduced in 
number compared to controls, very few YFP-positive ENS progenitors in GI tracts 
from both control and mutant embryos showed LysoTrackerTM Red staining (data 
not shown), suggesting that loss of Foxd3 did not affect survival of enteric 
progenitors. Together, these data clearly demonstrate that Foxd3 is required to 
maintain proliferation of vagal-NC derived ENS progenitors throughout the GI 
tract.  
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Figure 41. Foxd3 is required for proliferation of ENS progenitors.   
(A-C) Proliferating cells were labeled using immunofluorescence for pH3 in the 
duodenum from 14.5 dpc control (A, left panel) and Foxd3 mutant (A, right panel) 
R26RYFP embryos. Quantification of percent of YFP-positive and pH3-positive 
cells in the duodenum (B). Despite a clear reduction in the percent of proliferating 
YFP-positive cells in mutant embryos compared to controls (A,B), the percent of 
DAPI-positive nuclei that co-labeled with pH3 was increased in the duodenum 
from mutant embryos (C). (D-F). Immunofluorescence for YFP and pH3 in the 
colon from control and mutant embryos showed decreased proliferation of Ednrb-
iCre lineage cells in mutants (D). Quantification of the percent of YFP and pH3 
double-positive cells (E) and the percent of pH3-positive nuclei (F) in the colon 
from 14.5 dpc control and mutant embryos. Data in A-F represent confocal 
analysis of GI tracts from 3 mutant and 3 littermate control embryos. (G-I) 
Immunohistochemistry for YFP and pH3 in the colon from 16.5 dpc control and 
mutant embryos. Quantification of the percent of YFP and pH3 co-positive cells 
(H) and total proliferation (I) in the colon from control versus mutant embryos. n= 
3 control and 2 mutant embryos. 6 non-overlapping 40x confocal images were 
analyzed from each embryo. *(p< 0.05). Scale bars = 50 µm. All statistics are 
mean ± s.e.m., *(p< 0.05).  
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Discussion 
 
Foxd3 is required at multiple stages of ENS development 
 During migration, enteric NC progenitors undergo self-renewing divisions 
to maintain both neural and glial potency and generate a progenitor pool 
sufficient to form the entire ENS (Natarajan et al., 1999). Our previous work 
demonstrated that Foxd3 is essential in early NC progenitors for multipotency, 
self-renewal and generation of NC cells that are competent to enter the GI tract 
(Teng et al., 2008; Mundell and Labosky, 2011). However, its role in later ENS 
development was not known. Here, we present data to demonstrate that Foxd3 
expression is maintained in both enteric NC progenitors and in glia. Using a 
combination of fate mapping and a comprehensive examination of cell-type 
markers, we show that Foxd3 plays critical roles in maintenance of NC 
progenitors and glia throughout development of the ENS, and identify a 
subpopulation of Foxd3-expressing ENS progenitors that undergo regulative 
proliferation and differentiation to compensate for loss of Ednrb-iCre lineage 
cells. 
 Using a novel transgenic mouse line with an ENS-specific Ednrb enhancer 
directing Cre expression in NC cells after they populate the proximal GI tract, we 
generated mice in which Foxd3 was selectively deleted in vagal NC-derived cells. 
Without Foxd3, Ednrb-iCre lineage cells were progressively depleted in an 
anterior to posterior gradient in the GI tract. Our data support the hypothesis that 
Foxd3 maintains ENS progenitors in a proliferating and uncommitted state. In 
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mutant embryos, initial defects in neural patterning were associated with 
reduction of cell proliferation and loss of glial cells derived from the Ednrb-iCre 
lineage. Despite reduced numbers of cells, cell survival and overt differentiation 
of neurons was largely unaffected in Foxd3 mutant ENS. This suggests that 
without Foxd3, ENS cells that have committed to neural lineages may be 
unaffected, while proliferating neural/glial bi-potent progenitors acquire a neural 
fate and consequently lose glial potential. It is currently unclear if the initial neural 
patterning defects we observe in Foxd3flox/-; Ednrb-iCre embryos are directly 
related to the reduced numbers of neurons, or the depletion of glial precursors 
within the ENS. Our experiments do not rule out the possibility that Foxd3 has 
distinct cellular functions in proliferating ENS progenitors and later maintenance 
of enteric glia. While it is possible that the reduced numbers of Ednrb-iCre 
lineage cells in the distal GI tract from mutant embryos reflect migratory defects, 
our previous analysis of loss of Foxd3 in NC demonstrated that vagal NC cell 
migration was not overtly disrupted in vitro (Mundell and Labosky, 2011). 
 
Maintenance of proliferation and gliogenesis during ENS development 
 The precise molecular pathways in which Foxd3 functions to maintain both 
ENS progenitors and enteric glia are unclear. We propose a model in which 
Foxd3 is broadly expressed in self-renewing NCSCs within the gut and then 
downregulated in ENS progenitors as they undergo progressive differentiation to 
neuronal fates. For example, Foxd3 expression was downregulated as ENS 
progenitors differentiate into PGP9.5 enteric neurons, but was maintained in 
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p75NTR-expressing progenitors and S100b-positive glia well after initial NC 
colonization of the GI tract. Our data demonstrating that Foxd3 is required to 
maintain proliferation and glial differentiation, but not neuronal differentiation, are 
consistent with the temporal expression of Foxd3 and suggest that depletion of 
Foxd3 within ENS progenitors may be an important step in specification of 
enteric neurons. At present, the transcription factors and signaling pathways that 
regulate this dynamic expression of Foxd3 during ENS development are 
unknown.  
 Our experiments also demonstrate that the spatiotemporal expression 
pattern of Foxd3 is identical to expression of the transcriptional regulator Sox10 
during ENS development (Kuhlbrodt et al., 1998). Consistent with the overlapping 
roles for these two transcription factors in maintaining NCSCs, and Sox10 and 
Foxd3 function during segregation of neural and glial lineages, overexpression of 
Foxd3 or Sox10 inhibited neural differentiation in PNS derivatives (Dottori et al., 
2001; Kim et al., 2003). Strikingly, we demonstrate here that loss of Foxd3 in the 
Ednrb-iCre lineage resulted in depletion of Sox10 expression and loss of glial 
differentiation. The notion that Foxd3 is required to maintain Sox10 expression is 
further supported by our previous work demonstrating that Sox10 expression is 
reduced in Foxd3flox/−; Wnt1-Cre mutant embryos (Teng et al., 2008) and in vitro 
cultures of mutant NC (Mundell and Labosky, 2011). Because Sox10 is essential 
for the maintenance of NC progenitors (Southard-Smith et al., 1998; Paratore et 
al., 2002), and for differentiation and maturation of PNS glia (Britsch et al., 2001; 
Finzsch et al., 2010), it is tempting to speculate that the combined defects in 
 161 
maintenance of ENS progenitors and specification of enteric glia observed in 
Foxd3flox/-; Ednrb-iCre embryos are directly related to loss or reduction of Sox10. 
While it is possible that Foxd3 may directly regulate Sox10 expression, it is also 
possible that Foxd3 functions within a parallel pathway to maintain ENS 
progenitors. Recently, putative Foxd3 binding sites were identified within an 
evolutionarily conserved proximal promoter for zebrafish Sox10 (Dutton et al., 
2008), but functional binding or direct regulation of Sox10 expression by Foxd3 
has not been demonstrated. In principle, functional analysis of Foxd3 binding 
sites within the Sox10 promoter and transgenic overexpression of Sox10 in 
Foxd3 mutant embryos could help to resolve these questions and will be 
important future endeavors. 
 In addition to Sox10, other proteins may function with Foxd3 or in parallel 
to maintain ENS progenitor proliferation and glial differentiation. Both the Ednrb 
and Notch signaling pathways are important for maintaining undifferentiated ENS 
progenitors and the process of gliogenesis (Hearn et al., 1998; Morrison et al., 
2000b; Taylor et al., 2007). Previous reports demonstrated that Endothelin 3 
(Edn3) inhibits neuronal differentiation and maintains NCSCs in an 
undifferentiated state to allow for later glial differentiation (Hearn et al., 1998; Wu 
et al., 1999; Bondurand et al., 2006). Our data are consistent with the possibility 
that Foxd3 maintains Edn3 signaling through Ednrb in undifferentiated ENS 
progenitors and/or glia. Along similar lines, Notch signaling represses 
differentiation of ENS progenitors by inhibiting expression of the pro-neural 
transcription factor Mash1 while maintaining Sox10 expression (Okamura and 
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Saga, 2008). Strikingly, embryos with a NC-specific deletion of the Pofut1 gene, 
encoding an essential component of Notch receptor trafficking and activation, 
have defects in ENS progenitor proliferation, glial differentiation, and reduced 
numbers of Sox10-expressing cells; thus pheno-copying cell-autonomous 
changes we identified in Foxd3flox/-; Ednrb-iCre mutant embryos (Okamura and 
Saga, 2008). Further investigation of the precise pathways and mechanisms in 
which Foxd3 maintains ENS proliferation and gliogenesis will likely provide a 
more complete understanding of the transcriptional regulation mediating these 
discrete phases of ENS development. 
 
Activity of Ednrb-iCre is specific for vagal NC progenitors 
 In this study, we present the first characterization and use of an ENS-
specific transgenic Cre line that distinctly labels vagal NC-derived progenitors. 
We showed that Ednrb-iCre activity is first detected in vagal NC-derived cells at 
11.0 dpc as ENS progenitors migrated through the midgut and cecum. Using 
molecular markers in combination with fate mapping of the Ednrb-iCre lineage, 
we demonstrated that Ednrb-iCre labels the majority of Foxd3-expressing cells 
within vagal-derived ENS progenitors and thus not surprisingly, Ednrb-iCre 
lineage cells generate both neurons and glia during ENS development. The 
unique temporal expression of the minimal 1 kb enhancer region in Ednrb-iCre 
mice provides a novel molecular tool to examine the later functions of genes 
essential for early NC development after the initial establishment of vagal NC 
within the proximal GI tract.  
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 In addition, our finding that Ednrb-iCre expression specifically labels vagal 
NC, but not sacral NC, suggests that this novel Cre transgene could be utilized to 
identify molecular differences between vagal and sacral NC progenitors during 
development. Previous studies suggested that vagal and sacral NC have intrinsic 
differences in their ability to generate the ENS (Burns and Le Douarin, 1998; 
Burns et al., 2002). However, there is considerable controversy about the relative 
role of sacral versus vagal NC, primarily due to lack of specific molecular 
markers for each population. Despite having similar proliferation and migration 
properties in vitro (Delalande et al., 2008), heterotypic grafting experiments in 
chick demonstrated that vagal NC cells generated more ENS progenitors when 
transplanted to both vagal and sacral axial levels (Burns et al., 2002). This 
intrinsic difference in potential has been attributed in part to lower levels of Ret 
expression (Delalande et al., 2008). However, gene profiling of vagal versus 
sacral NC in neural tube explant culture failed to identify genes that were 
specifically expressed in either vagal or sacral NC (Delalande et al., 2008), 
indicating that identification of vagal and sacral NC after their migration into the 
gut may be required to definitively profile their gene expression and in vivo 
characteristics. Although there are a few markers specific to the vagal NC, 
including a Hoxb3 enhancer, which is expressed in a sub-population of vagal NC-
derived neurons but absent from enteric glial lineages (Chan et al., 2005; Lui et 
al., 2008), a specific and all-encompassing marker of vagal NC progenitors 
remains elusive. Thus, the relative extent of sacral NC contribution to the distal 
GI tract in mammals as well as intrinsic molecular differences between these two 
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NC populations is unknown. Our data suggest lineage labeling of Ednrb-iCre 
expressing cells would allow for prospective isolation and gene profiling of vagal 
NC-derived cells from the GI tract, potentially resolving some of these 
unanswered questions.  
 In contrast to previous characterizations of transgenic expression of the 
b3IIIa enhancer for Hoxb3 mentioned above, Ednrb-iCre is expressed in the vast 
majority of vagal NC-derived PGP9.5 and TUJ1-expressing neurons in the 
duodenum. In addition, our data demonstrate that Ednrb-iCre is expressed in 
S100b and Foxd3-positive glial cells during early stages of gliogenesis (14.5-16.5 
dpc). This indicates that Ednrb-iCre labels a larger population of the vagal NC-
derived cells within the GI tract than other specific markers. However, Ednrb-iCre 
does not appear to label all vagal-derived cells in the duodenum. An initially small 
population of Foxd3-expressing progenitors does not show Ednrb-iCre activity at 
15.5 dpc, and at later stages of ENS development (16.5 dpc to postnatal stages), 
this population slowly expands in control embryos. It is possible that this non-
Ednrb-iCre population represents a distinct sub-lineage of the vagal NC that 
primarily gives rise to glia during late gestation and postnatal development. In 
contrast, the Ednrb-iCre lineage encompasses cells that undergo earlier 
differentiation to both neural and glial lineages. Consistent with distinct phases of 
glial cell specification and temporal segregation of ENS lineages, most S100b or 
Foxd3-expressing cells demonstrate Ednrb-iCre activity at 15.5-16.5 dpc, 
however, in the adult ENS, Ednrb-iCre-lineage cells generated only ~60% of 
mature S100b-positive glia in the duodenum and ~30% of glia in the distal colon. 
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This discrepancy in the numbers of glia generated by the Ednrb-iCre lineage is 
likely due to dynamic changes in glial specification occurring between 15.5 dpc 
and early postnatal stages. Further experimentation is needed to determine if 
there are differences in developmental potency between Ednrb-iCre / Foxd3-
expressing cells and progenitors that express Foxd3 outside of the Ednrb-iCre 
lineage. 
 
Models of compensation in mutant ENS 
 One surprising finding from our work is that deletion of Foxd3 within the 
Ednrb-iCre lineage does not significantly disrupt patterning or function of the 
ENS. Despite initial disruption of neural patterning, AChE histochemistry 
revealed an overtly normal pattern of postnatal enteric ganglia, and lethality or 
obstructive bowel disease was not evident in postnatal or adult mutant mice. Our 
data demonstrate that ENS progenitors within the Ednrb-iCre lineage normally 
contribute the majority of neurons and glia within the developing ENS. Previous 
work demonstrated that deletion of the endogenous ENS-specific enhancer for 
Ednrb, which was used to generate the Ednrb-iCre transgene, resulted in loss of 
ENS precursors in the cecum and hindgut and postnatal death from megacolon 
(Zhu et al., 2004). This suggests that NC progenitors that activate this enhancer 
are critical for late stages of ENS development. However, in Foxd3 mutants, we 
demonstrate a profound shift in the relative contribution of enteric sub-lineages 
such that the ENS was primarily formed from non-Ednrb-iCre lineage cells. Our 
experiments establish that an independent population of ENS progenitors 
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expands in number following deletion of Foxd3 within the Ednrb-iCre lineage. 
Moreover, although proliferation was decreased in Cre-expressing cells, overall 
proliferation within developing enteric ganglia was unaffected and in some cases 
even increased. We propose that a unique sub-population of Foxd3-expressing 
progenitor cells underwent activation, regulative proliferation and differentiation 
into both neuronal and glial lineages in response to depletion of Ednrb-iCre 
lineage cells. Consistent with this possibility, cell-autonomous defects in Ednrb-
iCre lineage gliogenesis did not significantly alter the total numbers of 
differentiated glia at any stage of ENS development.  
 To our knowledge, our findings are the first to identify a sub-lineage within 
the ENS with the inherent capacity to respond to defects in other enteric lineages 
and compensate with altered proliferation and differentiation. However, the 
precise mechanisms or origin of the progenitors that mediate this compensation 
remain unclear. Our data are consistent with several non-exclusive models of 
compensation in Foxd3flox/-; Ednrb-iCre mice (Figure 42 A-C). First, we propose 
that there may be two distinct populations of NCSCs: Ednrb-iCre-expressing 
cells, and a sub-population of vagal NC cells that maintains Foxd3 expression 
but does not activate Ednrb-iCre expression (illustrated in Figure 42 A, left 
illustration). In response to unidentified signals during impaired development of 
mutant enteric ganglia, non-Ednrb-iCre-expressing NCSCs become activated 
and proliferate to generate the diversity of neurons and glia necessary to form a 
functional ENS (Figure 42 A, right). An important aspect of this model is that 
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expression of the minimal Ednrb enhancer was not activated in these cells as an 
obligate step in regeneration of the ENS.  
 Alternatively, Ednrb-iCre lineage cells may represent a more restricted 
transient-amplifying ENS progenitor population able to generate some neural and 
glial cells, but distinct from multipotent NCSCs present during initial colonization 
of the GI tract. In this model, activation of Ednrb may be essential for proper 
specification of distinct enteric cell types. While our data suggest the ENS in 
Foxd3flox/-; Ednrb-iCre mice contained neurons and glia that were quantitatively 
comparable to control mice, we cannot rule out the possibility that some enteric 
cell types were not generated by Ednrb-iCre lineage cells. This could result in yet 
unidentified, non-lethal defects in ENS function in Foxd3 mutant mice. Both 
scenarios are consistent with the notion that expansion of vagal NC-derived 
Foxd3-positive cells in mutants lead to the increased contribution of non-Ednrb-
iCre cells to the ENS.  
 Our analysis of Ednrb-iCre mediated fate-mapping in the colon from 13.5 
dpc control embryos indicated that Cre was not expressed in NC present at the 
leading edge of the NC wavefront (Figure 42 B, left panel). While Foxd3 
expression was absent from Ednrb-iCre lineage cells in mutant embryos (Figure 
42 B, right panel), there was a distinct population of Ednrb-iCre-negative, Foxd3-
expressing progenitors present in both control and mutant embryos. At this 
stage, sacral NC progenitors have entered the distal colon and migrate in a 
caudorostral direction, joining with vagal NC progenitors. Our data demonstrating 
increased non-Ednrb-iCre lineage proliferation and gliogenesis in both the 
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Figure 42. Non-exclusive models of compensation in Foxd3 mutant ENS.  
(A) Model 1: In control embryos (illustration on left), Endrb-iCre lineage cells 
(green) largely co-express Foxd3 (light green), and generate the vast majority of 
vagal NC-derived ENS. However, progenitors derived from the Endrb-iCre 
lineage (green) are distinct from a sub-population of Foxd3-expressing 
progenitors that does not express Ednrb-iCre (red). Loss of Foxd3 expression in 
the Ednrb-iCre lineage (right illustration) dramatically reduced proliferation and 
glial cell differentiation. In response to unidentified signals during impaired 
development of enteric ganglia, Foxd3-expressing cells become activated and 
proliferate to generate the diversity of neurons and glia necessary to form a 
functional ENS. Progeny of wavefront cells (far right in illustrations) are indicated 
by lines between cells. Enteric neurons that do not express Cre are shown in 
blue. (B) Possible compensation at the migration wavefront. Vagal NC cells that 
activate the 1 kb Ednrb promoter fragment may represent a more restricted 
transient-amplifying ENS progenitor population distinct from multipotent NCSCs 
present at the leading edge of the NC migration wavefront (images of migration 
wavefront in control and ENS-mutant embryos in B). As vagal NC cells undergo a 
specific cellular differentiation program they activate Ednrb-iCre expression, 
resulting in deletion of Foxd3 and impaired self-renewal. Mutant cells are rapidly 
replaced by NCSCs which generate neurons and glia without activation of Ednrb. 
Analysis of YFP, Foxd3 and TUJ1 expression in the colon from fate-mapped 13.5 
dpc control and mutant embryos revealed that Ednrb-iCre lineage cells represent 
a sub-population of NC present at the edge of the NC wavefront (left panel in B, 
yellow arrowheads). Foxd3 expression was absent from Ednrb-iCre lineage cells 
in mutant embryos (right panel in B, green arrowheads), however a distinct 
population of Foxd3-expressing progenitors was present in both control and 
mutant embryos (red arrowheads). (C) Model 2: Illustration showing control (left 
illustration) sacral NC compensation in Foxd3 mutant ENS (right illustration). In 
the absence of Foxd3, vagal NC progenitors (green, Cre+) are reduced in 
number, and sacral NC progenitors (red) expand to form the distal ENS. 
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duodenum and colon of Foxd3 mutant embryos suggest that sacral NC may not 
compensate for loss of Ednrb-iCre lineage cells in all regions of the GI tract. 
However, given that Foxd3 was deleted after vagal NC colonization of the 
proximal GI tract, it is also possible that the sacral NC progenitor pool expanded 
to form an increased proportion of the distal ENS (Figure 42 C). 
 
Implications for regenerative medicine 
 Recently, NCSC replacement has been suggested as a cell-based therapy 
for Hirschsprung’s disease and other GI neurodegenerative diseases (Kruger et 
al., 2002; Bondurand et al., 2003; Micci and Pasricha, 2007). However, 
therapeutic use of NCSCs for regeneration of the ENS will require a better 
understanding of the dynamic cellular properties of NC progenitors and the 
distinct sub-populations of NC that function to generate the ENS during 
development. The ability to activate intrinsic enteric NCSC populations to induce 
repair of congenital bowel defects is an intriguing possibility. However, before 
that possibility can be realized, it will be crucial to identify genes and signaling 
pathways controlling the self-renewal, migration and differentiation of ENS 
progenitor cells in vivo. Our findings demonstrate several crucial roles played by 
Foxd3 during ENS development including maintenance of the ENS progenitor 
pool, neural patterning and glial differentiation. In addition, our results suggest 
that distinct sub-lineages of ENS progenitors are intrinsically able to respond to 
ENS injury or disease.  
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CHAPTER V 
 
SUMMARY AND CONCLUSIONS 
 
 Understanding the molecular basis of multipotency and self-renewal is 
important for the ultimate goal of manipulating stem cells for treatment of 
disease. Our laboratory previously established that the forkhead transcription 
factor Foxd3 functions in both ESCs and TSCs to maintain stem cell properties 
and repress differentiation, suggesting a conserved molecular mechanism for 
stem cell self-renewal and multipotency. Here, I described experiments 
demonstrating a cell-autonomous requirement for Foxd3 in self-renewal and 
multipotency of NCSCs. Further, my studies provide evidence suggesting that 
Foxd3 functions as a critical regulator of fate potentials within distinct NC 
sublineages. 
 
Foxd3 is essential for NCSC multipotency and self-renewal 
 Upon their emigration from the neural tube, NC cells are morphologically 
indistinguishable from one another, yet this population of cells harbors both fate-
restricted cells and multipotent NCSCs. Molecules controlling NC multipotency 
and self-renewal or mediating cell-intrinsic distinctions between multipotent 
versus fate-restricted progenitors are poorly understood. Using a combination of 
in vitro clonal analyses and a NC-specific deletion in mouse embryos, I showed 
that Foxd3 maintains multipotent NC progenitors that generate neurons, glia, and 
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myofibroblasts. Individual Foxd3flox/-; Wnt1-Cre mutant NC cells underwent fate 
changes, losing neural and increasing myofibroblast potential. Additionally, loss 
of Foxd3 was coincident with decreased expression of the NCSC markers Sox10 
and p75NTR and impaired self-renewal of NC in neurosphere assays. My data 
indicate that Foxd3 maintains multipotency of NC by negatively regulating 
myofibroblast differentiation, thereby maintaining newly generated progenitors in 
an uncommitted multipotent state.  
 
Foxd3 controls context-dependent fate restriction choices in NC 
progenitors 
 Complementing these in vitro data, I demonstrated that Foxd3 is also 
essential in vivo for repression of mesenchymal cell fates and maintenance of 
neural lineage potential in newly-formed NC progenitors. Data from fate-mapping 
experiments suggest that Foxd3 is globally required for neural and glial 
derivatives, as NC-derived PNS cells from all anterior-posterior regions in the 
embryo (cranial, cardiac, vagal, sacral and trunk NC) were depleted or lost in 
Foxd3 NC-mutant embryos. In contrast, loss of Foxd3 resulted in accelerated 
mesenchymal differentiation in cranial NC and ectopic location of NC-derived 
VSMCs in the aorta, suggesting Foxd3 represses differentiation towards 
osteoblast, chondrocyte, and VSMC fates. These conclusions are further 
supported by data indicating that Foxd3 expression is rapidly downregulated in 
ectomesenchymal derivatives of NC and selectively maintained in PNS 
derivatives. 
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 Similarly, examination of later functions of Foxd3 in the ENS indicated that 
Foxd3 also regulates cell fate decisions during divergence of enteric neural and 
glial lineages. Foxd3 is expressed in most vagal NC progenitors after their entry 
into the GI tract, and then becomes progressively restricted to enteric glia, 
consistent with a role in maintaining ENS progenitors and glia. Analysis of 
Foxd3flox/-; Ednrb-iCre mutant embryos revealed that Foxd3 is necessary to 
maintain both proliferation of ENS progenitors and differentiation of glia. 
However, overt neural differentiation was unaffected in Cre-expressing cells in 
ENS-mutant embryos. Although the precise timing of neural versus glial 
specification in ENS has not been defined, it is clear that neurogenesis occurs 
well in advance of gliogenesis. Therefore, based on the timing of Ednrb-iCre 
expression (11.0 dpc), it is likely that neural fate was specified in many ENS cells 
prior to deletion of Foxd3. Although the lineage potency of individual Foxd3 ENS-
mutant cells was not tested, our results are consistent with the hypothesis that 
Foxd3 is required throughout ENS development to prevent lineage restrictions 
and maintain multipotency.  
 
Future directions 
 These findings support the model that NC progenitors undergo 
progressive restrictions in lineage potential. However, the precise timings of cell 
fate specification and the signaling pathways that establish lineage segregation 
remain poorly defined. Brian Nelms, a postdoctoral fellow in our laboratory, has 
engineered and used a lox cassette acceptor (LCA) allele, Foxd3LCA, and 
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recombinase-mediated cassette exchange (RMCE) system to insert a tamoxifen–
inducible Cre into the Foxd3 locus. This Foxd3ERCreT2 allele will be used to 
determine when and how developmental potency changes in Foxd3-expressing 
cells. By administration of tamoxifen at different times in embryonic development, 
Foxd3-expressing cells and their progeny can be identified and lineage traced in 
vivo. This genetic tool will be used to answer fundamental questions concerning 
the cellular and molecular nature of the relationship between Foxd3 and 
multipotency. Do Foxd3-expressing cells generate all NC lineages? When do 
Foxd3-expressing NC cells lose mesenchymal or neural potential? Additionally, 
NC cells could be isolated and characterized using the R26RYFP reporter and 
FACS. A combination of clonal analysis and microarray profiling of distinct 
populations of NC cells from Foxd3ERCreT2; R26RYFP embryos or mice could 
elucidate changes in gene expression associated with changes in developmental 
potential during NC development.  
 The mechanisms by which Foxd3 controls self-renewal and multipotency 
of NC are unknown, but are likely to involve the direct regulation of gene 
transcription. Although the specific targets of Foxd3 in NC progenitors are not yet 
defined, in principle a combined approach of ChIP-Seq (chromatin 
immunoprecipitation with high-throughput sequencing) and microarray analysis 
or RNA-Seq of NCSCs could begin the process of identifying the functionally 
important genomic binding sites for Foxd3. Our laboratory is in the process of 
generating mice that express an epitope-tagged Foxd3 allele (Foxd3FLAG-Foxd3) to 
be used for ChIP-Seq experiments. In addition, by combining 
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immunoprecipitation for Foxd3 with mass spectrometry analysis of proteins 
directly bound to Foxd3, it may be possible to identify NCSC-specific binding 
partners for Foxd3. 
 Lineage and differentiation analysis of Foxd3flox/-; Ednrb-iCre mutant 
embryos resulted in the discovery of a compensatory subpopulation within the 
ENS. Intriguingly, these cells appear to undergo regulative proliferation and 
differentiation into both neuronal and glial lineages in response to reduced 
numbers of ENS progenitors. Therefore, it is possible that this represents a 
distinct NCSC population that could be used therapeutically to repair or 
regenerate the ENS in the context of obstructive ENS disorders. Further, 
expression data suggest that this compensatory population may be identified on 
the basis of Foxd3 and Ednrb-iCre expression. Using the Foxd3LCA/RMCE 
system, our laboratory is generating a Foxd3mApple-Foxd3 allele. This novel tool 
could be used in FACS experiments to prospectively isolate ENS progenitors that 
express mApple-Foxd3 and do not derive from the Ednrb-iCre lineage. It would 
be especially interesting to evaluate the therapeutic potential of this ENS 
population by injecting them into the aganglionic region of the GI tract from a 
mouse model of Hirschsprung’s disease. 
 Together, my extensive analyses of Foxd3 gene function in the NC, 
NCSCs and ENS support the notion of a conserved role for this protein in 
multiple stem cell types and have identified a novel population of cells in the ENS 
that may be co-opted for therapeutic applications. In addition, my experimental 
evidence that Foxd3 regulates neural, glial and mesenchymal potency of NC 
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suggests that manipulation of Foxd3 expression may be important for 
development of therapeutic strategies to precisely control differentiation of 
NCSCs in vitro. While there is undoubtedly much to learn about the molecular 
regulation of NCSC multipotency and self-renewal, these studies provide a 
framework for future investigation of the molecular events involved in NC lineage 
determination with significant implications for potential NCSC-based replacement 
therapy.  
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